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Motor nerve injury results in a sequence of events known as Wallerian degeneration,
which takes 1 - 2 days in rodents. Wallerian degeneration is significantly delayed in the
naturally occurring C57BL/Wlds mutant mouse. The ability to produce compound action
potentials and the degradation of axonal material are delayed for up to 3 weeks following
nerve injury.
This thesis aims to examine the processes that occur after nerve section at
neuromuscular junctions of mutant Wlds and normal mice. Functional morphological
measurement of actively recycling synaptic vesicles at wild type nerve terminals using
the vital dye FM1-43 indicated that the loss of the ability to recycle synaptic vesicles
occurred within 24 hours, coinciding with disruption of neurofilament and SV2 proteins
(stained using immunocytochemical methods). In contrast, the degeneration of nerve
terminals in Wlds mice following nerve injury was significantly delayed, and once
initiated was further slowed, degeneration occurring between 3 and 10 days after
axotomy. The morphological appearance of Wlds nerve terminals after lesion differed
greatly from that of degenerating wild type terminals: Wlds terminals appeared to be
retracting from the endplate region rather than simply degenerating.
Electrophysiological recordings from degenerating junctions demonstrate that the delay
of degeneration/withdrawal from nerve terminals of Wlds mice is accompanied by a
coincident loss of synaptic function. These data indicate that, as in normal mice, the first
structural and functional changes to take place after nerve injury in mutant Wlds mice is
the disruption of nerve terminals at the NMJ. This thesis proposes that nerve terminal
retraction in the mutant mouse is caused by a withdrawal mechanism similar to that
observed during synapse elimination, a naturally occurring activity dependant
developmental phenomenon, rather than by classical Wallerian degeneration as
previously assumed. To test this hypothesis, botulinum toxin (which abolishes
neurotransmitter release) was administered to the nerve terminal region at the same time
as the nerves were lesioned. The results indicate that nerve terminal withdrawal still
occurs, but that it is reduced and further delayed in muscles treated with botulinum toxin
by 1.14 days, in comparison with denervated alone Wlds muscles.
Additional studies assessed the role of Schwann cells in nerve terminal withdrawal.
Terminal Schwann cells that overly the NMJ sprout in response to denervation, and have
been shown to guide axonal processes back to endplates during reinnervation.
Experiments were conducted to evaluate the Schwann cell reaction to the absence of
degeneration after nerve section, as observed during the first few days after axotomy in
the Wlds mouse. Schwann cell sprouts were present at various endplates in the mutant
mouse after nerve injury. However, when compared with denervated wild-type controls
there were fewer Schwann cell sprouts in the Wlds and sprouting in general appeared
less extensive. Thus, the presence of an intact nerve terminal and spontaneous activity
are sufficient to delay, but not abolish, Schwann cell sprouting in the Wlds mouse after
nerve lesion.
In sum, these studies provide an ideal opportunity for the further investigation of the
molecular and cellular mechanisms of synapse withdrawal.
ii
Acknowledgements
This thesis was only made possible with the help and support of many people throughout
course of my doctoral studies.
First, I would like to thank my supervisor, Richard R. Ribchester, whose ardent
enthusiasm for all things neuromuscular has managed to motivate and guide me through
the years. Our discussions were most helpful in formulating many of the ideas presented
in this thesis.
I would like to thank all my colleagues in the laboratory for making the lab a friendly
and interesting environment in which to work. Jacki Barry and Derek Thomson aided
me greatly with their technical knowledge, and I thank them for their assistance with
electrophysiological recording.
I would like to thank the technical staff of Medical Microbiology and the MFAA for
providing excellent care of the animals, and also thanks to Vivian Allison for putting up
with my experimental forays into tissue culture.
I would also like to thank Dave Price, my second supervisor, for initially motivating my
interest in neuroscience, and for his support when necessary. In addition, I would like to
acknowledge my fellow PhD students for accompanying me to the pub: Stuart Baker,
Darren Foster, Sue Cameron, Tom Gillingwater, Ellen Costanzo, Sinead Scullion,
Teresa Levers, and Julia Edgar.
I would like to thank my family for all their sympathy and understanding whilst 1 have
been doing this PhD - brief sojourns at Letterwalton have helped maintain some
modicum of sanity during my studies. Finally, and foremost, my love and thanks go to
Justine, whom has stood patiently by my side for these years. Without your support this
thesis would not have been possible.






Table of Contents iv
List of Tables and Figures viii
Abbreviations and Notations xi
Dedication xii
Chapter 1 - Introduction
1.1. Wallerian degeneration in the peripheral nervous system 2
1.1.1. Historical perspective 2
1.1.2. Description of process 5
1.1.3. Spatio-temporal sequence of Wallerian degeneration 8
1.1.3.1. Stump length dependency 9
1.1.3.2. Temperature dependency 10
1.1.3.3. Age dependency 10
1.1.3.4. Progression of nerve degeneration 11
1.1.4. Granular Disintegration of the Cytoplasm 12
1.1.5. Theory of Wallerian degeneration 13
1.1.6. Cellular responses of Schwann cells and macrophages 15
1.2. Peripheral nerve regeneration 18
1.2.1. Historical perspective 18
1.2.2. Regeneration of the peripheral nervous system 19
1.2.2.1. Schwann cell division 19
1.2.2.2. Cell body response 20
IV
1.2.2.3. Morphological response of the axon 21
1.3. The C57BL/Wlds mutant mouse 23
1.3.1. Retarded rates of degeneration 23
1.3.2. Molecular nature of the mutation 25
1.3.3. Biochemical and cellular events
during delayed axonal degeneration 27
1.3 .4. Nerve regeneration 29
1.4. Aims 31
Chapter 2 - Nerve terminal responses to axonal lesion in Wlds and wild type
mice
2.1. Introduction 33
2.1.1. Nerve terminal degeneration in wild type mice 35
2.1.1.1. Morphological degeneration 35
2.1.1.2. Functional degeneration 37
2.1.2. Nerve terminal degeneration in mutant C57BLAVlds mice 38
2.2. Materials and methods 40
2.2.1. Animal Care 40
2.2.2. Surgery 41
2.2.2.1. Transversus abdominus 41
2.2.2.2. Flexor digitorum brevis 41
2.2.3. FM1-43 Imaging 42
2.2.4. Immunocytochemistry 45
2.2.5. Repeated visualisation 46
2.2.6. Intracellular recording 46
2.2.6.1. Quantal analysis using high magnesium saline 47
2.2.6.2. Endplate potential analysis using p-conotoxin 47
v
2.2.6.3. Intracellular recording from identified junctions 48
2.3. Results 50
2.3.1. Functional and morphological assessment of
C57BL/Wlds nerve terminals after nerve section 50
2.3.1.1. FM1 -43 imaging 50
2.3.1.2. Neurofilament/SV2 imaging 65
2.3.1.3. Repeated visualisation of axotomized
Wlds nerve muscle preparations 76
2.3.2. Functional and morphological assessment of
wild type nerve terminals after nerve section 80
2.3.3. Electrophysiological assessment of
nerve terminal withdrawal in C57BL/Wlds mice after axotomy 87
2.3.3.1. Quantal analysis using elevated levels of magnesium 91
2.3.3.2. Endplate potential analysis using p-conotoxin 95
2.3.3.3. Intracellular recording from identified junctions 99
2.4. Discussion 100
2.4.1. Nerve terminal morphology following axotomy 105
2.4.2. Synapse withdrawal vs. degeneration 105
Chapter 3 - The role of activity in nerve terminal withdrawal following
axotomy in C57BLAVLDS mice
3.1. Introduction 119
3.1.1. Hypotheses 119
3.1.2. The role of activity in synapse elimination 120
3.1.3. Botulinum toxin 122




Chapter 4 - Reactive terminal Schwann cells at axotomized Wlds
neuromuscular junctions
4.1. Introduction 141
4.1.1. Aims and Hypotheses 146
4.2. Material and Methods 147
4.3. Results 149
4.4. Discussion 155
Chapter 5 General Discussion 158




List of Tables and Figures
Table 1: Time to loss of nerve excitability after nerve section 9
Table 2: Factional occupancy of axotomized endplates 54
Figure 1: Schematic diagram of the cellular and
molecular events ofWallerian degeneration 6
Figure 2.1: Structure and function of FM1 -43 43
Figure 2.2: FM1-43 staining at Wlds neuromuscular junctions 55
Figure 2.3: Occupied and unoccupied endplates
at axotomized Wlds neuromuscular junctions 56
Figure 2.4: Partial reduction in nerve terminal staining
at axotomized Wlds neuromuscular junctions 57
Figure 2.5: Fractional occupancy of axotomized
Wlds endplates as assessed by FM1-43 staining 58
Figure 2.6: Rate of loss of FM1-43 staining at
axotomized Wlds neuromuscular junctions 59
Figure 2.7: Punctate nerve terminal staining at
axotomized Wlds neuromuscular junctions 60
Figure 2.8: Variation in shape and size of
neuromuscular junctions 61
Figure 2.9: Effect of Endplate size on the withdrawal of
axotomized Wlds nerve terminals 62
Figure 2.10: Effect of Endplate shape on the withdrawal
of axotomized Wlds nerve terminals 63
Figure 2.11: Acetylcholine receptor intensity in occupied
and unoccupied regions of partially occupied endplates 64
Figure 2.12: Neurofilament and SV2 staining at
Wlds neuromuscular junctions 68
Figure 2.13: Fractional occupancy of axotomized
Wlds endplates as assessed by NF/SV2 staining 69
viii
Figure 2.14: Withdrawal of nerve terminal processes
from axotomized Wlds neuromuscular junctions 70
Figure 2.15: Occupied and unoccupied axotomized Wlds endplates 71
Figure 2.16: Comparison of fractional occupancy of axotomized
Wlds endplates as assessed by FM1-43 and NF/SV2 staining 72
Figure 2.17: Comparison of contralateral control and axotomized
Wld neuromuscular junctions 73
Figure 2.18: Withdrawal of nerve terminal processes results in the formation
of a retraction bulb at axotomized Wld5 neuromuscular junctions 74
Figure 2.19: Retraction bulbs at axotomized Wld5 neuromuscular junctions 75
Figure 2.20: Repeated visualisation of withdrawing
axotomized Wld5 nerve terminals 78
Figure 2.21: Repeated visualisation of withdrawing Wld5
nerve terminals 79
Figure 2.22: Visualisation of axotomized Wld5 nerve
terminals 9 hours ex vivo 80
Figure 2.23: FM1-43 staining at wild type mouse neuromuscular junctions 83
Figure 2.24: Fragmentation of FM1-43 staining at
denervated wild type neuromuscular junctions 84
Figure 2.25: FM1-43/NF/SV2 staining at denervated
wild type neuromuscular junctions 85
Figure 2.26: NF/SV2 staining at denervated
wild type neuromuscular junctions 86
Figure 2.27: Intracellular recordings from axotomized Wld5endplates 89
Figure 2.28: Miniature endplate potential frequencies
following axotomy of Wld5 endplates 90
Figure 2.29: Quantal analysis of axotomized Wld5 endplates 93
Figure 2.30: Variability of response of axotomized
Wld5 endplates to nerve stimulation 94
IX
Figure 2.31: Quantal analysis of failures at
axotomized Wlds endplates 97
Figure 2.32: Quantal analysis of failures at
identified axotomized Wlds endplates 99
Figure 2.33: Withdrawal of nerve terminal boutons
at axotomized Wlds neuromuscular junctions 104
Figure 2.34: Comparison of motor axon retraction bulbs 111
Figure 3.1: Withdrawal of nerve terminal processes from axotomized Wlds
neuromuscular junctions following botulinum buffer administration 129
Figure 3.2: Withdrawal of nerve terminal processes from axotomized
Wlds neuromuscular junctions following botulinum administration 130
Figure 3.3: Comparison of botulinum treated axotomized
and axotomized-alone Wlds neuromuscular junctions 131
Figure 3.4: Retraction bulbs at axotomized Wlds neuromuscular
junctions treated with botulinum toxin 132
Figure 3.5: Withdrawal of axotomized Wlds nerve terminals
in botulinum treated muscles 133
Figure 3.6: Rate ofWithdrawal following axotomy of
Wlds nerve terminals in botulinum treated muscles 134
Figure 3.7: Nerve terminal sprouts at axotomized Wlds
neuromuscular junctions treated with botulinum toxin 135
Figure 4.1: S-100 staining at Wlds neuromuscular junctions 151
Figure 4.2: Terminal Schwann cell sprouting at axotomized
neuromuscular junctions 152
Figure 4.3: Terminal Schwann cell sprouting is delayed
at axotomized Wlds neuromuscular junctions 153
Figure 4.4: Terminal Schwann cells progressively retract
at axotomized Wlds neuromuscular junctions 154
Figure 5.1: Mechanisms of synapse formation, withdrawal and maintenance 165
x
Abbreviations and Notations
BDNF brain-derived neurotrophic factor
BoTX botulinum toxin
CGRP calcitonin gene-related peptide
CNTF ciliary neurotrophic factor
EPP endplate potential
FDB flexor digitorum brevis muscle
FITC fluorescein isothiocyanate
GAP-43 glial associated protein 43
GDC granular disintegration of the cytoplasm
GFAP glial fibrillary acidic protein
IGF insulin-like growth factor
JE monocyte chemoattractant protein-1
LIF leukaemia inhibitory factor
MEPP miniature endplate potential
mRNA messenger ribonucleic acid
N-CAM neural cell adhesion molecule
NF neurofilament 2H3 protein
NGF nerve growth factor
NMJ neuromuscular junction
NT-4 neurotrophic factor 4
PBS phosphate buffered saline
SNAP-25 synaptosome-associated protein of 25kDa
SV2 synaptic vesicle protein 2
TA transversus abdominus muscle
TRITC tetramethylrhodamine B isothiocyanate
TTX tetrodotoxin
xi






The ancient Greek philosopher, Hippocrates, provided the first written description of
the peripheral nervous system as early as the 4th Century B.C., and later Herophilus
identified nerve tracts, tracing them to the spinal cord. In subsequent centuries,
studies of the peripheral nervous system provided insights into the workings of nerves
and nerve cells, but most scientists assumed that the nervous system, once developed,
was 'hardwired' and unalterable and doubted that nerve healing was possible. Thus,
without sufficient understanding of the anatomy, physiology and the regenerative
capacity of the peripheral nervous system surgeons were unable to deal with nerve
injuries and their subsequent repair. A plethora of studies in the past 150 years have
considerably broadened our knowledge in this area leading to the development of
various reconstructive strategies in treating nerve injury. One of the most fascinating
elements of the both the peripheral and central nervous system remains the ability of
axons and their endings, synapses, to respond to different stimuli with the remodelling
of their anatomical and physiological characteristics. Adult peripheral axons are able
to establish, withdraw, and re-establish synapses, grow and regenerate in response to
damage, and otherwise continually transform their structure and function in response
to different stimuli and to suit different environments. This thesis will attempt to
address certain aspects of the remodelling of peripheral synapses with the use of a
naturally occurring mutant, the C57BL/Wlds mouse, in which the phenomenon of
Wallerian degeneration is profoundly affected.
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Chapter 1
1.1 Wallerian Degeneration in the peripheral nervous system
Injury to axons results in an active process known as Wallerian degeneration. In the
peripheral nervous system focal damage to a nerve trunk triggers Wallerian
degeneration in the section of nerve distal to the site of injury. The nerve fibres
proximal to the injured area, which remain in continuity with their cell bodies, not
only survive but are also capable of regeneration. These principles were first
documented 150 years ago by an English physician named Waller, and provided
seminal insights into the organisation and function of nerves and nerve cells.
1.1.1 Historical perspective
It was once held that cells of the nervous system were intimately linked with one
another, and it was not until the late 19th Century that the advent of appropriate
staining techniques, pioneered by Camillo Golgi (1906) and advanced by Santiago
Ramon y Cajal (1905), firmly established the concept of the cell as an individual unit.
Thus, early neuroscientists considered the nervous system to be a syncytium of cells in
which the cytoplasm of individual neurons are united in an intricate reticulum, and
that separation of a section of axon from its cell body would not necessarily lead to
degeneration of that axon. Indeed, the experiments of Burdach (1837) illustrate this
point: he placed a ligature on the sciatic nerve of the frog and observed no alteration
of nerve fibres either above or below the constriction. However, it is now widely
accepted that severed distal axons of many types of neurons in mammals and some
lower vertebrates completely degenerate within a few days of axotomy. In two classic
reports Augustus Waller (1850, 1852) was the first to conclusively define the
phenomenon of secondary axonal degeneration, now know as Wallerian degeneration.
Waller demonstrated that a lesion to the frog hypoglossal nerve, which supplies the
tongue, resulted in a loss of both muscular contraction and sensation by three days
after nerve section. Histological examination of the nerve proximal to the lesion site, a
technically challenging task at that time, revealed a coagulated medulla which
eventually separated into pieces of various sizes which he termed ovoid bodies. The
axons at this time appeared discontinuous and granulated. Waller ascribed these
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observations to a degenerative phenomenon, hypothesising that the damaged fibres of
the distal stump were of no use in the process of regeneration. He proposed that
regeneration resulted from the production of new nerve fibres from the proximal, or
central, stump which remained connected with their cell bodies in the spinal cord. It
was their continuity and nutritive support that allowed the new fibres to rebuild the
distal segment, and restore function. According to Waller, the death of the axons of
the distal, or peripheral, stump was due to the separation of these axons from their
cell bodies, or trophic centres.
Ranvier made the first detailed descriptions of Wallerian degeneration in 1871. He
observed a contraction of myelin as early as two days after nerve section, which
subsequently transformed into elongated drop shaped entities (ovoid bodies). The
axons themselves became pale and granular, and fragmented into irregular spiral
segments. He supposed that the destruction of this 'conducting filament' brought
about both muscle paralysis and the transformation in the cells of Schwann: Schwann
cell nuclei became enlarged and divided, surrounding themselves with a thick
protoplasm. By 15 to 20 days all remnants of the axons had completely disappeared.
At this time Ranvier noted the appearance of migratory leucocytes, whose function it
was to collect the detritus of the old nerve. By 20 to 30 days Schwann cell nuclei had
diminished in their number, abandoning the central axial zone for a more marginal
position: thus forming a space to receive the newly generated axons. Ranvier called
this series of events the 'functional degeneration of the peripheral stump'. Bungner
(1891) carefully studied the mitotic phenomena of Schwann cells and observed that
they joined together tip to tip to form cordons or longitudinal bands that fill in the old
perimedullar sheath. He called these bands "Zellbander", and they have since become
known as the Bands ofBungner. These conglomerations of Schwann cells are thought
to provide an ideal growth substrate down which the regenerating axons can proceed.
The technical constraints of that era meant that it was often difficult to be sure of
clearly staining degenerating axonal processes. Thus, the observations of Waller,
Ranvier, and Bungner were by no means necessarily in full agreement with those of
their colleagues or each other, and it was not until the elegant studies of Ramon y
Cajal (1909, 1928) and his contemporaries that they were finally corroborated.
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Ramon y Cajal, using a silver staining technique (reduced silver nitrate), confirmed
many of the observations and theories of Waller and Ranvier, and conclusively
demonstrated that nerve degeneration and regeneration are intimately linked. He also
drew a distinction between the degeneration at the immediate site of the injury, and
that which takes places further down the axon. Wallerian or trophic degeneration, he
surmised, takes place in the peripheral stump when the stimulus from the nerve cell
body or trophic centre is interrupted. Traumatic degeneration arises in both the
central and distal stumps close to the vicinity of the nerve damage, and is a result of
acute trauma and subsequent phlogosis. Therefore, Ramon y Cajal was of the opinion
that in reality the distal segment presents two different types of degeneration:
traumatic and Wallerian degeneration.
The work of this century has clarified and detailed the process of Wallerian
degeneration, but the fundamental physiological mechanism remains to be validated.
The initial studies of Wallerian degeneration at the start of this century were primarily
morphological in nature and described the destruction ofboth axon and myelin sheath,
division of Schwann cells, and infiltration of macrophages from the circulatory
system. Subsequent investigations utilised electrophysiological techniques to
demonstrate that one of the first changes is the failure of neuromuscular transmission
and the loss of the ability to transmit a compound action potential along the distal
stump, which occurs 3 days after denervation in mice (Lissak et al., 1939). The
advent of electron microscopy in the 1950s also yielded further insights, elucidating
the disintegration of the axoplasm and its constituent components, and degradation
and phagocytosis of myelin debris. Modern studies use molecular,
immunocytochemical and a multitude of other techniques to examine molecular and
cellular events that take place during Wallerian degeneration. These studies will be
further addressed in context, in the subsequent sections.
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1.1.2 Description of process
Wallerian degeneration is a term that describes a distinct series of biochemical and
morphological events that occur following the separation of an axon from its cell body
(see Figure 1.1). Physical damage to nerves produces a variety of degrees of injury.
The effect of focal pressure on a single nerve fibre depends entirely on the severity of
the pressure applied. The peripheral nerve is surrounded by longitudinally orientated
collagen fibrils of substantial tensile strength, as well as basal lamina and the myelin
sheath produced by Schwann cells. In this way, the delicate construction of a single
axon is physically strengthened by its surroundings. Modest pressure applied briefly
and focally to a nerve will result in the compression of cytoskeletal elements and a
reduction in the calibre of the axon as a whole. This is a rapidly reversible process and
does not result in degeneration of the distal portion of the axon. In some cases, focal
pressure can distort the myelin overlying the nodes of Ranvier to produce a
conduction block without causing the degeneration of the axon: this is known as
nenrapraxia (Seddon, 1943). Greater pressure applied to the nerve results in the
displacement of both axonal constituents and myelin from the crush site, whilst the
surrounding basal lamina and collagen remain in continuity. This type of injury causes
the Wallerian degeneration of axons distal to the damaged region, and is often known
as a crush injury. Regeneration after nerve damage of this type occurs more often
because the extracellular matrix, comprising the basal lamina, remains intact and is an
ideal substrate for axonal elongation - as such it provides a preferred route for
regenerating axons. Transection of the entire nerve, including its connective tissue
components and basal lamina as well as the axons themselves, invariably results in
Wallerian degeneration. Nerve trauma of this kind often produces less favourable
conditions for regeneration; peripheral nerves are under substantial tensile stress and
after nerve section tend to separate a considerable distance. This gulf has to be
crossed by the regenerating fibres of the proximal stump before reaching the
facilitating growth substrate of the distal stump. Ramon y Cajal (1928) noted that, in
comparison with crush injuries, axonal sprouts often stray over considerable distances
and axon pathways are not as well defined after an injury of this type. Thus,
regeneration and complete restoration of function occurs less
5
Chapter 1
Figure 1: Schematic diagram of the cellular and molecular events of
Wallerian degeneration.
A. Normal myelinated axon with intact axonal cytoskeleton. The axon is
surrounded by myelin and associated with one Schwann cell per internode. The
dotted line represents Schwann cell basal lamina. Note the dense distribution of
neurofilament (NF), and the normal appearance of the cell body.
B. 24 hours after nerve injury. Nerve lesion creates a breach in axonal integrity,
which results in the release of chemotactic factors at the lesion site. The ends
of the distal and proximal axon rapidly reseal. The distal axon undergoes
granular disintegration of the cytoplasm (GDC), whilst the proximal axon
prepares for regeneration. Signals caused by the injury induce alterations in the
cell body, that ultimately lead to changes in gene activation and protein
expression; these prime the proximal axon for regeneration.
C. 48 hours after axotomy. The myelin sheath segments into structures known as
'early ovoids', which encapsulate the watery remnants of the axoplasm.
Schwann cells undergo longitudinal division and begin to phagocytose myelin
and axonal debris. Invading macrophages contribute to this process. The
proximal axon sprouts and advances across the lesion site. The growth cone is
supplied by newly synthesised proteins from the cell body.
D. From 7 to 14 days most myelin and axonal debris has been cleared and the
division of Schwann cells form a longitudinal scaffold, called the 'bands of
Bungner', which acts as a growth substrate to facilitate axonal elongation.
Nerve growth factor (NGF) and the NGF receptor are upregulated and, upon







frequently after nerve trauma of this sort. This thesis will be confined to the discussion
of Wallerian degeneration, without examining the phenomenon of neurapraxia.
After separation of the distal and proximal regions of the nerve, Wallerian
degeneration takes place in the distal section whilst the proximal stump prepares for
regeneration. Rupture of the axonal membrane results in the disruption of the ionic
balance of the axonal cytoplasm (the axoplasm). At the site of injury, the axoplasm
liquefies upon exposure to extracellular calcium (Hodgkin and Katz, 1949). This
appears to be limited to the local region of damage - the axoplasm does not liquefy
along the entire length of the axon, and is thus able to maintain structural integrity. A
decreasing gradient of damage with increasing distance from the lesion site occurs,
presumably influenced by cytosolic calcium buffering or sequestration/extrusion
(Emery et a/., 1987; Gross and Higgins, 1987). Ionic gradients are re-established
following the sealing of the axons, which occurs within 10-30 minutes. The re-sealing
process has been shown to be dependent upon calcium ions activating phospholipase
A2 (Schlaepfer and Bunge, 1973; Yawo and Kuno, 1983). Restoration of membrane
integrity results in a return to an appropriate ionic equilibrium and the damaged axon
is once more able to conduct compound action potentials by external stimulation (no
intrinsic evoked activity occurs after the nerve has been severed or crushed).
Large swellings form on either side of the lesion site within 5 hours of nerve injury,
formed by materials ferried along the axon by axonal transport and axoplasmic flow
(Blumcke, Niedorf and Rode, 1966; Tomatsuri, Okajima and Ide, 1993).
Mitochondria, vesicles and multivesicular bodies, and unidentified material accumulate
adjacent to the site of injury in the sealed end of each axon segment. More
pronounced swelling is apparent on the proximal side, where neurofilaments,
microtubules and microfilaments recently synthesised by the cell body and destined for




1.1.3 Spatio-temporal sequence of Wallerian degeneration
One of the first detectable events after nerve damage is the failure of neuromuscular
transmission, in conjunction with the precocious degeneration of nerve terminals at
the neuromuscular junction (Titeca, 1935; Lissak, Dempsey and Rosenbleuth, 1939;
Birks, Katz, and Miledi, 1960; Salafsky and Jasinski, 1967; Miledi and Slater, 1970).
Failure of neuromuscular transmission takes place after a period of quiescence, during
which it is still possible to elicit a compound muscle action potential by stimulating the
distal nerve. This is termed the post-axotomal lag or latency period and lasts 8 to 10
hours in the rat phrenic nerve (Miledi and Slater, 1970). During this time motor axons
and their terminals appear functionally and morphologically normal. However, after
this period nerve terminals begin to show signs of degeneration and neuromuscular
transmission fails. This occurs from 8 to 10 hours onwards after nerve section in the
rat phrenic nerve, until at 20 hours no endplates are able to transmit an action
potential to the muscle (Miledi and Slater, 1970). Neuromuscular transmission fails
abruptly at endplates, apparently without passing through an intermediate or
weakened stage; stimulation of degenerating nerves produces an all on nothing
response at the neuromuscular junction. The nerve action potential fails a day or two
later, at which time it is possible to detect axonal disintegration in the nerve trunk
(Weddel and Glees, 1941; Causey and Strattman, 1953; Luttges, Kelly and Gerren,
1976). The temporal distribution of Wallerian degeneration varies from species to
species (see Table 1).
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Table 1: time to loss of nerve excitability after nerve section
Species Nerve
Time to loss of nerve
excitability (days)
Reference
Rabbit Tibial 11/2 to 2 Gutmann and Holubar, 1950
Rat Sciatic 1 to 11/2 Miledi and Slater, 1970
Mouse Sciatic 1 to 2 Lunn er a/., 1989
Guinea Pig Sciatic 11/2to 2 Kaesar and Lambert, 1962
Cat Sciatic 3 Lissak et at., 1939
Baboon Lateral popliteal 4 to 6 Gilliat and Hjorth, 1972
Frog Sciatic 6 to 7 Levenson and Rosenbluth, 1990
Fluman Facial 4 to 7 Gilliat and Taylor, 1959
Adapted from Chaudhry. Glass and Griffin, 1992.
1.1.3.1 Stump length dependency
The length of the distal stump influences the duration of the interval before
neuromuscular transmission fails (Eyzaguirre, Espildora and Luco, 1952; Luco and
Eyzaguirre, 1955; Birks, Katz and Miledi, 1960; Miledi and Slater, 1970; Lubinska,
1982). Nerves with shorter distal stumps have a shorter post-axotomal lag before
cessation of neuromuscular transmission. The converse applies to nerves with longer
distal stumps. This length dependency phenomenon is not only determined by the
length of the extramuscular nerve, but is also a result of the length of the
intramuscular nerve branches: end plates further away from the intramuscular nerve
trunk degenerate more slowly (Miledi and Slater, 1970). In the rat, the length of the
latency period is increased by approximately 45 minutes for every additional
centimetre of distal nerve stump. This value is about 10 times greater in the
tenuissimus of the cat (Luco and Eyzaguirre, 1955).
The calibre and myelination of degenerating nerve fibres also influence the rate of
degeneration. Axons which are unmyelinated degenerate first, followed by small
myelinated fibres, with the largest myelinated axons degenerating later (Ranvier,
1878; Cajal, 1928; Weddel and Glees, 1941; Friede and Martinez, 1970; Lubinska,
1977). In comparison with large fibres, small fibres have a relatively larger surface
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area to volume ratio and a high rate of metabolism with limited energy reserves
(Gerard 1927; Brody, 1966), and therefore would be expected to degenerate first
(LoPachin etal., 1990).
1.1.3.2 Temperature dependency
The rapidity of Wallerian degeneration is also influenced by temperature. Nageotte
(1932) demonstrated that fragmentation of injured axons in vitro develops only within
certain temperature limits. Morphologic disruption of isolated fibres did not occur at
lower temperatures, or after a nerve had been heated to 45 °C. Subsequent studies on
the temperature dependency of Wallerian degeneration have provided additional
support for this hypothesis (Joseph and Whitlock, 1972; Torrey, 1934). Wallerian
degeneration is also altered in animals which are intrinsically cold-blooded:
degeneration is slower in frogs than in mammals, reflecting the cooler nerve beds, and
varies depending on the ambient temperature (Birks, Katz, and Miledi 1960). In some
instances in vivo mammalian Wallerian degeneration can vary depending on body
temperature. Long term survival of transected motor axons in the limbs of hibernating
squirrels has been reported (Albuquerque, Deshpande and Guth, 1978), where the
temperature is almost certainly low relative to 37 °C. The temperature dependence of
Wallerian degeneration suggests that the process may be regulated by enzymatic
degradation (see below, 1.1.4: Granular Disintegration of the Cytoplasm).
1.1.3.3 Age Dependency
Wallerian degeneration is affected by age. In the optic nerve of cats, the rate of
degeneration is considerably faster in kittens than in adult cats (Cook et al., 1974).
Wallerian degeneration in mice also appears to be influenced in the same way: the
sciatic nerves of mice show slightly decreased rates of degeneration and regeneration




1.1.3.4 Progression of nerve degeneration
The spatial sequence of degeneration within the nerve trunk of the distal stump has
been difficult to define in mammals, largely due to the remarkable rapidity of the
process, and remains a controversial issue. The debate arises as to whether axonal
degeneration proceeds from proximal to distal (centrifiigally), distally first with
subsequent centrifugal spread, or simultaneously along the length of the axon. In the
latter half of the 19th Century and the early part of this century several
neuroanatomists sought to resolve this problem. Their studies merely had the effect of
enhancing the controversy. Cajal (1909) and others (SchifF, 1856; Mitchell 1872)
supported the view that Wallerian degeneration evolves simultaneously along the
axon, and was contested most notably by the studies of Boeke (1916) who claimed
that degeneration proceeded in a centrifugal manner. Latterly Parker (1933) and
others (Causey and Strattman, 1953; Rosenbleuth and del Pozo, 1943), confirmed
Boeke's observations by demonstrating that loss of conductive capacity occurred in a
proximo-distal fashion. Yet more investigators provided evidence for simultaneous
degeneration (Guttman and Holubar, 1950; Levenson and Rosenbleuth 1990; Miledi
and Slater 1970; Salafsky and Jasinski, 1967). In a non-mammalian nerve, the
olfactory nerve of the Garfish, this issue has been clearly resolved. Degeneration
spreads in a proximo-distal fashion, with the axoplasm disappearing first near the site
of lesion with a rate that corresponds to slow axonal transport (Cancalon, 1982).
However, it appears that in this case the axon disappears as a result of continued
emptying of the distal stump via axonal transport rather than by degeneration. In
mammals, however, the origin of degeneration beyond the initial loss of nerve
terminals has been more difficult to pinpoint. If indeed there is a spatio-temporal
gradient in axonal breakdown it must have a very steep slope, and that the resolution
of certain techniques will have to be enhanced to truly clarify the situation. Some
confusion over the interpretation of results is to be expected however. Many studies
which describe the progressive Wallerian degeneration of the nerve in a proximo-
distal manner may in fact be describing the traumatic degeneration that inevitably
takes place in the first 2-3 mm from the site of nerve injury. Donat and Wisniewski
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(1973) divide the degenerating nerve into 3 zones: the traumatic zone (the first 1-2
mm from the lesion site), the peritraumatic zone (the next 2-3 cm), and the rest of the
nerve. In this study the traumatic and peritraumatic zones exhibit signs of organelle
accumulations and dense pellets, but the rest of the nerve did not have any apparent
gradient of degenerative changes before axonal degeneration, as would be expected if
the centrifugal hypothesis were correct. It appears most likely that, in mammals at
least, there is synchronous breakdown of the axoplasm along the length of the axon
after the initial loss of nerve terminals at the neuromuscular junction. A recent
electrophysiological analysis of injured human nerves supports this theory (Chaudhry
and Cornblath, 1992).
In contrast, it is clear that the responses of Schwann cells to degeneration, such as the
formation of ovoids and the clearance of myelin, proceed in a proximal to distal
manner (Causey and Palmer, 1953; Lubinska, 1977).
1.1.4 Granular Disintegration of the Cytoplasm
One of the pivotal events in Wallerian degeneration is the reduction of the axoplasm,
including cytoskeletal elements such as neurofilaments and microtubules, to granular
and amorphous debris (Donat and Wisniewski, 1973; Vial, 1958). This so-called
granular disintegration of the cytoskeleton (GDC) underlies the failure of both
neuromuscular transmission and nerve conduction, and the timing of GDC correlates
well with the physiological data previously described. For example, GDC occurs
abruptly along the length of the axon after a post-axotomal lag, in an identical
timeframe to the failure of the nerve action potential (Guttman and Holubar, 1950;
Levenson and Rosenbleuth 1990; Miledi and Slater, 1970; Salafsky and Jasinski,
1967). The latent period of GDC varies between species; axons of transected distal
stumps in young rodents are reduced to granular and amorphous debris within 24
hours (Miledi and Slater, 1970), whilst in baboons and humans the same process takes
several days (Gilliatt and Hjorth, 1972; Kaesar and Lambert, 1962). The axolemma
degenerates at the same time, leaving a myelin sheath that contains only watery
remnants of the axon. Microtubule dissolution precedes neurofilament degradation
(Schlaepfer 1974). GDC is thought to be triggered by endogenous neutral proteases,
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mediated by an injury induced rise in the free calcium concentration within the
axoplasm. Such an increase in intracellular calcium could result from either the entry
of extracellular calcium through calcium channels (George, Glass, and Griffin, 1995),
by the reversal of the sodium exchangers (Lopachin and Lehning, 1997), by failure of
calcium pumps, by breaches in the axolemma, or from the release of calcium that is
sequestered within the axon. Schlaepfer (1971, 1974) has demonstrated that chelation
of calcium (EGTA), or reduction of external calcium concentration prevented both
primary axonal alterations and associated linear fragmentation of myelin sheaths of
isolated nerves. Furthermore, degenerative changes were accelerated by the
introduction of a calcium ionophore (A23187) and by raising extracellular calcium
concentration (Schlaepfer 1971, 1977). Other investigators have identified a calcium
concentration threshold for complete loss of neurofilament medium and heavy chain
subunits as 0.20mM in organ cultures of mouse sciatic nerve (Glass, Schryer , and
Griffin, 1994). This property of calcium is thought to be mediated by the activity of
one or more calcium dependent proteases, known as calpains (Schlaepfer and
Zimmerman, 1984; Kamakura et al., 1983; Schlaepfer et al., 1985; George, Glass,
and Griffin, 1995).
1.1.5 Theory of Wallerian degeneration
The physiological mechanism by which Wallerian degeneration occurs remains subject
to speculation. Scientists such as Waller (1850), Scott (1906) and Cajal (1929)
assumed that the distal stump, upon separation from the trophic centre of the axon,
the cell body, literally starved to death due to lack of nutritive support. According to
this theory, motor nerve terminals degenerate after axotomy because their cell bodies
can no longer supply them with the essential cellular components to ensure the
maintenance of synaptic integrity and function. It has been well established that
varying the length of the degenerating section of nerve alters the latency period and
subsequently delays Wallerian degeneration. Miledi and Slater (1970) proposed that
this effect was due to the migration of an as yet unidentified substance along the nerve
which, upon arrival, influenced nerve terminal degeneration. It is probable that this
putative factor arrives in the nerve terminal via an active transport mechanism. This
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phenomenon can be explained in two ways. First, in support of the trophic theory,
nerve terminals require an as yet unidentified factor (or factors), which is synthesised
in the cell body and transported via fast axoplasmic transport down the axon. Use or
loss of this substance at the neuromuscular junction would have to be balanced by its
supply from the cell body. Interruption of the nerve would therefore isolate the nerve
terminal from the source of this factor and when the concentration falls below a
critical level, nerve terminal degeneration would ensue. A larger nerve stump would
contain more of the factor being transported to the nerve terminal and as such prolong
its survival. Miledi and Slater also outlined a different interpretation of this result,
namely that a deleterious process or signal engendered at the site of injury is
transported to the nerve terminal, and once there effects Wallerian degeneration.
Presumably this 'wound substance' would initiate an active disassembly and
degeneration of the nerve terminal, rather than death by starvation. Apoptosis, a
naturally occurring form of programmed cell death, is an active process that removes
inappropriate, senescent, damaged or abnormal cells that could interfere with organ
function or develop into tumours (Kerr, Wyllie and Currie, 1972). Raff and colleagues
(Jaconson, Burne and Raff, 1994) demonstrated that apoptosis can take place in the
absence of a nucleus, via a mechanism that probably involves the activation of cellular
proteases such as calpains (Squier et al., 1994). This has led some investigators to
hypothesise that Wallerian degeneration takes place by mechanism akin to cytoplasmic
apoptosis, (Lapper et al., 1994; Ribchester et al., 1995). In support of this theory,
Wallerian degeneration and apoptosis bear many similarities. First, apoptosis is
genetically regulated, and is thought to arise from an imbalance between positive and
negative regulators (such as Bcl-2 and Bax) which in turn leads to downstream
signalling and the activation of cellular proteases and endonucleases. Wallerian
degeneration may also be genetically regulated, as degeneration is delayed in a
naturally occurring mutant, the C57BL/Wlds mouse. Second, Wallerian degeneration
appears to be a calcium dependent process involving calpains (Schlaepfer and
Zimmerman, 1984), and some forms of apoptosis are also dependent on calcium and
calcium-activated proteases (Squier et al., 1994). Third, the ovoid bodies that develop
in the distal nerve as a result of Wallerian degeneration are reminiscent of 'apoptotic
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bodies', which form during apoptosis as a result of the packaging of degenerating
cellular constituents into membrane bound entities that are destined for phagocytosis
by neighbouring cells or macrophages. Finally, the time course of Wallerian
degeneration is similar to that of apoptosis; anucleate cells die within approximately
48 hours after the initiation of apoptosis (Jacobson, Burne, and Raff, 1994).
1.1.6 Cellular responses of Schwann cells and macrophages to Wallerian
degeneration
Schwann cells undergo prompt changes in the synthesis of myelin components
following axotomy. There is a dramatic reduction in the synthesis of myelin lipids
within the first 12 hours in the rat (White et al., 1989). After two days there is a
marked fall in mRNA content for many of the major myelin proteins, such as P0 and
myelin basic protein (Trapp, Hauer and Lemke, 1988; Mitchell et al., 1990), reaching
basal levels by 5 days after denervation. These changes demonstrate that the presence
of an intact axon is required for signalling myelination and myelin maintenance by the
Schwann cell; in nerves that fail to degenerate after injury (see below, 1.3: The
C57BL/Wlds mutant mouse), Schwann cells maintain their myelin and synthesise new
myelin (Thomson et al., 1991). In response to denervation, reactive Schwann cell
changes result in the withdrawal of Schwann cell cytoplasm and the collapse of the
myelin sheath. One of the earliest changes is the retraction of the myelin sheath from
the nodes of Ranvier (Causey and Palmer, 1953; Lubinska, 1977). The myelin sheath
separates into several short segments, which then collapse and fold around the cavity
originally occupied by the axon. These entities are called ovoid bodies. Each section
of myelin that forms an internode, belonging to one Schwann cell, collapses into six to
10 ovoids. After several days the ovoids condense and become separated by
intervening Schwann cell cytoplasm. This process takes place in the proximal region
of the distal stump first, before spreading distally (Causey and Palmer, 1953;
Lubinska, 1977). However, although the general advance of degeneration is proximo-
distal, there is no directional trend within individual internodes: ovoid bodies form in




Most of the degenerating elements of the distal nerve are cleared by phagocytosis
three weeks after nerve injury in the rodent. However, there remains some
controversy as to the origin of the phagocytic cells which mediate this process.
Previously it was assumed that Schwann cells digested the remnants of the axon and
myelin sheath (Btingner, 1891; Satinsky et al., 1964; see review: Sunderland, 1978).
In recent years it has generally been accepted that both macrophages and Schwann
cells may play a part in removing the end products of Wallerian degeneration. The
extent to which these cell types were responsible for myelin clearance was a difficult
issue to examine: investigators were unable to reliably distinguish between these two
cell types using morphological criteria alone (Abercrombie and Johnson, 1946;
Gibson, 1979). This led to speculation that Schwann cells and macrophages were
merely different morphological forms of the same cell (Weiss and Wang, 1945).
However, in the 1980s it became possible to selectively label macrophages with
antibodies such as F4/80 (Austyn and Gordon, 1981). With the use of this antibody,
Perry et al. (1987) demonstrated that there is a small population of irregularly
scattered resident macrophages in peripheral nerves, and that these were
supplemented by the infiltration of more macrophages from the circulatory system.
The recruitment of macrophages is thought to be initiated by the release of the
immediate early gene product monocyte chemoattractant protein-1 (JE) which is
synthesised by an as yet unidentified cellular subpopulation within the zone of trauma,
in response to nerve injury (Carroll, and Frohnert, 1998). JE is first detected at 1.5
hours after lesion, reaching maximal levels by 24 hours and persisting to 18 days.
Other studies demonstrate that in the rat sciatic nerve Schwann cell cytoplasm
contains small amounts of myelin debris at a time before macrophage recruitment
(Stoll et al. 1989), indicating that Schwann cells digest at least some myelin before the
arrival of macrophages, and in co-cultures with dorsal root ganglion neurons Schwann
cells are able to degrade myelin in the absence of macrophages (Fernandez-Valle,
Bunge, and Bartlett Bunge, 1995). In opposition to this, the experiments of Beuche
and Friede (1984) demonstrated that when degenerating nerve segments were
incubated within millipore chambers whose pore sizes were too small to admit
macrophages (0.22 pm) myelin debris remained for up to eight weeks. In contrast,
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nerves held within chambers that had pore sizes large enough to permit macrophage
entry (5.0 p,m) had normal myelin clearance. These investigators therefore claimed
that Schwann cells do not remove any myelin debris. Although this issue has not been
clearly resolved, a plausible rationalisation for these conflicting results would involve
the clearance of myelin debris in a biphasic manner, with Schwann cells digesting the
myelin sheath in the early stages of degeneration and the later stages of phagocytosis
and myelin lipid processing being performed by recruited macrophages (Ballin and
Thomas, 1969; Bigbee et al1987; Stoll et al., 1989; Goodrum et al., 1994; Perry
and Brown, 1992). The recognition of degenerating myelin by phagocytic cells
appears to be extremely specific - in a partially damaged nerve myelin that belongs to
undamaged axons is not phagocytosed, nor are the membranes of resident Schwann
cells, of which myelin is composed (Perry et al., 1987).
The importance of myelin clearance is twofold. First, 'pathway clearance' mediated by
Schwann cells and macrophages is an important step in allowing axonal regrowth. A
substance presented on the surface of the myelin sheath, called myelin-associated
glycoprotein (MAG), has been shown to be inhibitory for neurons in the central
nervous system (McKerracher et al., 1994) and degeneration of myelin, containing
MAG, is an essential prerequisite to nerve regeneration in the peripheral nervous
system - MAG inhibits nerve regeneration and antibodies to MAG reverse this
inhibitory effect (Schafer et al., 1996; Torigoe and Lundborg, 1998). Second,
phagocytosis of myelin debris recycles the lipids present in myelin for the purpose of
remyelination, after regeneration has occurred. Both Schwann cells and macrophages
phagocytose myelin, but most of the hydrolysis of myelin lipids takes place within
macrophages, and yields cholesterol and phospholipids (Rawlins et al., 1970, 1972;
Goodrum et al., 1995). These are complexed to a lipid carrier molecule called
apolipoprotein E, and transferred to Schwann cells for reutilization in the synthesis of
new myelin (Ignatius et al., 1987; Boyles et al., 1989; Goodrum et al., 1995).
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1.2 Peripheral Nerve Regeneration
1.2.1 Historical perspective
Although Waller's contemporaries did not doubt his observations of degeneration
after nerve trauma, many questioned his supposition that function was restored by the
regeneration of nervous fibres arising from the central stump. Indeed, Waller's
hypotheses initiated a debate that lasted nearly 60 years. The dispute centred around
two polarised doctrines, which were as follows: the theory of continuity or
monogenist hypothesis and the theory of discontinuity or polygenist hypothesis. The
adherents to the monogenist doctrine up held Waller's principles, believing that the
regenerated fibres of the periphery were formed by the elongation of the intact fibres
of the central stump. Polygenists maintained that regenerated fibres were formed by
the differentiation and transformation of the cells of the distal stump. This theory
states that these cells produce segments of axons which constitute a chain, and that
during the process of regeneration these links ultimately unite to form continuous
conductors. Phylippeaux and Vulpian (1859) were the first polygenists to contest
Waller's theories. They asserted that in young mammals and birds the distal stump
regenerated after nerve lesion, but was at all times anatomically separated from the
proximal stump. Phylippeaux and Vulpian concluded that the distal stump was
therefore able to regenerate independently. They named this phenomenon autogenous
regeneration. Bethe (1899), agreed with these findings and contrived further
experiments by which he claimed proved this theory beyond reasonable doubt. After
sectioning the nerve he arranged the severed ends so that there could be no physical
contact and therefore no possibility of physiological continuity. Once regeneration had
taken place he examined the region between the proximal and distal stumps and
observed no new nerve fibres bridging the gap. Stimulation of the distal stump
produced contractions in the muscle, whilst stimulation of the central stump in the
same preparation produced no response: Thus, the distal portion of the severed nerve
had regenerated independently of the proximal stump. Many investigators had
observed the division of Schwann cells within the distal stump after nerve injury, and
18
Chapter 1
Bethe claimed that the newly formed nerve fibres arose from the differentiation of
these cells. The debate was only settled with the advent of the reduced silver nitrate
staining technique, which was the first reliable axonal stain. The polygenist doctrine
was firmly refuted by the experiments of Ramon y Cajal (1909), who clearly observed
axon sprouts emerging from the central stump and growing into the distal stump, and
Harrison (1910), who was the first to demonstrate the new growth of axons in tissue
culture.
1.2.2 Regeneration of the peripheral nervous system
Wallerian degeneration leads to the removal and recycling of axonal and myelin
derived material to create the appropriate local environment for the regeneration of
axons from the proximal stump. As previously mentioned, before nerve regeneration
can proceed the remaining debris, collapsed myelin and the remnants of the axon,
must be cleared away. This is a pivotal step in the regeneration of peripheral nerves.
Subsequent changes in Schwann cells and macrophages lead to the presentation of a
favourable environment for the regrowth of axons from the proximal segment.
Alterations in the molecular machinery of the cell body downregulate proteins
normally associated with cellular stability and upregulate proteins necessary for
growth, readying the proximal axons for elongation.
1.2.2.1 Schwann cell division
Following degradation and extrusion of their myelin sheaths Schwann cells de¬
differentiate and divide (Cajal 1928; Abercrombie and Johnson, 1946). Cell division
occurs in two waves. The first wave peaks at around four days in cats and rodents
(Pellegrino et al., 1986; Clemence et al., 1989). The second wave of Schwann cell
mitosis becomes evident 14 days after the time of injury (Pellegrino and Spencer,
1985). The total number of divisions depends upon the original distance between
Schwann cell nuclei; Schwann cells that were originally in close proximity divide only
a few times whilst those that were further apart divide many more times (Thomas,
1948). Therefore, Schwann cells of myelinated fibres with long internodes produce
more daughters cells. These observations suggest that mitosis continues until a
relatively short distance between Schwann cells is achieved, and their cytoplasmic
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processes become interlaced (Spencer et al., 1979). The first Schwann cell division
takes place in the central area of the internode close to the Schwann cell perikaryon,
and divides the old internode into two cells. Subsequent divisions take place until a
continuous tract is formed in line with the original basal lamina, consisting of inter¬
linking Schwann cells processes. This can be observed as a longitudinal band (the
Bands of Btingner) along which regenerating axons grow (Thomas, 1964), and is
thought to provide a favourable substrate for axonal elongation (see below).
The precise signal that stimulates Schwann cell mitosis is unknown, although it is
thought that both nerve degeneration products and macrophage infiltration stimulate
the first mitotic peak. In cultures, axonal membrane and myelin debris can promote
Schwann cell mitosis (Salzer et al., 1980; Yoshino et al., 1984; Meador-Woodruff et
al., 1985) Macrophages that have digested myelin membrane release a soluble
Schwann cells mitogen (Baichwal et al., 1988), and TGF-p, which is a macrophage
product, stimulates the Schwann cells division in vitro (Ridley et al., 1989). The
second wave of Schwann cell mitosis probably occurs in response to nerve
regeneration and stimulated by axonal contact (Salzer and Bunge, 1980; Pellegrino
and Spencer, 1985).
1.2.2.2 Cell body responses
At the same time as these changes are taking place in the distal stump, the neuronal
cell bodies activate and prepare for regeneration. Within the first few hours the early
response genes c-fos and c-jun and the low affinity nerve growth factor receptor are
expressed (Jenkins and Hunt, 1991; Wu, 1996). The main early morphological events
are chromatolysis, which is the dispersal of the Nissl substance due to the
disintegration of large granular condensations of rough endoplasmic reticulum, and
the migration of the nucleus to an acentric position (Barr and Hamilton, 1948;
Watson, 1968). These observations are indicators of increased mRNA and protein
synthesis and signify that the neuron is entering a growing state. Following nerve
injury cellular concentrations of tubulin and actin, structural proteins involved in
axonal growth, and growth associated proteins such as GAP-43 increase (Skene et
al., 1986; Tezlaff et al., 1988). The pattern of synthesis of cytoskeletal components
recapitulates that observed during development. It is probable that these changes are
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initiated when a putative trophic factor is no longer conveyed via fast retrograde
transport to the neuronal cell body (reviewed in Cragg, 1970; Richardson and Verge,
1986), or from the arrival of an injury-induced factor (Ambron and Walters, 1996).
These changes have the effect of preparing the cell body and proximal axon for
regeneration, and if a subsequent lesion is made at this time the growth response is
faster than if only a single lesion had been created originally (McQuarrie, 1973, 1979;
Lankford, Waxman, and Kocsis, 1998). In this paradigm the second lesion is known
as a conditioned lesion.
1.2.2.3 Morphological response of the axon
Axons begin to send out processes from the terminus of the proximal stump as early
as 5 hours after axotomy (Tomatsuri, Okajima and Ide, 1993). The first sprouts
usually originate from the terminal nodes of Ranvier, through the gap left by the
partial retraction of Schwann cells (Friede and Bischausen, 1980). Within a few days
regenerating axons grow down the endoneurial sheath at a rate of approximately
4mm/day in the rat sciatic nerve (Forman and Berenberg, 1978). This is equivalent to
the rate of slow axoplasmic transport, and has led some investigators to propose that
axonal growth is limited by the supply of actin reaching the growth cone (Wujek and
Lasek, 1983).
Neurites are known to be attracted by degenerated peripheral nervous system tissue
(Kuffler, 1986) and the distal stump may provide trophic support during axonal re-
growth (Politis, Ederle, and Spencer, 1982; Politis, 1985). Schwann cells are also
thought to play a major role in the guidance and support of regenerating axons. In
some cases, Schwann cells form a cellular bridge spanning the gap between the ends
of the severed nerves (Abercrombie and Johnson, 1942). In vitro experiments have
demonstrated that several components of the Schwann cell basal lamina sheath, such
as laminin, fibronectin and the heparin sulfate proteoglycan complex, provide growth
substrates for regenerating axons (Rogers et al., 1983; Jessel, 1988). Schwann cells
produce neurotrophic factors which promote the survival and extension of axons re-
growing into the distal stump. Schwann cells synthesise NGF and NGF receptors,
peaking at 24 hrs and persisting for at least 2 weeks after nerve injury (Heumann et
al., 1987). This synthesis is stimulated by the presence of the cytokine interleukin-1,
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produced by infiltrating macrophages (Lindholm et al., 1987). NGF is a trophic factor
that supports axonal regeneration in specific susceptible neurons, and it is thought that
NGF receptors immobilise NGF protein on the Schwann cell plasmalemma to
facilitate axonal elongation (Johnson, Taniuchi, and Di Stefano, 1988; Taniuchi et al.,
1988). Schwann cells also express brain-derived neurotrophic factor (BDNF) and
ciliary neurotrophic factor (CNTF) which have been shown to promote axon growth
and may act as lesion factors after nerve injury (Acheson et al., 1991; Stockli et al.,
1989; Sendtner et al., 1992, 1994). BDNF increases to several times the normal level
by 4 days after axotomy, reaching maximal levels 4 weeks later (Meyer et al., 1992).
CNTF, however, is present at a high level in Schwann cells of intact nerves, and is
downregulated after axotomy (Rende et al., 1992; Sendtner et al., 1992). CNTF
disappears from Schwann cells 30-60 days after denervation and re-appears with re-
innervation (Smith et al., 1993). This suggests that CNTF is only synthesised when
axonal contact is re-established. The administration of both these factors, by injection
or osmotic minipump, improves the functional regeneration of the rat sciatic nerve
(Lewin et al., 1997; Cheng et al., 1998). In a recapitulation of the developmental
environment, Schwann cells re-express certain cell adhesion molecules such as LI and
N-CAM, which have been shown in cell cultures to improve the rate of axonal growth
(Martini and Schachner, 1988). Tenascin-C, an extracellular matrix glycoprotein, is
strongly expressed by Schwann cells after nerve section and appears to be essential
for the growth of axons in the distal stump (Fruttiger, Schachner, and Martini, 1995),
and a lipid carrier molecule, apolipoprotein E, can modulate neurite outgrowth
(Handelmann et al., 1992). Therefore, it is apparent that Schwann cells are a
fundamental component in the support and growth of axons along the distal stump
during peripheral nerve regeneration.
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1.3 The C57BL\Wlds Mutant Mouse
Wallerian degeneration is a rapid and concise process that occurs after nerve damage.
The physiological mechanism by which axons degenerate after nerve lesion remains
subject to speculation. The two main theories favour either passive degradation due to
loss of some trophic factor, or a more active mechanism in which the axon initiates its
own demise following nerve injury. One aspect of degeneration has recently come to
light - Wallerian degeneration is under genetic control. Lunn et al. (1989), during
their investigation into the role of macrophages in Wallerian degeneration, discovered
by chance that the strain of mouse they were using, C57BL/01a, had remarkably
retarded rates of Wallerian degeneration. This naturally occurring mutant mouse
strain, now called C57BLAVlds, carries a mutation which considerably slows the
degenerative phenomena that occur after nerve section. The normal allele has been
named 'Wld' for Wallerian degeneration and the mutant is called 'Wlds', where s
denotes 'slow Wallerian degeneration'.
1.3.1 Retarded rates of degeneration
Distal Wlds axons appear structurally intact for up to one month (Glass and Griffin,
1991; Glass et al., 1993) and can conduct compound action potentials for up to 3
weeks after nerve lesion (Lunn et al., 1989; Perry et al., 1990b; Tsao et al., 1994).
The mutation occurred spontaneously at Harlan-Olac Laboratories (Bicester, U.K.)
and does not appear to exert any harmful effects on the mice. In fact, the C57BL/Wlds
mouse is indistinguishable from the C57BL strain from which the mutation arose -
both strains have identical appearance, behaviour, histocompatibility and genotype of
more than 50 microsatellites and restriction fragment length polymorphisms (Lunn et
al., 1989; Coleman et al., 1998). The developmental phenomenon of synapse
elimination, the removal of excess synapses from neuromuscular junctions, also
appears to be normal (Parson, MacKintosh and Ribchester, 1997). In sum, Wlds mice
have considerably retarded rates of Wallerian degeneration, but the studies to date
indicate that apart from this aberration the C57BL/Wlds mouse is unaffected by the
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mutation in any other way.
Initial experiments suggested that the delay in Wallerian degeneration in Wlds mice
was caused by a defect in the recruitment of macrophages from circulatory system
(Lunn et al., 1989). In wild type mice denervation results in an influx of
myelomonocytic cells, which contribute to the phagocytosis of the degenerating debris
of Wallerian degeneration (Perry, Brown and Gordon, 1989). In Wlds mice,
transection of peripheral nerves results in extremely retarded rates of macrophage
recruitment. To investigate the possibility that the lack of macrophage recruitment
resulted in slow Wallerian degeneration, Lunn et al. (1989) prevented recruitment of
myelomonocytic cells by administration of a selective monoclonal antibody against the
complement type 3 receptor in normal mice. The authors observed that this had the
effect of slowing axonal degeneration, thus validating the theory that monocyte
recruitment causes slow Wallerian degeneration. A subsequent report suggested that
certain environmental factors influence the rate of degeneration in Wlds mice,
probably via an inflammatory mechanism, further implicating monocyte recruitment in
Wallerian degeneration (Perry et al., 1990b). However, a series of studies have
demonstrated that the mutation affects an intrinsic property of nerve axons. Perry and
colleagues (1990a) replaced bone marrow in Wlds mice with that from
histocompatible C57BL/6J mice in order to determine whether the slow recruitment
of monocytes was due to the failure of the nerve to produce a chemotactic signal, or
the failure of monocytes to respond. If the lack of recruitment was due to a defect in
Wlds monocytes then a bone marrow transplantation would correct for this, and
normal recruitment would ensue after nerve injury. However, the authors observed
that Wlds mice with C57BL/6J bone marrow still had retarded rates of monocyte
recruitment. When Wlds bone marrow was transplanted to 6J mice, and the nerve
lesioned, normal rates of recruitment were observed during degeneration. The
response of Wlds myelomonocytic cells to a range of inflammatory agents and chronic
infection was tested and found to be similar to that of 6J mice. Furthermore,
C57BL/Wld's mice were used for a study of delayed hypersensitivity, and once more
were found to respond as normal (Rosen, Milon and Gordon, 1989). Demyelination
of axons by an intraneural injection of lysophatidyl choline results in normal rates of
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macrophage recruitment in Wlds mice (Hall, 1993). To further preclude the
involvement of macrophage recruitment in the phenotype of Wlds mice isolated
segments of nerve were placed in culture medium for several days, whereby
recruitment of monocytic cells was not possible (Perry et al., 1990a). Wlds nerves still
degenerated much more slowly than wild type nerves. In subsequent study, pre-
degenerated sections of Wlds nerve sheath were transplanted into 6J mice, and the
axons allowed to regenerate before being sectioned once more (Glass et al., 1993).
Lesioned axons from 6J mice degenerated at a normal rate. The converse situation
was also applied - 6J nerve sheaths were transplanted into Wlds mice, the regenerated
nerve sectioned, and axonal degeneration was retarded. These observations suggest
that the intrinsic cells of Wlds nerve sheaths are not responsible for the slow rates of
degeneration. Finally, in vitro experiments using primary cultures of dorsal root
ganglion and superior cervical ganglion showed that transected Wlds axons were able
to survive for up to seven days (Glass et al., 1993; Buckmaster et al., 1994;
Deckwerth and Johnson, 1994). In sum, slow Wallerian degeneration in C57BL/Wlds
mice is an intrinsic property of the axon.
1.3.2 Molecular nature of the mutation
Investigations into the molecular nature of the mutation have yielded further insights
as to the mechanism of slow Wallerian degeneration in the Wlds mouse. The Wlds
mutation is thought to be due to the naturally occurring spontaneous alteration of an
as yet unidentified autosomal dominant gene (Perry et al., 1990b). Further studies
mapped the genetic locus, using conventional methods and genetic markers, to the
distal end of mouse chromosome 4, near the locus of proantriodilatin (Lyon et al.,
1993). The most recent investigation suggests that the mutation is due to an 85-kb
tandem triplication that arose from illegitimate or nonhomologous recombination
between short homologous sequences (Coleman et al., 1998). Interestingly, a form of
Charcot-Marie-Tooth disease (CMT2A), which is characterised by axonal loss, has
been mapped to a homologous locus in humans, lp36 (Ben-Othmane et al., 1993).
Coleman et al. (1998) envisaged three ways in which the Wld gene could be affected
by a tandem triplication. First, if the entire Wld gene and all its regulatory components
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was located within the triplicated region, then it is conceivable that the gene product
would be increased threefold resulting in an increase in the steady state level of the
protein. Second, if the Wld gene was split by the triplication then this might result in a
truncated protein product, or the formation of a hybrid protein with a novel function.
Third, the gene could remain intact but come under the control of a different
regulatory element or transcription factor. This could in turn affect the transcription of
the gene; the rate of transcription could increase even more than threefold, and could
affect genes adjacent to the triplicated region. A further complication arises from the
possibility that the 85-kb region may encode for more than one gene, on the basis that
there is an average spacing of one gene per 30-60 kb in the mouse genome. The
authors note that further studies are required to provide formal proof that the
triplication is indeed the cause of the Wlds mutation. To truly characterise the
molecular nature of the Wlds phenotype it is necessary to construct a detailed map of
the Wld locus, and to use a functional model to transfer the candidate Wlds gene to
wild type neurons.
It is generally accepted that the Wlds mutation declines in its effectiveness with
advancing age. Various studies have demonstrated that degeneration in older Wlds
mice takes place more rapidly, but nevertheless still slower than wild type
degeneration (Perry Brown and Tsao, 1992; Tsao et al., 1994; Ribchester et al.,
1995; personal observation). This phenomenon is interesting because in wild type
mice the converse applies - older nerves degenerate more slowly (Tanaka and
Webster, 1991; Perry Brown and Tsao, 1992; Tsao et al., 1994). However, a
conflicting study by Crawford and colleagues (1995) reported that the rates of
degeneration in young and old Wlds nerves remains constant. A possible explanation
for the discrepancy may arise from the use of the British and American stocks
respectively in the studies of C57BLAVlds mice, which may differ slightly in their
phenotypic characteristics, although this is unlikely (Crawford et al., 1995). This issue
remains to be definitively resolved.
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1.3.3 Biochemical and cellular events during delayed axonal degeneration
The first study of the C57BLAVlds mouse revealed that axonal degeneration after
peripheral nerve section is considerably delayed in comparison with normal, rapid
Wallerian degeneration (Lunn et al., 1989). Wallerian degeneration is also delayed in
the central nervous system (Perry, Brown and Lunn,, 1991; Ludwin and Bisby, 1992).
The distal stump of lesioned peripheral Wlds nerves can transmit a compound action
potential for up to 3 weeks (Lunn et al., 1989; Perry et al., 1990b; Tsao et al., 1994)
and retain structural integrity for as long as one month (Glass and Griffin, 1991; Glass
et al., 1993). Neuromuscular transmission fails earlier, from 3 days to two weeks, and
this coincides with the morphological degeneration of nerve terminals (Ribchester et
al., 1995). Furthermore, the overall rate of degeneration in Wlds nerves is dependent
upon the length of the distal stump, similar to wild type mice, although the rates are
still of a slower order in wild type mice. Neuromuscular transmission of Wlds nerves
fails one to two days later per additional centimetre of distal nerve, as compared with
45 minutes per centimetre in normal mice (Ribchester et al., 1995; Miledi and Slater,
1970). Axonal disintegration in the C57BL/Wlds mouse is dependent upon calcium as
in normal mice, and several studies have identified that calpains are present -
proteases which can degrade the axonal skeleton in the presence of calcium (Glass,
Schryer and Griffin, 1994; Tsao et al., 1994). However, it appears that more calcium
is needed to effect axonal disintegration in Wlds axons (Glass, Schryer and Griffin,
1994): the threshold calcium concentration for the complete disintegration of the
cytoskeleton is 0.2mM in wild type mice, whilst some Wlds axons are still preserved at
0.25mM as assessed by neurofilament immunoreactivity.
The remarkable preservation of Wlds axons after nerve injury led some investigators
to speculate that axonal transport may be slowed or stopped. However, fast axonal
transport of organelles in isolated nerve segments proceeds at normal anterograde and
retrograde rates for up to eight days post lesion (Smith and Bisby, 1993). Slow axonal
transport of neurofilaments, tubulin and actin continues for up to 14 days post
axotomy (Glass and Griffin, 1991, 1994; Watson Glass and Griffin 1993).
In addition to slowed Wallerian degeneration, C57BL/Wlds mice also exhibit a
slowing of the rate of retrograde degeneration of retinal ganglion cells after optic
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nerve section (Perry, Brown and Lunn, 1991). This was an intriguing result as it had
previously been assumed that cell body degeneration occurred via apoptosis, a quite
distinct phenomenon from Wallerian degeneration. Axotomy of a neonatal peripheral
nerve results not only in the Wallerian degeneration of the distal axons, but also
retrograde cell death of motor neuron cell bodies via apoptosis. In the Wlds mouse,
apoptotic neuronal cell death after neonatal nerve injury was delayed by several days,
but not prevented (Lapper, Brown and Perry, 1994). This result led to the speculation
that Wallerian degeneration and apoptosis are related phenomenon (Lapper, Brown
and Perry, 1994; Ribchester et al., 1995). However, Deckwerth and Johnson (1994)
demonstrated that, in vitro at least, cell body death appears to take place
independently of axonal degeneration. In this study, trophic support was withdrawn
from sympathetic neurons of Wlds explants. In normal mice this would result in death
of cell body and neurite simultaneously but in Wlds explants, whilst the soma died by
apoptosis, the neurites survived and remained metabolically viable for up to seven
days after axotomy. Based on these results the authors proposed that neuritic
degeneration occurs independently and autonomously of cell body death, and thus via
separate mechanisms.
The fact that granular disintegration of the cytoplasm and myelin breakdown in Wlds
mice does not occur until after a long lag period has compounding effects on the other
changes that are subsequent to Wallerian degeneration. It is known that the delay in
Wallerian degeneration in C57BL/Wlds mice is an intrinsic property of the axon. The
original report of slow Wallerian degeneration by Lunn et al. in 1989 demonstrated
that recruitment of macrophages after nerve injury was retarded in Wlds mice.
Therefore, it is sensible to assume that the delay in the recruitment of myelomonocytic
cells must be attributable to the prolonged integrity of the axonal cytoskeleton. A
recent study demonstrated that Monocyte Chemoattractant Protein-1 (JE) may be
implicated in the recruitment of macrophages (Carroll and Frohnert, 1998). JE is a
potent chemoattractant for macrophages (Schall and Bacon, 1994) and JE mRNA is
initially strongly expressed in an endoneurial cell population at the site of nerve injury
(Carroll and Frohnert, 1998). The expression pattern of JE mRNA changes, becoming
widespread along the distal segment by 16 days post axotomy, coincident with the
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distribution of infiltrating macrophages. However, JE is not expressed after nerve
trauma in the C57BLAVlds mouse, in which macrophage recruitment is almost non¬
existent. These data suggest that JE is released initially at the site of injury to attract
circulatory myelomonocytic cells, and then subsequently released along the length of
the distal stump once macrophage invasion has taken place. The absence of JE
expression in the axotomized Wlds nerve suggests that Wallerian degeneration is
required to initiate the production of JE from endoneurial cells. Schwann cell division
and myelin degradation are also delayed in the Wlds mouse (Lunn et al., 1989; Brown
et al., 1991b), and down regulation of the myelin protein gene for P0 does not occur
until after nerve degeneration takes place (Thomson et al., 1991). Furthermore, the
muscle wastage that takes place as a result of denervation in wild type animals does
not occur in Wlds muscle (Brown et al., 1991a).
1.3.4 Nerve regeneration in the Wlds mutant mouse
Surprisingly, regeneration of peripheral nervous system motor axons to the soleus
muscle takes place as rapidly and comprehensively as in other mice (Lunn et al., 1989;
Perry et al., 1992b). In the sciatic nerve, which supplies the soleus muscle,
regenerating motor axons are thought to associate with Schwann cells that normally
surround unmyelinated axons (Brown, Lunn and Perry, 1992). In contrast, sensory
axons do not regenerate as quickly as wild type axons after nerve injury (Bisby and
Chen, 1990; Brown, Lunn and Perry, 1991,1992). However, sensory axons are able
to elongate as normal in culture (Buckmaster et al., 1994), and the regenerative
capacity of both motor and sensory Wlds neurons in vivo remains intact: Brown et al.
(1994) observed a copious sprouting reaction at the site of injury in both motor
(phrenic) and sensory (saphenous) nerves. Furthermore, the initial increase in c-jun
and GAP-43, and the decrease in medium weight neurofilament mRNA expression,
were similar in facial motor neurons and dorsal root ganglion neurons of Wlds and 6J
mice (Gold, Storm-Dickerson and Austin, 1993; Brown et al., 1994; Bisby, Tetzlaff
and Brown, 1995). Interestingly, the subsequent recovery of c-jun and GAP-43
mRNA to normal levels, which occurs after target innervation in normal mice, is
delayed in Wlds neurons (Bisby, Tetzlaff and Brown, 1995). These findings suggest
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that the initial cell body response to axotomy in Wlds mice is similar to that of normal
mice, and that Wlds neurons do not have a reduced capability to regenerate.
Therefore, it is possible that Wlds nerve sprouts are prevented from regenerating
down the distal stump by the lack of a permissive environment, caused by the delay of
Wallerian degeneration. Several factors may contribute to this.
Apolipoproteins are upregulated after nerve injury in normal mice, and are thought to
facilitate myelin breakdown and remyelination (Ignatius et al., 1986; Boyles et al.,
1989). In the Wlds mouse, apolipoprotein E production is confined to regions where
myelin destruction and phagocytosis occur (Saada et al., 1995). Furthermore,
regeneration of Wlds axons only occurs where myelin associated glycoprotein, a factor
thought to be inhibitory to axonal growth, has been cleared or disrupted (Schafer et
al., 1996). Likewise, tenascin-C, which supports neurite outgrowth, is only expressed
after axonal degeneration in Wlds mice, and regrowing axons were invariably
associated with tenascin-C expression (Fruttiger, Schachner and Martini, 1995).
Therefore, the success of regeneration in peripheral nerves of the C57BLAVlds mouse
appears to be partly dependent on the degeneration of axotomized distal axons.
Without this event it is probable that sprouts face a hostile and non-permissive
environment in which it is difficult to proceed. The success of motor axon regrowth to
the soleus muscle can be explained by the fact that the unmyelinating Schwann cells of
the sciatic nerve provide an alternative environment for growth of motor axons
(Brown, Lunn and Perry, 1992): motor axons do not regenerate in the phrenic nerve,
where there are no unmyelinated axons and as such no associated unmyelinating




This thesis explores the phenomenon of slowed Wallerian degeneration in
C57BLAVlds mice, and in particular the effect of peripheral nerve lesion on motor
nerve terminal structure and function. The majority of the studies of the C57BLAVlds
mutant mouse to date have specifically examined Wallerian degeneration in the
peripheral nerve trunk. The conclusion of these reports is that Wallerian degeneration
of distal axons is suspended for a limited period of time following nerve injury. This
remarkable finding suggests that Wallerian degeneration may be under genetic
control. How does the mutation that results in slowed Wallerian degeneration of
peripheral nerves affect neuromuscular synapses? Preliminary investigations of Wlds
neuromuscular junctions indicate that Wallerian degeneration is delayed for up to 2
weeks (Ribchester et al., 1995). However, many other possibilities remain to be
explored. For instance, are axotomized neuromuscular synapses maintained as normal
during the delay period, or are there subtle changes in the morphological and
physiological characteristics of motor nerve terminals preceding the initiation of
degeneration? Are persistent nerve terminals functionally efficacious? Does Wallerian
degeneration proceed as normal in motor nerve terminals once initiated, or does some
other process take place? What is the role of spontaneous activity in persistent
axotomized Wlds neuromuscular synapses? How are terminal Schwann cells, which
normally respond rapidly to Wallerian degeneration, affected by the persistence of
intact neuromuscular junctions following nerve damage? This thesis attempts to
address these questions, and others, with the use of several techniques. The first series
of experiments, in Chapter 2, further characterises the effect of peripheral nerve
damage on Wlds motor nerve terminals at the neuromuscular junction. These studies
resulted in unexpected findings, which formed the basis of subsequent experiments
(Chapters 3 and 4). Possible reasons for these surprising findings, discussed in
Chapter 2, resulted in the formulation of hypotheses which were tested in Chapter 3.
Chapter 2 comprises a detailed study of the changes in nerve terminal morphology and
function following axotomy. The structural changes that occur following nerve
axotomy at the neuromuscular junction are examined using two techniques for
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assessing morphology: vital staining, utilising dyes that label living preparations, and
immunocytochemical techniques to visualise fixed preparations. Both of these
techniques employ fluorescent imaging. Functional changes at C57BL/Wlds
neuromuscular junctions were measured using three electrophysiological recording
techniques.
Chapter 3 is a study of the effect of activity on the changes that take place at
axotomized Wlds neuromuscular junctions. Botulinum toxin was used to block
neurotransmitter release from Wlds nerve terminals following axotomy.
Morphological changes in motor nerve terminals were quantitatively examined using
immunocytochemical labelling of nerve terminals, preterminal axons, and postsynaptic
acetylcholine receptors.
Chapter 4 entails an investigation into the effect of persistent motor nerve terminal
structure, which occurs following lesion of Wlds nerves, on the phenomenon of
Wallerian degeneration-induced reactive Schwann cell sprouting. The effect of the
intrinsically slow axonal degradation on associated cell types has been studied to some
extent in the peripheral nerve trunk. However, there have been no studies that address
the consequences of intact peripheral nerves and nerve endings on associated cell
types at the neuromuscular junction, which have distinct and characteristic reactions
to normal Wallerian degeneration.
The discussion in Chapter 5 focuses on the implications of the findings as a whole,
and suggests directions for future research.
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Nerve terminal responses to axonal lesion in
Wlds and wild type mice.
Chapter 2
Chapter 2: Motor nerve terminal responses to axonal lesion
in Wlds and wild type mice.
2.1 Introduction
The vertebrate neuromuscular junction is arguably the most comprehensively studied
and accessible synapse, and as such is one of the leading preparations for the analysis
of synaptic plasticity. The mammalian neuromuscular junction, which will be the
focus of this thesis, can be simplified to three different cell types: motor neuron,
muscle fibre, and Schwann cell. All three cell types are highly specialised, and at the
synapse there are high concentrations of organelles and molecules that are found in
low concentrations outwith the region of the neuromuscular junction.
The motor nerve terminal lies in a shallow gutter on the muscle fibre, and capped by
terminal Schwann cells. The major function of the motor nerve terminal is the release
of neurotransmitter to elicit muscle action potentials and thereby induce muscle fibre
contraction. The mammalian motor nerve terminal is polarised into two halves, into
which specialised organelles are organised. The presynaptic region of the nerve
terminal, which is directly adjacent to the synaptic cleft, is dominated by a high
density of 50-nm-diameter synaptic vesicles, that are packaged with the
neurotransmitter, acetylcholine. Synaptic vesicles are clustered around dense areas of
the presynaptic membrane (active zones) where they fuse with the membrane to
release their contents. Active zones are associated with voltage-dependent potassium
and calcium channels, which regulate calcium-dependent secretion of synaptic
vesicles (Robitaille et al., 1993; Sugiura et al., 1995; Day et al., 1997). The
mechanism of synaptic vesicle fusion has yet to be fully elucidated, but involves the
interaction of several vesicle-specific proteins such as SV2, synaptophysin, syntaxin
and SNAP-25 (reviewed in Sudhof, 1995; Calakos and Scheller, 1996). Active zones
lie directly adjacent to postsynaptic specialisations called junctional folds, which are
capped by acetylcholine receptors. Vesicle fusion results in the release of
acetylcholine, which diffuses across the synaptic cleft and acts on postsynaptic
receptors to induce muscle contraction. Thus, synaptic 'strength' is primarily a
function of the number of quanta released on presynaptic excitation (the quanta!
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content) (Katz and Thesleff, 1957). The more proximal region of the nerve terminal,
which is adjacent to the overlying Schwann cell, is occupied by largely occupied by
mitochondria, which are necessary for the synthesis and release of transmitter, with
some microtubules and neurofilaments. The preterminal axon collateral consists
mainly of microtubules and neurofilaments and contains very few vesicles and
mitochondria, and no active zone (Yee et al, 1988).
The postsynaptic endplate on the muscle fibre is geared to respond rapidly and
reliably to acetylcholine released from the nerve terminal. Junctional folds, which are
highly invaginated, are juxtapositioned to active zones in the nerve terminal. At the
top of the junctional folds there is an extremely high density of acetylcholine
receptors (>10,000/p.m2), which are associated with a number of signalling
molecules, and which maintains the high postsynaptic density of acetylcholine
receptors (Moscoso et al., 1995; Valenzuela et al., 1995; Martin et al., 1996). The
density of acetylcholine receptors decreases in extrasynaptic areas of the muscle fibre
membrane to > 10/pm2 (Salpeter et al., 1988). Sodium channels and N-CAM are
concentrated in the depths of the junctional folds (Covault and Sanes, 1986; Flucher
and Daniels, 1989). An elaborate network of cytoskeletal proteins support the
junctional folds, with rapsyn, utrophin and a-dystrobrevin-1 at the top and ankyrin,
a-dystrobrevin-2, and dystrophin at the bottom, and are thought to maintain the
different domains within them (Sealock et al., 1984; Covault and Sanes, 1986;
Flucher and Daniels, 1989; Wood and Slater, 1998; Peters et al., 1998). The
organisation of the postsynaptic junction, with acetylcholine receptors at the crest of
the junctional folds, and sodium channels clustered in the depths of the folds, is
thought to enhance the efficacy of synaptic transmission (Wood and Slater, 1997).
One or more terminal Schwann cells caps the motor nerve terminal, surrounding the
entire nerve terminal with finger-like cytoplasmic projections. Terminal Schwann
cells are thought to provide the nerve terminal with trophic sustenance (Bunge,
1993), and also play a major role in innervation and reinnervation of muscle fibres by
growing axons, and during other forms of synaptic remodelling. These will be
reviewed in depth in Chapter 3.




2.1.1 Nerve terminal degeneration in wild type mice
One of the earliest events that occurs after a peripheral nerve lesion is the
degeneration of motor nerve terminals at the neuromuscular junction. This
degeneration manifests itself in two ways: loss of neuromuscular transmission
coincident with morphological disruption of nerve terminal structure.
2.1.1.1 Morphological degeneration
The first degenerative changes in the ultrastructure of nerve terminals take place as
early as three hours after nerve lesion, and are characterised by disruption of
mitochondria, a reduction in the number of synaptic vesicles, an increase in
neurofilamentous material, and the presence of membrane 'whorl' structures
surrounding vesicular aggregations. Immediately after nerve injury there is a 'lag
period', between 3 and 8 hours in rodents, during which no obvious structural
changes take place, and all nerve terminals appear normal (Miledi and Slater, 1970;
Manolov, 1974; Winlow and Usherwood, 1975).
After nerve section, mitochondria become circular in shape, increase in diameter to
-0.4-0.5pm, and the cristae become disorganised and fragmented (Birks, Katz, and
Miledi, 1960; Miledi and Slater, 1970). Disrupted mitochondria can be detected in
some terminals as early as 3 hours post axotomy (Manolov, 1974). By 6 hours after
nerve injury, many nerve terminals have swollen mitochondria. By 12-18 hours all
mitochondria appear abnormal, and most have degenerated into dense bodies. By 24
hours post lesion no mitochondria can be detected (Winlow and Usherwood, 1975).
In normal preparations, synaptic vesicles are densely packed in nerve terminals and
the overall population density varies between 56 and 209 pm"2 (Winlow and
Usherwood, 1975). Synaptic vesicles are generally more concentrated near the
presynaptic membrane than in the rest of the nerve terminal (Hubbard and
Kwanbunbumpen, 1968; Winlow and Usherwood, 1975). The total number of
synaptic vesicles declines from 6 hours post axotomy onwards, but the overall
distribution does not appear to change significantly (Winlow and Usherwood, 1975).
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During this time, synaptic vesicles sometimes cluster together to form multivesicular
bodies; the tendency for vesicles to aggregate is more apparent in terminals with low
vesicle populations. By 12 hours post lesion very few synaptic vesicles remain, and
the nerve terminal is dominated by multivesicular bodies, membranous whorls, dense
granules, degenerating mitochondria and an accumulation of neurofilamentous
material (Manolov, 1974; Winlow and Usherwood, 1975).
At this time, the nerve terminal membrane becomes fragmented and several small
axon profdes appear in the synaptic groove. Terminal Schwann cells, which overlie
the neuromuscular junction, engulf and digest nerve terminals during Wallerian
degeneration. Glial processes begin to penetrate nerve terminals by six hours after
nerve section (Manolov, 1974). By 24 hours after axotomy terminal Schwann cells
have completely replaced the nerve terminal in the synaptic gutter, and lie adjacent to
the muscle membrane. It appears that Schwann cells phagocytose nerve terminals in
varying stages of degeneration. Miledi and Slater (1970) described the engulfment of
an almost intact nerve terminal, whilst in other preparations nerve terminals which
were clearly in the final stages of degeneration remain distinct from terminal
Schwann cells. After 48 hours post axotomy no distinguishable remains of the nerve
terminal can be recognised, and Wallerian degeneration at the neuromuscular
junction is complete.
It is important to note that during the course of these studies the investigators
observed many nerve terminals in varying stages of degeneration, even at the same
timepoint. This variability seems to indicate that nerve terminal degeneration occurs
asynchronously. It is interesting to note that Miledi and Slater (1970) reported a lag
period of 8-10 hours, during which nerve terminals remained morphologically
normal, whilst Manolov (1974) described mitochondrial disruption as early as 3
hours post axotomy. Two factors could account for this apparent discrepancy
between the studies. Manolov (1974) took the presence of swollen and abnormal
mitochondria to indicate the first signs of degeneration after nerve lesion. However,
Winlow and Usherwood (1975) demonstrated that even normal nerve terminals
contain mitochondria that appear to be swollen and disorganised (up to 19%).
Therefore, some care must be taken when interpreting the presence of disrupted
mitochondria in motor nerve terminals. Miledi and Slater (1970) demonstrated that
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the duration of nerve terminal degeneration is dependent upon the length of the distal
nerve stump. This may account for the differences between various studies: different
experimental procedures may leave shorter lengths of distal nerve, which would
account for the observation of more rapid alterations in nerve terminal morphology.
In sum, Wallerian degeneration of nerve terminals takes place from approximately 3
to 24 hours post axotomy and involves gross organelle disruption, neurofilament
accumulation, reduction in the number of synaptic vesicles, and nerve terminal
membrane fragmentation followed or preceded by Schwann cell phagocytosis.
2.1.1.2 Functional degeneration
Degeneration-induced disruption of the ultrastructural morphology of the
neuromuscular junction closely parallels the changes that occur in the functional state
of nerve terminals. Concurrent with the structural disintegration of the nerve
terminal, there is a decline in the ability to release transmitter.
In the rat diaphragm, all nerve terminals retain the ability to transmit impulses for 8-
10 hours after nerve section (Miledi and Slater, 1970). This lag period, in which
nerve terminals remain functionally normal, is similar to the lag period that occurs
during morphological degeneration of nerve terminals. After this time some end-
plates lose the ability to produce endplate potentials (EPPs) after stimulation of the
distal stump. Failure of EPPs occurs abruptly, without proceeding through a
transitory weakened state. Failure of spontaneous MEPPs occurs at the same time as
EPP failure. However, Miledi and Slater (1970) presented evidence to indicate that
before MEPP failure occurs the overall frequency of MEPPs seems to decline. Nerve
terminals functionally degenerate asynchronously: often nerve terminals transmitting
as normal neighbour endplates which are functionally silent (Miledi and Slater,
1970). This reflects the morphological data, in that degeneration does not occur
simultaneously at all neuromuscular junctions. From 8 hours post axotomy onwards,
the number of endplates failing to respond to nerve stimulation progressively
increases, until at 20 hours no endplates can transmit (Miledi and Slater, 1970).
Various studies have demonstrated that this is dependent on the length of the distal
stump (Eyzaguirre, Espildora and Luco, 1952; Luco and Eyzaguirre, 1955; Birks,
Katz and Miledi, 1960; Miledi and Slater, 1970; Lubinska, 1982).
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2.1.2 Nerve terminal degeneration in mutant C57BL/Wlds mice
Wallerian degeneration in the C57BL/Wlds mouse is considerably delayed (Lunn et
al., 1989). Severed distal nerves are able to conduct compound action potential for
up to 3 weeks, and retain structural integrity for up to one month (Lunn et al., 1989;
Tsao et al., 1994; Glass and Griffin, 1991; Glass et al., 1993). In normal mice the
structural and functional integrity of nerve terminals declines at an earlier stage than
in the main nerve trunk. Is this relationship represented similarly in the Wlds nerve?
Preliminary reports suggested that normal neuromuscular junction and normal
terminal morphology, visualised with silver stain, were present up to five days after
nerve section in the Wlds mouse (Crawford et al., 1995). In the preceding report to
this thesis, Ribchester and colleagues (1995) demonstrated that neuromuscular
transmission, as evaluated from tension measurements and intracellular recordings,
was comparable with control levels 3 days after nerve section. The number of
innervated fibres declined from this point until, after two weeks, no endplates
responded to stimulation. Spontaneous activity persisted even after the loss of EPPs,
a phenomenon distinct from that observed in wild type mice (cf. Miledi and Slater,
1970). The physiological evidence for the maintenance of functionally normal nerve
terminals was corroborated by FM1-43 imaging. FM1-43 is a styryl dye that labels
actively recycling synaptic vesicles. Motor nerve terminals up to 7 days denervated
retained the ability to stain and destain with FM1-43, indicating that synaptic vesicles
were able to recycle for this period (Ribchester et al., 1995). Furthermore, nerve
terminals labelled with zinc iodide osmium (ZIO) to visualise nerve terminal
structure appeared normal for up to 7 days after axotomy. After 8 days, however,
nerve terminals appeared fragmented and abnormal. Electron micrographs of
neuromuscular junctions 5 days after nerve section indicated that mitochondria were
morphologically unaltered and that synaptic vesicles appeared normal. Interestingly,
one micrograph showed clustering of vesicles close to the plasma membrane. Some
terminals also displayed accumulation of neurofilamentous material that was not
present in control images. As in wild type mice, the rate of degeneration was
dependent on nerve stump length. However, the nerve stump length dependent delay
in Wlds mice was 1-2 days per centimetre of nerve as opposed to -45 minutes per
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additional centimetre of nerve in wild type mice.
To conclude, nerve terminal degeneration in C57BL/Wlds mice is considerably
delayed. Nerve damage results in alterations in motor nerve terminal structure and
function after 3 days, progressing until approximately 2 weeks post axotomy when
few terminals persist. In the main nerve trunk at this time most axon profiles remain,
and Wlds nerves are still able to conduct a compound action potential after 2 weeks.
Therefore, degeneration of nerve terminals in Wlds mice is considerably delayed, but
appears to take place faster than axonal disintegration in the main nerve trunk.
However, the precise characterisation of events that occur after nerve section at the
neuromuscular junction remains to be elucidated
The experiments detailed in this chapter address aspects of degeneration in both wild
type and Wlds mice. First, a serial study was undertaken to assess in detail the ability
of Wlds motor nerve terminals to recycle synaptic vesicles for prolonged periods
after nerve section. A parallel study investigated the same phenomenon in wild type
terminals for comparison. Further experiments analysed Wlds and wild type nerve
terminal morphology after axotomy, using immunocytochemical techniques. The
purpose of this study was to elaborate in detail on the similarities and differences
between wild type and Wlds motor nerve terminals after axotomy. A 24 hour time-
period study investigated the rate of degeneration in Wlds nerve terminals ex vivo.
Morphological data was corroborated with information about the decline of
transmitter release in Wlds nerve terminals post axotomy. Standard
electrophysiological techniques were used to investigate quantal content in Wld"
terminals after nerve section, using two independent techniques. This analysis was
combined with a study of MEPP frequency post axotomy. To consolidate the
morphological and electrophysiological findings a study of both structure and
function at the same neuromuscular junction was undertaken.
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22 Materials and Methods
2.2.1 Animal Care
C57BL/Wlds mice bred in the Department of Medical Microbiology in Edinburgh.
This colony (formally designated C57BL/6/EUMM) shares the property of slow
Wallerian degeneration with the colony of C57BL/Wlds mice maintained in Oxford,
on which the initial experiments were performed (Lunn et al., 1989). Both of these
stocks were originally derived from Harlan-Olac, and appear to be identical
(Ribchester et al., 1995, Parson et al., 1997). Animals were ordered direct from
Harlan-Olac for the immunocytochemistry studies. Experiments were performed on
mice aged 3 weeks to 2 months; previous studies indicated that the property of slow
Wallerian degeneration in Wlds peripheral nerves gradually lessens after 3 months of
age, so that that rate of degeneration approaches that of wild-type mice (Perry,
Brown and Tsao, 1992; Tsao et al., 1994; Ribchester et al., 1995).
The 'wild type' strains used in these experiments were CBA or C57BL/6J.
Experiments were performed on mice age-matched with Wlds animals, in order to
minimise variation.
The structure and function of neuromuscular junctions was examined in transversus
abdominus (TA) and flexor digitorum brevis (FDB) after nerve injury to the
intercostal nerves or the tibial (lateral plantar) nerve respectively. The TA muscle is
only 2-3 fibres thick in some regions, which has the effect of minimising background
fluorescence, and therefore was selected for imaging purposes (vital staining and
immunocytochemistry). The TA muscle is innervated by 6 intercostal nerves,
distributed over a relatively large area, and as such yields many endplates suitable for
detailed morphological examination. The FDB muscle has relatively short muscle
fibres (~500pm), which have been shown to be electrically isopotential along their
length (Bekoff and Betz, 1977; Ribchester, 1989). This facilitates intracellular
recording and subsequent analysis of transmitter release as a correlate to the quantal




Mice were anaesthetised by inhalation of halothane (2-5% in N2O/O2; 1:1), until
heavy sedation and the loss of reflex responses had occurred. The animals were
placed on a heat blanket to minimise heat loss during the surgical procedure. The
relevant area was shaved and sterilised to reduce risk of infection. All surgical
procedures were performed in accordance with UK Home Office Regulations. The
animals had free access to water and feed at all other times.
2.2.2.1 Transversus abdominus
Unilateral sections of the left second to eighth intercostal nerves were carried out
with small spring scissors. A section of nerve (3-5mm) was removed to ensure
complete axotomy. The nerves were severed close to the vertebral column (~0.5cm),
in an attempt to equalise the length of the distal portion, and the wound closed with
6/0 Mersilk suture. Occasionally, the intercostal muscle was accidentally breached,
causing a pneumothorax to develop. These mice were stabilised and usually
recovered immediately after the anaesthetic had worn off. In general, the mice
recovered rapidly and did not appear to suffer any breathing difficulties or restriction
in movement. The animals were sacrificed 6 hours to 10 days after axotomy, by
stunning and dislocation of the cervical vertebrae. The experimental and contralateral
muscle and nerve preparations were dissected out, typically leaving the ribcage
attached to the muscle, and bathed in normal physiological saline (aerated with 95%
O2 and 5% CO2) (see Appendix A). These preparations were attached with steel pins
to the base of a 3 cm Sylgard-lined chamber and the nerves were checked for signs of
axotomy.
2.2.2.2 Flexor digitorum brevis
Mice were prepared as above, and unilateral sections to the tibial nerve of the right
hind limb were carried out. A segment of tibial nerve was resected to ensure
complete axotomy. Mice were allowed to recover, and sacrificed as above 3 to 13
days after axotomy. Dissected isolated nerve-muscle preparations were bathed in
normal physiological saline, aerated with 95% O2 and 5% CO2, and pinned in a




FM1-43 is a vital aminostyryl dye that selectively labels synaptic vesicles all species
examined to date (for review, see Cochilla, Angleson and Betz, 1999). FM1-43
inserts into the outer leaflet of the vesicular membrane during the endocytic phase of
synaptic vesicle recycling, in response to a depolarising stimulus (Figure 2.1). Once
loaded, preparations remain visible for several hours. The loading process is
reversible, and synaptic vesicles labelled with FM1-43 can be destained by
promoting transmitter release over a period of several minutes at high frequencies.
Background fluorescence in stained preparations is usually very minimal because
FM1-43 is virtually non-fluorescent in aqueous medium, and is considerably more
fluorescent when bound to vesicular membranes. This dye is particularly useful
because it enables visualisation of living tissue, and facilitates the assessment of
synaptic vesicle recycling in motor nerve terminals.
Isolated TA nerve-muscle preparations were first incubated with 5pg/ml TRITC
conjugated a-bungarotoxin in normal physiological saline for 20 minutes.
Bungarotoxin stains muscle endplates by irreversibly binding to acetylcholine
receptors. This facilitates the localisation of neuromuscular junctions, whose nerve
terminals may be in a state of degeneration. The a-bungarotoxin solution was then
rinsed off and the muscle washed for a further 15 to 20 minutes. The preparation was
then bathed in a 2pM solution of FM1-43, in physiological saline containing elevated
levels of potassium (50mM; see Appendix A); to compensate, the sodium
concentration was reduced by 45mM. Elevating the levels of potassium in the
bathing solution has the effect of depolarising the nerve terminal membrane.
Depolarisation causes neurotransmitter release, maximally stimulating exocytosis
and endocytosis, thus enabling optimal loading of the terminal with FM1-43. Also,
vesicles stain even though nerve conduction may be blocked proximal to the
neuromuscular junction. In effect, all endplates that are able to recycle synaptic
vesicles are loaded with FM1-43, regardless of any other loss of functionality. The
preparations were incubated for 4 minutes, then washed with normal saline for a
further 20 minutes before imaging.
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Figure 2.1: STRUCTURE AND FUNCTION OF FM1-43
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Structure of FM1 -43
N-(3-triethylammoniumpropyl)-4-(4-(dibutylamino)styryl)pyridinium dibromide
Mechanism of action
A. Schematic representation of a mammalian neuromuscular junction. (NT denotes
nerve terminal.)
B. FM1-43 staining protocol. Inset depicts synaptic vesicles loading with dye.
Isolated nerve muscle preparations were bathed in FM1-43, in physiological
saline containing elevated levels of potassium to promote synaptic vesicle
exocytosis and endocytosis. The dye is taken up during endocytosis and
preferentially partitions into the vesicular membrane.
C. FM1-43 destain. Inset shows dye leaching out of vesicles. Preparations are
washed in physiological saline containing elevated levels of potassium, to induce
vesicle exocytosis. This allows FM1-43 to diffuse out into the synaptic cleft,
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The preparations were then viewed with a fluorescence microscope using a 100W
mercury lamp, and the appropriate filter block. FM1-43 was visualised using a Nikon
filter block with a 435 nm excitation filter, 455 nm dichroic mirror and a 515 nm
interference barrier filter. TR1TC conjugated a-Bungarotoxin was imaged using a
Nikon filter block fitted with a 540 nm excitation filter, 580 nm dichroic mirror and a
590 nm interference barrier filter. Images were captured through either a Falcon
LTC1160 SIT camera (yielding black and white images) or a Hamamatsu 3 CCD
camera (colour images). The video gain and offset were set optimally for the range of
fluorescence intensity at each endplate, in order to maximise the visualisation of each
neuromuscular junction studied. These images were processed on a Powermac
8500/150 using Openlab, Photoshop or NIH Image (public domain software)
software packages. Occupancy, size and area analyses were carried out using
Openlab. This program enables the viewer to digitally surround the boundary of the
object, which yields a range of precise information about the object such as area,
perimeter, shape, pixel intensity, and a number of other parameters. This tool was
used in the offline analysis of endplates. Photographic quality images were prepared
using Photoshop and printed using a Kodak ColorEase printer.
2.2.4 Immunocytochemistry
Nerve-muscle wholemount preparations were dissected, and treated as follows:
1. Fix for 10 minutes in 4% paraformaldehyde in Ix phosphate buffered saline
(PBS) solution.
2. Wash for 1 hour in PBS.
3. Incubate with TRITC conjugated a-Bungarotoxin (5pg/ml) for 20 minutes,
followed by 20 minute PBS wash.
4. Place preparation in 100% methanol at -20 °C.
5. Wash 3x10 minutes PBS.
6. Preblock (0.3% Triton-X, 0.2% Bovine Serum Albumin, 0.1% Sodium Azide in
PBS) for 30 minutes.
7. Incubate overnight with primary antibodies ( goat anti-rabbit NF 1:500, SV2
1:250 in preblock solution) at 4°C.
8. Wash 3x10 minutes with preblock solution.
45
Chapter 2
9. Incubate >1 hour with secondary antibody (rabbit anti-mouse FITC 1:250 in
preblock solution). Cover preparation with tinfoil from this point onwards.
10. Wash 3x10 minutes PBS.
11. Mount and coverslip preparation with Vectashield. Store at 4 °C.
Endplates were imaged and analysed as described in 2.2.3.
2.2.5 Repeated visualization
Nerve-muscle preparations were dissected and stained with FM1-43 and a-
Bungarotoxin 3 days after axotomy, as described above. A superficial scan of the
preparation yielded the appropriate area for visualisation, and an en face endplate
was chosen for closer inspection. Neutral density filters of 0.3 and 1.0, which reduce
transmitted light by 50% and 90% respectively, were employed to minimise the risk
of photobleaching and phototoxicity that may occur as a result of prolonged exposure
to fluorescent light. The preparation was superperfused with physiological saline at
all times, and both the Sylgard dish and the saline were heated to 37 °C to mimic in
vivo conditions as closely as possible. The physiological saline was changed every 3
to 4 hours. Endplates were visualised every 2 hours up to 10 hours post dissection,
and thereafter at 24 hours. It was sometimes necessary to restain the nerve terminal
with FM1-43 after prolonged periods. However, this had the effect of raising the
background fluorescence considerably.
2.2.6 Intracellular recording
Intracellular recordings were performed on isolated FDB nerve-muscle preparations
3 to 13 days post axotomy. The preparations were initially bathed in normal
physiological saline aerated with 95% 02 and 5% C02, and attached to the base of a
Sylgard-lined recording chamber using fine steel pins.
Focal recordings of endplate potentials (EPPs), action potentials and spontaneous
miniature endplate potentials (MEPPs) were obtained using standard intracellular
recording techniques. Muscle fibres were impaled with glass microelectrodes of
approximately 40 MQ resistance, filled with 3 M potassium chloride. The frequency
of MEPP occurrence was monitored for each fibre in one or more 10 second sweeps
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on a slow oscilloscope time base. The muscle nerve was electrically stimulated using
a suction electrode with pulses of 0.2 ms duration and up to 100 V in amplitude.
Action potentials and EPPs evoked by nerve stimulation were recorded. For each
muscle, recordings from at least 20 unambiguous muscle fibres were obtained.
Muscle fibres apparently unresponsive to nerve stimulation were included in
subsequent analyses. Intracellular recordings were digitised using a modified SONY
PCM 701ES digital pulse code modulator and recorded on VHS videotape.
Measurements and analyses were carried out either online or offline, using a
CED1401+ interface and a personal computer, using the WCP software package. All
intracellular recordings were performed at room temperature (17-22 °C).
2.2.6.1 Quantal analysis using high magnesium saline
Intracellular recordings were obtained as above. Normal physiological saline was
substituted for saline containing elevated levels of magnesium and lowered levels of
calcium (high magnesium saline: see Appendix A). An estimate of quantal content
can be made by analysing the postsynaptic EPP (see below). Neuromuscular
transmission requires entry of calcium ions into the nerve terminal, and therefore is
weakened by suppressing transmitter release with solutions containing reduced
calcium ions. Furthermore, magnesium ions antagonize the effect of calcium by
blocking calcium channels. Thus, muscles bathed in high magnesium/low calcium
solution have suppressed neurotransmitter release, which prevents the generation of
action potentials leaving EPPs. The quantal content can subsequently be measured
from EPPs in the muscle fibre. This method has limitations: the use of high
magnesium suppresses the overall transmitter release from the nerve, and therefore
measurement of quantal content may result in a reduced estimate. A more accurate
measure of quantal release can be made by using p-conotoxin, which suppresses the
muscle action potential without affecting the EPP.
Only muscle fibres that responded to nerve stimulation were further investigated.
The response of axotomized and contralateral muscles following repetitive
stimulation of the nerve (100 times; at 2Hz) was recorded as above. These responses
were subsequently processed offline, and an assessment of transmitter release was
made using the 'failures method' of quantal content analysis. This method uses the
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following equation: M = In (no. trials/no. failures), where M denotes the quantal
content. This formula estimates the probability of transmitter release based on the
number of failures to respond to repetitive nerve stimulation. Another method of
analysing the quantal content uses the 'variance' method, described as follows: M =
l/(cv)2, where cv = standard deviation (a)/ mean amplitude. This method takes into
account the variability of EPP amplitude during repeated stimulation. A comparison
of the two methods demonstrated that in most cases these analyses yielded similar
results, and the failures method was chosen for the analysis of quantal release at
axotomized Wlds neuromuscular junctions.
2.2.6.2 Endplate potential analysis using p-conotoxin
Intracellular recordings were obtained as detailed above, p-conotoxin (2pM) was
added to normal physiological saline at a concentration sufficient to abolish the
muscle action potential. The preparation was bathed in this solution for 15 minutes or
until all muscle action potentials ceased before intracellular recording was
performed. Only muscle fibres that responded to nerve stimulation were further
investigated. The response of axotomized and contralateral muscle to repetitive nerve
stimulation (100 times) was recorded, and assessed offline for the number of failures.
2.2.6.3 Intracellular recording from identified junctions
TA nerve terminals 4 days post axotomy were stained with 2pM FM1-43 as detailed
above (see 2.2.3). Labelled nerve terminals were briefly visualised, and a suitable
endplate chosen for intracellular recording. Recording microelectrodes were filled
with potassium chloride solution. The microelectrode was carefully guided towards
the selected muscle fibre under the microscope. TA nerve muscle preparations were
bathed in physiological saline containing p-conotoxin (see above, 2.6.1.2) in order to
abolish muscle action potentials. Intracellular recordings were performed as detailed
above (see 2.6). Recordings were only made from neuromuscular junctions that were
occupied by a visibly stained nerve terminal. Several muscles fibres were recorded
from in this manner, and then the preparation was stained with TRITC conjugated a-
Bungarotoxin (see 2.2.3) in order to label acetylcholine receptors. An analysis of
endplate occupancy was performed in order to determine direct correlations between
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nerve terminal structure and function. Electrophysiological recordings in part of this




2.3.1 Functional and morphological assessment of C57BLAVlds nerve
terminals after nerve section
The morphology of motor nerve terminals in C57BL/Wlds mice after nerve injury
was examined in three ways. First, FM1-43 loading combined with TRITC
conjugated a-Bungarotoxin allowed the visualisation of recycling synaptic vesicles
and acetylcholine receptors respectively. This technique permitted the investgation of
living neuromuscular junctions. Second, nerve terminals in fixed preparations were
examined using immunocytochemical techniques to stain NF and SV2 proteins.
Third, nerve terminals were visualised over a 24 hour period to investigate the rate of
morphological changes after nerve section.
2.3.1.1 FM1-43 imaging
Motor nerve terminals of Wlds mice were stained with the vital dye FM1-43 and
TRITC a-Bungarotoxin to assess the ability of synaptic vesicles to recycle over a
period of 3 to 10 days after nerve lesion.
Unoperated Wlds nerve terminals loaded with FM1-43 were identical to unoperated
wild type mouse motor nerve terminals, indicating that there were no obvious
morphological abnormalities of adult motor nerve terminals due to the Wld mutation.
Low power observations of nerve muscle preparations revealed that motor nerve
terminals were characteristically distributed in a wide band across the middle third of
the muscle. Within this central band, neuromuscular junctions were segregated into a
series of endplate regions, concordant with the segmental innervation of the TA
muscle by the intercostal nerves 2 to 6. In most muscles, approximately a third of all
endplates were clearly visible and en face, such that the majority of nerve terminal
and acetylcholine receptors staining were visible. These junctions were selected for
further investigation. The staining pattern of FM1-43 almost exactly matched the
distribution of acetylcholine receptors. The complete overlap of staining pattern
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between the dyes was therefore designated '100% occupancy', to represent complete
occupancy of the synaptic gutter by the nerve terminal (Figure 2.2).
FM1-43 staining confirmed that synaptic vesicles in axotomized Wlds nerve
terminals remain able to recycle for a relatively long period of time (cf. Ribchester et
al., 1995). At 3 days nearly all terminals examined displayed 100% occupancy, that
is the FM1-43 staining pattern completely corresponded to the receptor distribution.
From this time onwards the number of nerve terminals stained with FM1-43 declined
until, at 10 days post axotomy, no terminals remained stained with the dye (Figure
2.3). The loss of FM1-43 terminal staining occurred asynchronously throughout the
nerve-muscle preparation - some endplates presented complete terminal stain whilst
neighbouring junctions had very little or no FM1-43 stain (Figure 2.3). Furthermore,
the loss of FM1-43 stain did not occur abruptly over the entire junction but rather
appeared to decline in a fragmentary or piecemeal manner (Figure 2.4). Thus, within
a nerve terminal some regions appeared to lose recycling synaptic vesicles earlier
than other regions. The loss of FM 1-43 stain did not occur randomly, but appeared to
localise to specific regions or boutons whose synaptic vesicles were simultaneously
affected. The incidence of fragmented nerve terminals (placed into bins as follows:
0%, 1-24%, 25-75%, 76-99% and 100% occupancy) transiently increased from 3 to 5
days post axotomy, thereafter declining (Table 2.1 and Figure 2.5).
The number of endplates that did not exhibit any FM1-43 staining, denoted as '0%
occupancy', increased in a linear fashion up to 10 days, at which time no labelled
terminals remained. The linearity of the 0% occupied series suggests that the rate of
complete loss of terminal staining is relatively constant between 3 and 10 days post
axotomy. Assuming this, approximately 12.5% of endplates degenerate per day over
this time period (Figure 2.6). Furthermore, 26% of all endplates are 100%
unoccupied by 4 days after axotomy, whereas at 3 days nearly all endplates had no
morphological alterations. This observation, coupled with the estimation of the
overall rate of FM 1-43 loss, implies that after a variable lag period loss of recycling
synaptic vesicles in motor nerve terminals of C57BL/Wlds mice takes less than 24
hours once initiated.
Many nerve terminals developed a more punctate staining pattern from 4 to 5 days
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post axotomy in comparison with wild type terminals. This consisted of highly
stained 'bright spots', usually localised to small regions of the nerve terminal (Figure
2.7). This phenomenon was particularly noticeable in nerve terminals that were in
advanced stages of loss of vesicular staining.
Endplate size and shape was correlated with the extent of withdrawal that had
occurred. Size analysis was conducted to establish whether larger endplates withdrew
faster. This theory was proposed in light of the fact that in older Wlds mice axotomy-
induced changes take place at a faster rate (Perry, Brown and Tsao, 1992; Tsao et a/.,
1994; Ribchester et al., 1995). Older mice in general have larger endplates (see
Sanes and Lichtman, 1999). Therefore, it is possible that larger endplates withdraw
faster than smaller ones. Morphometric analysis of endplates between 3 and 10 days
post axotomy indicated that fragmentation and loss of FM1-43 staining was
independent of either size or shape. Both these parameters were measured in the
Openlab software package by drawing a digital lasso around the endplate region.
Overall, neither large nor small endplates were especially predisposed to loss of
vesicle recycling (Figure 2.8, 2.9). Using the Spearman Rank Correlation test, at 7
and 9 days post axotomy smaller nerve terminals were significantly more persistent
than larger terminals, although the correlation coefficient of these regressions were
relatively low (-0.243 and -0.3524 respectively, 1 designates perfect correlation for
persistent large endplates, -1 vice versa). In addition, the shape of a particular
endplate had little influence on the loss of FM1-43 staining (Figure 2.8, 2.10). The
shape coefficient was calculated from the formula 4n Area/Perimeter2, which
produces a value of 1.0 for a perfect circle. A value farther from 1.0 would describe a
more irregularly shaped endplate. According to the Spearman Rank Correlation, at 6
days post axotomy irregularly shaped endplates were significantly persistent over
more regular shaped ones (-0.251, 1 designates perfect correlation for persistent
regularly-shaped endplates, -1 vice versa). At 8 and 9 days post lesion the converse
was true - regular shaped nerve terminals were significantly more persistent (0.345
and 0.4788). At all other days examined, neither round nor irregularly shaped
endplates were significantly predisposed to loss of vesicle recycling.
Although the nerve terminal staining pattern clearly changed, the distribution and
fluorescent intensity of a-Bungarotoxin stained acetylcholine receptors did not
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appear to change over the period examined. Morphometric quantification indicated
that the fluorescent intensity of acetylcholine receptor staining did not significantly
alter during the period of loss of synaptic vesicle recycling in Wlds nerve terminals
(Figure 2.11). Staining of endplates 3 to 10 days post axotomy was assessed by
measuring the pixel intensity of acetylcholine receptors labelled with TRITC a-
Bungarotoxin. The pixel intensities of receptors in occupied and unoccupied regions
at the same neuromuscular junction were compared. Note that the receptor
measurements were gathered from preparations that had been stained only with
TRITC conjugated a-Bungarotoxin, then latterly loaded with FM1-43 and the same
endplates relocated to assess the extent of loss of FM1-43 stain. This method
removed the possibility of 'bleed through' of FM1-43 dye into the a-Bungarotoxin
emission spectrum, which would affect quantitative measurement of pixel intensity.
The results indicate that the pixel intensity of receptors underlying regions of
actively recycling vesicles did not differ significantly from the pixel intensity of
receptors below unoccupied regions (paired t-test: p = 0.434; see Figure 2.11).
To summarise, Wlds motor nerve terminals undergo a piecemeal reduction in actively
recycling synaptic vesicles from 3 days post axotomy onwards, resulting in the
complete loss of all staining by 10 days. Decline in actively recycling vesicles is
randomly initiated after a variable time delay, and once begun appears to proceed in
a linear fashion until complete. Acetylcholine receptor distribution does not change
significantly during this period.
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Table 2: fractional occupancy of axotomized endplates
Occupancy (as % of total no. endplates)
-n
, Total no.
ays pos 0% 124% 25-75% 76-99% 100% endplates/
axotomy r .J animals
3 0 0 0 9.3 90.7 129/4
4 26.2 2.4 19.0 19.0 33.3 112/4
5 28.2 16.7 12.8 16.7 25.6 118/6
6 58 15 8 9 10 157/6
7 54.5 13.0 11.7 15.6 5.2 87/5
8 56.1 26.8 7.3 4.9 4.9 101/4
9 80 14.3 5.7 0 0 98/3
10 100 0 0 0 0 146/4
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FIGURE 2.2: FM1-43 STAINING AT WLDS NEUROMUSCULAR JUNCTIONS.
FM1-43 staining at unoperated control TA Wlds neuromuscular junctions.
Images A and C show acetylcholine receptors labelled with TRITC-conjugated a-
Bungarotoxin.
Images B and D show recycling synaptic vesicles loaded with the vital dye FM1-43. Faint
preterminal staining can be detected in B.
Note the precise overlap between the distribution of FM1-43 stained synaptic vesicles and
postsynaptic acetylcholine receptors. This is denoted as '100% occupancy'.




Figure 2.3: OCCUPIED AND UNOCCUPIED ENDPLATES AT AXOTOMIZED WLDS
NEUROMUSCULAR JUNCTIONS.
Axotomized Wlds TA neuromuscular junctions, showing complete absence of FM1-43
staining (0% occupancy), and adjacent occupied endplates.
A. and B. Acetylcholine receptors labelled with TRITC-conjugated a-Bungarotoxin (A), and
FM1-43 staining (B) from the same neuromuscular junction 8 days after axotomy. There was
no FM1-43 staining detected at this junction, suggesting that all synaptic vesicles had
stopped recycling. This endplate was denoted as 0% occupied.
C. and D. Acetylcholine receptors labelled with TRITC-conjugated a-Bungarotoxin (C). and
FM1-43 staining (D) at two neuromuscular junctions 7 days after nerve lesion. At one
junction (located in the middle of the image), no vesicular staining was detected and this
endplate was classed as 0% occupied. An adjacent endplate displayed robust FM1-43
staining.




Figure 2.4: PARTIAL REDUCTION IN NERVE TERMINAL STAINING AT
AXOTOMIZED WLDS NEUROMUSCULAR JUNCTIONS.
Axotomized Wlds TA neuromuscular junctions, showing piecemeal reduction in endplatc
occupancy by nerve terminal processes stained with FM1-43.
A and B; C and D; E and F: Acetylcholine receptors labelled with TRITC-conjugated a-
Bungarotoxin (A, C and E), and FM1-43 staining (B, D and F) from the same
neuromuscular junction.
A and B. Reduction of FM1-43 nerve terminal staining at one bouton 7 days after axotomy
(see B, red arrow), leaving the underlying acetylcholine receptors unoccupied (see A). The
preterminal axon is clearly stained.
C and D. Wlds neuromuscular junction 9 days after axotomy. Morphometric measurements
indicate that this endplate has 76% occupancy.
E and F. Wlds neuromuscular junction 8 days after axotomy. Large regions of the nerve
terminal are not stained with FM1-43 (see F). This endplate is 54% occupied.





Figure 2.5: FRACTIONAL OCCUPANCY OF AXOTOMIZED WLDS ENDPLATES AS
ASSESSED BY FM1-43 STAINING.
Loss of actively recycling synaptic vesicles at axotomized TA neuromuscular junctions. 948
endplates and 36 animals were morphometrically assessed for occupancy criteria. The
average occupancy of an endplate is correlated with days following axotomy.
At 3 days post axotomy the average endplate is 99% occupied, and largely remains
morphologically unaltered.
From 4 days post axotomy onwards the average occupancy of endplates declines, until at 10
days an average of only 1% of the muscle endplate was covered by actively recycling
vesicles, as assessed by FM1-43.


















FIGURE 2.6: RATE OF LOSS OF FMl-43 STAINING AT AXOTOMIZED WLDS
NEUROMUSCULAR JUNCTIONS.
An estimation of the rate of loss of FM1-43 staining at Wlds TA neuromuscular junctions.
Rate of endplates entering 0% occupied state (total loss of FMl-43 stain). The number of
endplates that are 0% occupied, taken as a percentage of the total number of endplates
examined, is plotted against the number of days post axotomy. The data represent pooled
results from 948 endplates and 36 animals. The linearity of the data was assessed using the
non-parametric Spearman Rank Correlation. The correlation coefficient, r, was calculated as
0.9286 (p=0.0022), which indicates that the number of endplates which become completely
unoccupied is directly proportional to the number of days post axotomy. This predicts that
these data are nearly perfectly linear. Therefore, the rate of increase in 0% occupied
endplates can be calculated using the slope of the linear regression. From this, it is estimated
that the number of endplates that become fully unoccupied increases by 12.49% per day
from 3 days post axotomy to 10 days post axotomy. Conversely, the number of endplates
that remain either fully occupied or partially occupied declines by 12.49% every day.
Assuming this rate, 99.92% of nerve terminals entirely lose actively recycling vesicles
between 3 and 10 days post axotomy.






Figure 2.7: PUNCTATE NERVE TERMINAL STAINING AT AXOTOMIZED WLDS
NEUROMUSCULAR JUNCTIONS.
Axotomized Wlds TA neuromuscular junctions in advanced stages of loss of actively
recycling vesicles often developed a pattern of highly localised FM1-43 staining.
Acetylcholine receptors labelled with TRITC-conjugated a-Bungarotoxin (A and C), and
FM1-43 staining (B and D) from the same neuromuscular junction.
A and B. Wlds neuromuscular junction 7 days after axotomy. This nerve terminal is in the
advanced stages of loss of FM1-43 staining. Intensely stained regions of synaptic vesicles
(sec B) are represented as bright spots in this image.
C and D. Wlds neuromuscular junction 6 days after axotomy. One bouton appears saturated
with FM1-43 dye, perhaps indicating a clustering of recycling synaptic vesicles.






FIGURE 2.8: VARIATION IN SHAPE AND SIZE OF NEUROMUSCULAR
JUNCTIONS.
In the TA muscle, neuromuscular junctions were of extremely variable shape and size.
Distinctly different junctions arc represented below.
Acetylcholine receptors labelled with TRITC-conjugated a-Bungarotoxin (A and C), and
FM1-43 staining (B and D) from the same neuromuscular junction. Both junctions are from
control, unoperated Wlds TA muscles.
A and B. Small, circular-shaped neuromuscular junction. Note the compact distribution of
nerve terminal boutons. This endplate has a shape coefficient of 0.98.
C and D. Large, irregular-shaped neuromuscular junction. This junction is distributed over a
large area, with a dispersed patterning of nerve terminal processes and underlying
acetylcholine receptors. The shape coefficient for this endplate is 0.20.




Figure 2.9: EFFECT OF ENDPLATE SIZE ON THE WITHDRAWAL OF
AXOTOMIZED WLDS NERVE TERMINALS.
Graphs A to H (illustrating data from 3 to 10 days post axotomy) show the effect of the size
of endplates on the withdrawal of axotomized Wlds TA nerve terminals. Each point
represents one endplate. Some points superimpose. These data are pooled from 948
endplates and 36 animals.
All graphs were statistically analysed using the non-parametric Spearman rank correlation to
investigate the relationship between the size of a neuromuscular junction on the withdrawal
of the nerve terminal from that junction. This analysis indicated that at 7 and 9 days (see E
and G) post axotomy larger nerve terminals were significantly more predisposed to loss of
FM1-43 staining than smaller ones (r = -0.243 and -0.352, p = for 7 and 9 days post axotomy
respectively; see trend lines). At all other days there was no significant correlation between
the size of an endplate and the withdrawal of the overlying nerve terminal.
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Figure 2.10: EFFECT OF ENDPLATE SHAPE ON THE WITHDRAWAL OF
AXOTOMIZED WLDS NERVE TERMINALS.
Graphs A to H (illustrating data from 3 to 10 days post axotomy) show the effect of the
shape of endplates on the withdrawal of axotomized Wlds TA nerve terminals. Each point
represents one endplate. Some points superimpose. These data are pooled from 948
endplates and 36 animals.
The shape coefficient of an endplate was measured using the following formula:
4 7i Area/Perimeter2, which returns a value of 1.0 for a perfect circle. Irregular shaped
endplates have shape coefficients farther from 1.0.
These data were analysed using the non-parametric Spearman rank correlation to assess the
influence of the shape of an endplate on the withdrawal of Wlds nerve terminals following
axotomy. At 6 days post axotomy (see D), irregularly-shaped endplates were significantly
more persistent than more regular shaped endplates (r = -0.251, p =; see trend line). At 8 and
9 days (see F and G) more circular and regular shaped endplates were persistent (r = 0.345
and 0.479, p = for 8 and 9 days post axotomy respectively; see trend lines). At all other time
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Figure 2.11: ACETYLCHOLINE RECEPTOR INTENSITY IN OCCUPIED AND
UNOCCUPIED REGIONS OF PARTIALLY OCCUPIED ENDPLATES.
Acetylcholine receptor intensity measurements at TA neuromuscular junctions.
The pixel intensity of TRITC a-Bungarotoxin stained receptors was analysed in occupied
and unoccupied regions of the same endplate. There was no significant difference (paired t-
test, p = 0.434) in the pixel intensities of occupied and unoccupied areas of 30 endplates
from 8 muscles, 3 to 10 days post axotomy.
Error bars are standard error of the mean.

















Motor nerve terminals of Wlds mice 4, 6 and 10 days post axotomy were labelled
with antibodies to neurofilament 200 protein (NF) and synaptic vesicle protein 2
(SV2). Acetylcholine receptors were labelled with TRITC conjugated a-
Bungarotoxin.
In unoperated nerve terminals NF and SV2 labelled the preterminal axon, including
the intramuscular nerve, and the nerve terminal itself At the neuromuscular junction
there was complete overlap between the nerve terminal and distribution of
acetylcholine receptors labelled with a-Bungarotoxin (Figure 2.12, and Figure 2.17).
This was designated as 100% occupancy, and appeared identical to the overlap
between FM1-43 and a-Bungarotoxin staining patterns. The distribution of NF/SV2
labelling in unoperated Wlds nerve terminals was identical to that observed in
unoperated wild type terminals.
In accordance with the persistence of recycling synaptic vesicles, as assessed by
FM1-43, NF/SV2 staining was observed in axotomized nerve terminals for up to 10
days post axotomy. The number of 100% occupied endplates gradually declined
from 4 to 10 days (Figure 2.13). Correspondingly, the number of 0% occupied
endplates increased during this time until at 10 days nearly all endplates examined
showed no signs of NF/SV2 labelling. During this time, endplates that were partially
occupied endplates transiently increased during this period (see Figure 2.14, and
Figure 2.15).
These findings correlate with the data gathered using the FM1-43 staining protocol.
A graphical comparison of FM1-43 and NF/SV2 staining procedures is presented in
Figure 2.16. Unlike the loss of vesicle recycling, however, which was complete by
10 days post axotomy, some endplates did show signs of NF/SV2 labelling at this
time, although it was impossible to distinguish whether this was attributable to
labelling of NF or SV2 protein. It must be noted that the presence of NF/SV2 label in
nerve terminals 10 days post axotomy was often difficult to discern from background
levels. However, in these cases any staining pattern over the endplate area was
considered to represent residues of the synaptic vesicles and quantified as such.
Similar to the observations of loss of FM 1-43 staining, the loss of NF/SV2 proteins
after axotomy is asynchronous both between different nerve terminals and within the
65
Chapter 2
nerve terminal itself. Inter-terminal loss of NF/SV2 protein is shown in figure 2.15c,
which illustrates fully occupied endplates adjacent to endplates which have no
NF/SV2 labelling. Intra-terminal loss, which compares with images obtained using
FM1-43 staining, is characterised by a piecemeal reduction in the number of boutons
occupying the synaptic gutter (Figure 2.14, and Figure 2.15). Nerve terminals
labelled with NF/SV2 were not fragmented, as would be expected if they were
undergoing Wallerian degeneration, but rather appeared to be systematically
withdrawing from the neuromuscular junction sequentially. An overview of a nerve
muscle preparation 6 days after axotomy shows nerve terminals in varying stages of
NF/SV2 loss (Figure 2.17). During the withdrawal period the parent axon always
persisted, and eventually appeared to absorb its nerve terminal and recede. Thus
various stages of withdrawal were apparent, ranging from an almost intact nerve
terminal beginning to pull away from an outlying bouton to more a penultimate
situation where only one or two boutons remain, connected to the preterminal axon
by fine strands (Figure 2.18, and Figure 2.19). In cases where only a small portion of
the nerve terminal remained, terminal boutons were always connected to the parent
axon; isolated regions of nerve terminal were not observed at any of the 886
endplates assessed, consistent with the proposal that nerve terminal boutons undergo
a withdrawal process. The final stage involved the withdrawal of all terminal
ramifications into an oval swelling, or retraction bulb, near the margin of the
endplate (Figure 2.18). Often one or more swellings were observed proximal to the
terminal retraction bulb, resulting in a bead-like appearance of axonal staining.
Terminal retraction bulbs and the more proximal swellings were usually oval in
shape, although some were almost circular. Measurements of the shortest and longest
cross-sectional diameters of 25 terminal retraction bulbs indicated that the average
size was 5.4 pm x 9.9 pm (± 0.5 x 1.1 pm), whilst more proximal swellings were
larger at 6.4 pm x 11.0 pm (± 1.1 x 1.2 pm). The largest terminal retraction bulbs
were observed in preparations 10 days after axotomy. Retraction bulbs were first
detected in nerve terminals in the final stages of withdrawing from the
neuromuscular junction, from 4 days onwards. As time progressed, the incidence of
retraction bulbs increased until at 10 days post axotomy nearly all axons were
associated with a terminal retraction bulb. Initially most terminal swellings were
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located on or close to the endplate zone. However, in the latter stages (6 days post
axotomy onwards) retraction bulbs were most often observed nearby or within the
intramuscular nerve. This is illustrated in Figure 2.19D. In sum, axotomized motor
nerve terminals of C57BL/Wlds mice withdraw from the neuromuscular junction
after nerve section after a variable delay. This withdrawal is characterised by gradual
loss of terminal boutons and formation of a retraction bulb, which then recedes from
the endplate region into the intramuscular nerve. Withdrawal of the nerve terminal
precedes any loss of preterminal axonal labelling.
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Figure 2.12: NEUROFILAMENT AND SV2 STAINING AT WLDS
NEUROMUSCULAR JUNCTIONS.
NF/SV2 staining at unoperated control Wlds TA neuromuscular junctions.
A shows acetylcholine receptors labelled with TRITC-conjugated a-Bungarotoxin.
B illustrates nerve terminal boutons and preterminal axons labelled with NF/SV2.
C depicts an image taken using a triple band pass filter block, which allows both red and
green fluorescent wavelengths to be visualised simultaneously. Overlap between the green
fluorescent nerve terminal and the red fluorescent acetylcholine receptors is visualised as
yellow.
Note the precise overlap between the distribution of NF/SV2 stained nerve terminal
ramifications and postsynaptic acetylcholine receptors. This is denoted as '100%
occupancy'.




FIGURE 2.13: FRACTIONAL OCCUPANCY OF AXOTOMIZED WLDS ENDPLATES
AS ASSESSED BY NF/SV2 STAINING.
Loss ofNF/SV2 labelling at axotomized TA neuromuscular junctions. Endplates from 886
endplates and 13 animals were morphometrically assessed for occupancy criteria, and placed
into bins of 0%, 1-24%, 25-75%, 76-99%, and 100% occupancy. Each group is represented
as a percentage of the total number of endplates analysed. The number of fully occupied









Figure 2.14: WITHDRAWAL OF NERVE TERMINAL PROCESSES FROM
AXOTOMIZED WLDS NEUROMUSCULAR JUNCTIONS.
The loss of nerve terminal structure at axotomized Wlds TA neuromuscular junctions results
from the retraction of terminal ramifications from the endplate area.
A illustrates the withdrawal of nerve terminal boutons, leaving unoccupied regions of
acetylcholine receptors. Fine strands connect retracting nerve terminal processes to the
parent axon.




Figure 2.15: OCCUPIED AND UNOCCUPIED AXOTOMIZED WLDS ENDPLATES.
Axotomizcd WlcT TA neuromuscular junctions, in varying states of nerve terminal
withdrawal.
A and B show nerve terminals which are in the process of retraction. Vacant regions of
acetylcholine receptors, which have been denuded by the withdrawal of terminal boutons,
are visualised as red.
C illustrates the inter-terminal variation between the retraction of nerve terminal boutons.
Two almost fully occupied endplates lie adjacent to two endplates at which withdrawal is
complete.






FIGURE 2.16: COMPARISON OF FRACTIONAL OCCUPANCY OF AXOTOMIZED
WLDS ENDPLATES AS ASSESSED BY FM1-43 AND NF/SV2 STAINING.
Loss of FM1-43 staining and NF/SV2 labelling at axotomized TA neuromuscular junctions.
Loss of NF/SV2 labelling at axotomized neuromuscular junctions.
Loss of actively recycling synaptic vesicles at axotomized Wlds neuromuscular junctions
was assessed at 189 endplates from 5 animals These endplates were measured and placed
into bins of 0%, 1-24%, 25-75%, 76-99%, and 100% occupancy. Each group is represented
as a percentage of the total number of endplates analysed.
NF/SV2 labelled endplates from 886 endplates and 13 animals were morphometrically
assessed for occupancy criteria, and placed into bins of 0%, 1-24%, 25-75%, 76-99%, and
100% occupancy. Each group is represented as a percentage of the total number of endplates
analysed.
These data indicate that there is a close correspondence between the two techniques used for
labelling Wlds nerve terminals following axotomy.
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Figure 2.17: COMPARISON OF CONTRALATERAL CONTROL AND
AXOTOMIZED WLDS NEUROMUSCULAR JUNCTIONS.
Low power images of unoperated contralateral control and 6 day axotomized Wlds TA
neuromuscular junctions.
A shows xlO magnification of a control Wlds TA muscle immunocytochemically labelled
with antibodies to NF/SV2. All motor endplates are innervated by axons. Axons in
intramuscular nerve bundles are clearly visible.
B shows an overview (xlO magnification) of a 6 day axotomized Wlds TA muscle. Many
endplates are unoccupied by nerve terminals. There is evidence of nerve terminal withdrawal
at some endplates. Axons in the intramuscular nerve bundle are still visibly connected to
retracting nerve terminal processes.




Figure 2.18: WITHDRAWAL OF NERVE TERMINAL PROCESSES RESULTS IN
THE FORMATION OF A RETRACTION BULB AT AXOTOMIZED WLDS
NEUROMUSCULAR JUNCTIONS.
The loss of nerve terminal structure at axotomized Wlds TA neuromuscular junctions results
in the formation of a perijunctional swelling known as a retraction bulb.
A illustrates a retraction bulb overlying a small area of acetylcholine receptors at a 4 day
axotomized junction. The majority acetylcholine receptors are unoccupied, presumably
reflecting the withdrawal of terminal boutons. A secondary, more proximal, swelling is also
evident.




FIGURE 2.19: RETRACTION BULBS AT AXOTOMIZED WLDS NEUROMUSCULAR
JUNCTIONS.
Retraction bulbs are present at various stages after nerve lesion, and eventually recede to the
intramuscular nerve bundle.
A to D depict retractions bulbs in axotomized Wlds TA muscles.
A. Retraction bulb located close to a an endplate 4 days after nerve lesion. It is probable that
this process originally innervated the endplate close to it.
B. and C. Progressive withdrawal of retraction bulbs (see arrow in B) from the endplate area
in 4 and 6 day axotomized muscles. Retraction bulbs are located at distances further from the
endplate region as time progresses.
D illustrates two retraction bulbs (see arrows) located within the intramuscular nerve bundle
6 days after axotomy.





2.3.1.3 Repeated visualisation of axotomized Wlds nerve muscle preparations
Motor nerve terminals of Wlds mice were axotomized and after 4 days stained with
the vital dye FM1-43 and TRITC a-Bungarotoxin and visualised over a period of 24
hours ex vivo in order to determine the rate of degeneration once initiated.
Individual endplates were chosen for repeated visualisation. It was not possible to
distinguish any FM1-43 staining after 12 hours, so data was only obtained up to 9
hours ex vivo. In 3 muscles, several endplates were examined and 6 were selected for
repeated visualisation. Of those, 3 endplates showed signs of loss of terminal staining
over periods ranging from 1 to 7 hours ex vivo, and one of these endplates is
illustrated in Figure 2.20. From these images, it appears that nerve terminals recede
from the endplate region relatively swiftly once the withdrawal process has been
initiated. These endplates were assessed for occupancy criteria and the data are
represented in Figure 2.21. These observations confirm that the decline in synaptic
staining takes place gradually and in a piecemeal manner rather than abruptly.
The decline in occupancy of endplates may merely be an effect of prolonged
exposure to fluorescent light, and as such considered an artefactual finding.
However, two observations suggest that this is not so. First, photobleaching, the
reduction of fluorescence labelling by overexposure to fluorescent light, would
presumably have a global effect on the nerve terminal being visualised, and as such
result in the reduction of FM1-43 stain uniformly over the entire terminal. This did
not occur in any instance. Second, phototoxicity (disruption of morphology resulting
from toxic side effects of exposure to fluorescent light) or photobleaching would
affect the entire region which was illuminated for that period, rather than selectively
causing damage or bleaching to one nerve terminal and not another. Figure 2.22
shows examples of nerve terminals labelled with FM1-43 appear fully or nearly fully
functional after 9 hours ex vivo. These terminals, although not directly repeatedly
visualised for this period, were nevertheless exposed to fluorescent light for the same
time as the endplates that were studied.
Alternatively, the decline in the occupancy may be a result of the trauma involved in
dissection, and the conditions in which the preparation was placed. To counter this
fresh physiological saline was routinely supplied to the preparation, and both the
saline and the preparation were maintained at 37 °C at all times. Furthermore, as
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previously mentioned, most endplates visualised appeared normal even after 9 hours
ex vivo (Figure 2.22). Thus, not all nerve terminals underwent withdrawal, as would
be expected at 4 days post axotomy. However, it would be imprudent to discount the
possibility that some alterations in terminal morphology may have resulted from the
constraints of the experimental protocol, and these results represent only one
interpretation of the decline in FM1-43 staining. Further evidence is needed to
consolidate these findings, although the technical difficulty of ex vivo labelling of
living endplates precluded an in-depth study in this thesis.
Overall, it is apparent that nerve terminal withdrawal proceeds within a relatively
short time span once initiated, over approximately 4 to 6 hours.
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Figure 2.20: REPEATED VISUALISATION OF WITHDRAWING AXOTOMIZED
WLDS NERVE TERMINALS.
Nerve terminal withdrawal ex vivo in axotomized Wlds TA muscles, visualised over 4 hours.
These images depict the progressive retraction of terminal boutons at endplate 1 (see Figure
2.21).
A. and B. Acetylcholine receptors labelled with TRITC-conjugated a-Bungarotoxin (A), and
FM1-43 staining (B) from the same neuromuscular junction 4 days after axotomv, ex vivo.
These images were taken soon after dissection (t = 0).
C illustrates the decline in FM1-43 staining at some region of the nerve terminal (see arrows)
2 hours after first visualisation (t = 2). This may reflect the withdrawal of nerve terminal
processes. Some regions appear more persistent than others.
D. Almost complete loss of FM1-43 staining over the endplate region, 4 hours after first
visualisation (t = 4). Two bright spots remain.




Figure 2.21: REPEATED VISUALISATION OF WITHDRAWING WLDS NERVE
TERMINALS.
Repeated visualisation of Wlds TA nerve terminals undergoing withdrawal. All data from 4
day axotomized TA endplates, 4 muscles.
Repeated visualisation of 3 endplates. Two endplates were visualised over a 6 hour period
(endplates 2 and 3), and one endplate for 4 hours (endplate 1). Decline in occupancy was
initiated at different times, but once begun proceeded to completion over approximately 4


















Time ex vivo (hours)
79
Chapter 2
FIGURE 2.22: VISUALISATION OF AXOTOMIZED WLDS NERVE TERMINALS 9
HOURS EX VIVO.
Persistent axotomized Wlds TA nerve terminals are evident after 9 hours ex vivo.
Images A and C show acetylcholine receptors labelled with TRITC-conjugated a-
Bungarotoxin.
Images B and D show recycling synaptic vesicles loaded with the vital dye FM1-43.
A and B. Acetylcholine receptors (A) and presynaptic nerve terminal (B). A small region of
the nerve terminal, stained by FM1-43, is absent.
C and D. 100% occupancy of the endplate by the nerve terminal. There appears to be
complete overlap between the distribution of acetylcholine receptors (C) and recycling
synaptic vesicles (D).




2.3.2 Functional and morphological assessment of wild type nerve terminals
after nerve section
Motor nerve terminals of C57BL/6J mice were denervated and nerve-muscle
preparations stained with FM1-43 and TRITC a-Bungarotoxin 6, 12, 18 and 24
hours post axotomy. After visualisation using the vital dyes, preparations were fixed
and labelled for NF/SV2. This procedure was problematic, as the process of labelling
with FM1-43 appeared to impart a residual background fluorescence to the muscle,
which made it difficult to immunocytochemically label junctions with NF/SV2.
Furthermore, it proved extremely difficult to visualise a neuromuscular junction
using the vital dyes and subsequently relocate and visualise the same junctions
labelled with NF/SV2. However, sufficient results were obtained to conduct a broad
survey of the degenerative changes that take place after the axotomy of wild type
muscles.
Unoperated nerve-muscle preparations stained with the FM1-43 were identical in
appearance to unoperated Wlds preparations. There was complete overlap between
the FM1-43 staining pattern and the distribution of the TRITC a-Bungarotoxin
labelled acetylcholine receptors (Figure 2.23). Terminal morphology was assessed
for occupancy criteria in the same way as Wlds nerve terminals.
At 6 hours after denervation most endplates appeared fully occupied, with a few
exceptions. At the majority of neuromuscular junctions FM1-43 staining revealed
actively recycling vesicles similar to that of unoperated animals, and passive staining
demonstrated that the preterminal axon appeared intact. However, some endplates
shows signs of degeneration. In these cases, FM1-43 labelling appeared fragmented
and diffuse, and these changes appeared to occur over the entire endplate region
rather than localising to specific regions of the nerve terminal (Figure 2.24). NF/SV2
staining appeared normal in most cases, with the nerve terminal and innervating axon
visibly labelled. However, some endplates were clearly undergoing degeneration.
Degenerating endplates were characterised not only by a fragmented nerve terminal
structure, but also by a reduction in the NF/SV2 labelling of the parent axon
supplying the terminal. The staining pattern observed in these cases did not resemble
that of axotomized Wlds nerve terminals.
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After 12 to 18 hours post axotomy, many endplates were abnormal and clearly
undergoing degenerative changes (Figure 2.24). Some nerve terminals appeared to
have completely degenerated at this stage, with only receptor staining visible at the
endplate. Those terminals that had not entirely degenerated were diffusely stained
with FM1-43, and appeared fragmented over the entire endplate region. At many
degenerating nerve terminals FM1-43 staining appeared to be randomly clustered
over various regions of the endplate, whilst other boutons were only slightly labelled
see (Figure 2.25). NF/SV2 staining of these endplates confirmed that the terminal
structure was fragmented, and suggested that synaptic vesicles were clustering in
various areas of the nerve terminal (Figure 2.25, and Figure 2.26). Furthermore,
preterminal axon staining was also extremely fragmented, and often apparently
discontinuous with more proximal sections of the axon and the intramuscular nerve
(Figure 2.26). In some cases the preterminal axon persisted beyond the in situ
degeneration of its associated nerve terminal (Figure 2.26).
Motor nerve terminal degeneration was largely complete by 24 hours post
denervation. Some isolated incidences of FM1-43 staining were observed, but in
every case appeared severely fragmented.
At all the denervated endplates examined (437 endplates in 11 muscles), there was
no evidence of piecemeal withdrawal, sequestration of the nerve terminal into the
parent axon, formation of terminal retraction bulbs, or withdrawal from the endplate
region. In wild type preparations degeneration clearly took place in situ, with the
nerve terminal disassembling at the neuromuscular junction, followed by the loss of
the parent axon at various points. This was confirmed by both vital FM1-43 staining
and NF/SV2 labelling of fixed preparations.
82
Chapter 2
Figure 2.23: FM1-43 STAINING AT WILD TYPE MOUSE NEUROMUSCULAR
JUNCTIONS.
FM1-43 staining at unopcrated control C57BL/6J mouse neuromuscular junctions in TA
muscles.
A illustrates acetylcholine receptors labelled with TRITC-conjugated a-Bungarotoxin.
B shows recycling synaptic vesicles loaded with the vital dye FM1-43. Preterminal staining
is evident in this image.
Note the precise overlap between the distribution of FM1-43 stained synaptic vesicles and
postsynaptic acetylcholine receptors. This is denoted as '100% occupancy'.




Figure 2.24: FRAGMENTATION OF FM1-43 STAINING AT DENERVATED WILD
TYPE NEUROMUSCULAR JUNCTIONS.
FM1-43 staining at denervated C57BL/6J mouse TA neuromuscular junctions appeared
fragmentary and disorganised.
Acetylcholine receptors labelled with TRITC-conjugated a-Bungarotoxin (A, C and E), and
FM1-43 staining (B. D and F) from the same neuromuscular junction.
Images A and B show that the distribution of recycling synaptic vesicles 6 hours after nerve
section appears disrupted. FM1-43 staining is extremely fragmented and irregular, and there
is no clear pattern of FM1-43 loss. Brightly stained regions are evident.
C and D. At 12 hours post denervation, two boutons appear heavily loaded with FM1-43
dye, whilst the rest of the nerve terminal labelling is scattered, and reduced to background
levels in most areas.
E and F. At 18 hours after nerve section, very few recycling synaptic vesicles remain. Two
heavily stained regions remain. Some areas of brightly stained preterminal axon are visible.




FIGURE 2.25: FM1-43/NF/SV2 STAINING AT DENERVATED WILD TYPE
NEUROMUSCULAR JUNCTIONS.
FM1-43 visualisation at dcnervated C57BL/6J mouse TA neuromuscular junctions was
followed by labelling with antibodies to NF and SV2 verified loss of recycling vesicles was
coincident with a disruption in nerve terminal structure (A to C).
Acetylcholine receptors labelled with TRITC-conjugated a-Bungarotoxin (A), FM1-43
staining (B). and NF/SV2 labelling (C) from the same neuromuscular junction 18 hours after
denervation.
B shows irregular and fragmentary FM1-43 staining.
C illustrates the concurrent morphological disruption of NF/SV2 protein distribution. Note
that the preterminal axon appears to be discontinuous with the nerve terminal.





Figure 2.26: NF/SV2 STAINING AT DENERVATED WILD TYPE
NEUROMUSCULAR JUNCTIONS.
NF/SV2 visualisation of degenerating nerve terminals at denervated C57BL/6J mouse TA
neuromuscular junctions.
A depicts a neuromuscular junction occupied by one small NF/SV2 region 18 hours after
nerve section. The preterminal axon appears fragmented and is not connected with the
remaining nerve terminal process (arrow).
B Illustrates a largely intact nerve terminal overlying acetylcholine receptors 18 hours after
axotomy. The nerve terminal does not appear to be connected to the parent axon (see arrow).
C. A completely denervated endplate lies adjacent to an innervated endplate 12 hours after
nerve section, illustrating the variation of Wallerian degeneration between nerve terminals.




2.3.3 Electrophysiological assessment of nerve terminal withdrawal in
C57BL/Wlds mice after axotomy.
Standard electrophysiological techniques were employed to assess functional
alterations at Wlds neuromuscular junctions after nerve lesion.
Inspection of the distal nerve stump up to 2 weeks after axotomy revealed the
characteristic banded appearance of intact nerves, confirming previous reports that
the main nerve trunk remains structurally intact for prolonged periods. Freshly
dissected muscles often had signs of muscle fibre fibrillation, probably caused by
spontaneous contractile activity (Ribchester et al., 1995). Intracellular recordings
were performed on muscles 4, 5, 6, 7, 8, 12 and 13 days axotomized. In unoperated
control muscles, electrical stimulation of the distal nerve stump invariably resulted in
either an action potential or an EPP. At 4 days post lesion, the majority of muscles
fibres responded to nerve stimulation (39 out of 40). The number of innervated fibres
gradually declined from 4 days post axotomy, until at 12 days no fibres responded to
maximal nerve stimulation (Figure 2.27). During this time MEPPs were recorded,
and in many cases MEPPs were registered in fibres that were otherwise unresponsive
to nerve stimulation, confirming previous reports (Ribchester et al., 1995). Some
muscle fibres showed signs of deterioration of transmitter release (low EPPs,
sporadic failure to respond to stimulation) and in these fibres MEPPs were often
unusually large, and were sometimes of frequencies of more than 10 MEPPs per 10
second sweep. However, from 6 to 13 days post axotomy lower frequencies of
MEPPs were recorded. This is represented in Figure 2.28. Unoperated control Wlds
muscles had MEPP frequencies distributed around 1 MEPP/ 10 second sweep, or 0.1
Hz. At 4 days post axotomy, this distribution was similarly represented. From 6 days
post axotomy most endplates had unusually low MEPP frequencies, which resulted
in a skewed distribution. This is illustrated in the histograms by an asymmetric tail
extending towards the lower frequencies. Thus, the number of innervated muscle
fibres and the MEPP rate at those endplates declines during the withdrawal of Wlds
nerve terminals after axotomy.
In some cases repetitive stimulation of a muscle fibre resulted in intermittent failure
of synaptic transmission. This suggests that there may have been a decline in
transmitter release at some endplates. Therefore, a more detailed study was
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undertaken to examine transmitter release (quantal content) at endplates that remain
functionally innervated, and responded to nerve stimulation. In order to determine
the quantal content of nerve terminals, preparations were first treated to abolish
muscle action potentials so that EPPs could be analysed. Nerve-muscle preparations
were bathed either in physiological saline containing lowered levels of calcium and
elevated levels of magnesium, or p-conotoxin was added to the bathing medium.
Elevating the magnesium concentration has the effect of suppressing the overall
quantal content of nerve terminals, which abolishes action potentials, p-conotoxin
blocks sodium channels on the muscle membrane which removes the possibility of
muscle action potentials without affecting the overall quantal content.
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FIGURE 2.27: INTRACELLULAR RECORDINGS FROM AXOTOMIZED WLDS
ENDPLATES.
Timecourse of loss of synaptic transmission after axotomy in FDB muscles.
Incidence of functionally innervated fibres per 20 impaled, from 15 muscles. Each point























FIGURE 2.28: MINIATURE ENDPLATE POTENTIAL FREQUENCIES FOLLOWING
AXOTOMY OF WLDS ENDPLATES.
MEPP rates decline following axotomy ofWlds FDB muscles.
Graphs A to H (illustrating data from control, 4, 5, 6, 7, 8, 12 and 13 days post axotomy)
show the change in MEPP rate at axotomized Wlds motor endplates. These data are pooled
from 323 endplates and 15 muscles. MEPPs were sampled over a period of 10 seconds.
These data are represented as the number of MEPPs per 10 second sweep, placed into bins,
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2.3.3.1 Quantal analysis using elevated levels of magnesium
Nerve-muscle preparations were first tested in normal physiological saline, then
incubated in physiological saline incorporating elevated levels of magnesium, and
lowered levels of calcium (designated as high magnesium saline).
Muscles that were 12 and 13 days axotomized did not respond to nerve stimulation in
normal saline, and were discounted for further analysis. Intracellular recordings were
performed on 8 axotomized muscles, ranging from 4 to 8 days post axotomy
inclusive, and 8 contralateral muscles. Several fibres in each muscle were impaled
and those that responded to stimulation were further investigated. Functionally
transmitting muscle fibres were repetitively stimulated (over 100 times), and the
resulting EPPs analysed using the 'failures' method for quantal content.
The quantal contents of nerve terminals that responded to nerve stimulation are
presented in Figure 2.29. Intracellular recordings from contralateral muscles bathed
in high magnesium saline varied considerably at each data point. This was probably
due to the differential effect of high magnesium saline on each set of muscles.
Therefore, comparisons were only made between an axotomized muscle and its
contralateral control, rather than between days post axotomy. In this way,
experimental and contralateral muscles were from the same animal, subjected to
identical environmental conditions, and bathed in the same high magnesium solution.
The results indicate that at 4 days post axotomy, axotomized and contralateral muscle
fibres did not have significantly different quantal content. Thus, in muscle fibres 4
days axotomized there was no difference in the amount of transmitter release at
neuromuscular junctions which exhibited EPPs or action potentials. In this case, the
majority of neuromuscular junctions responded to nerve stimulation (see Figure 2.27)
and therefore synaptic transmission remained normal in nearly all junctions. From 5
days post axotomy onwards, the mean quantal content was significantly different
from that of nerve terminals from the contralateral muscles. This clearly represented
a deterioration of synaptic transmission at endplates that were still able to respond to
nerve stimulation. Therefore, rather than an all or none response synaptic
transmission in these muscles appears to decline gradually. In these muscles the
quantal content of individual nerve terminals varied greatly between muscle fibres:
repetitive stimulation of some fibres resulted in very few failures, or none at all,
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whilst in neighbouring adjacent fibres many failures were recorded with only a few
weak EPPs. In some muscle fibres nerve stimulation produced varying responses
from the nerve terminal: some EPPs were relatively large, whilst another stimulation
would produce a very low amplitude EPP. This variability of response is illustrated
in (Figure 2.30). The average standard deviation of EPP amplitude, pooled from
individual muscle fibres, was considerably greater from 5 to 7 days post axotomy
than that of the amplitude from the contralateral muscles. These data indicate that at
5, 6, and 7 days post axotomy Wlds nerve terminals produce erratic EPPs after nerve
stimulation in comparison with controls. At 4 and 8 days, the variability of EPP
amplitude was comparable with control. There may be two explanations for this.
First, at 4 days post axotomy the quantal content was similar to that of unoperated
controls, and most muscle fibres responded to nerve stimulation. Therefore, it is
reasonable to propose that the variability of EPPs would not differ from that of
normal muscles. At 8 days post axotomy the quantal content was significantly lower
than that of the contralateral, and very few muscles fibres responded to nerve
stimulation. In these cases, the number of endplates that remain functionally
persistent is relatively small, and therefore the sample number was accordingly low
(7 out of 35 muscle fibres responded to stimulation). In addition, the mean amplitude
was consistently low when compared to EPPs from the contralateral muscle, which
would lower the variability of the response.
Thus, EPPs recorded from muscle fibres 8 days post axotomy probably represent
nerve terminals in the final stages of withdrawal, which results in low quantal
contents, low amplitude, and a decline in variability. Nerve terminals 5 to 8 days
axotomized have significantly lower quantal contents in comparison to contralateral
controls. Furthermore, intracellular recordings from these muscles indicate highly
variable response between endplates, and also high variability of responses within
endplates. At 4 days post axotomy nearly all endplates appeared functionally
identical to those of unoperated contralateral controls.
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Figure 2.29: QUANTAL ANALYSIS OF AXOTOMIZED WLDS ENDPLATES.
Quantal content (transmitter release) of axotomized FDB endplates bathed in high
magnesium saline.
A. Intracellular recording in elevated magnesium saline from contralateral control muscle
fibres (100 traces overlaid). There were few incidences of failures at this endplate, and
the mean EPP amplitude was relatively high at 5.7mV.
B. Intracellular recordings from repetitively stimulated 7 day axotomized FDB
neuromuscular junction (100 traces overlaid). Note the large number of failures, and the
mean amplitude of EPP was low at 2. lmV.
C. Average quantal content of axotomized and contralateral endplates, data pooled from
217 fibres and 19 muscles. Error bars represent the standard error of the mean.
Significances were tested using Students' paired t-test.
* denotes p < 0.05
** denotes p <0.001
*** denotes p <0.0001















FIGURE 2.30: VARIABILITY OF RESPONSE OF AXOTOMIZED WLDS ENDPLATES
TO NERVE STIMULATION.
The variation in EPP amplitude increased in FDB muscle fibres that remained functionally
innervated. These data represent the average standard deviation of EPP amplitude, pooled
from individual muscle fibres. These data are pooled from 217 fibres and 19 FDB muscles.
Muscles were bathed in high magnesium saline.
Variability of EPP amplitude




2.3.3.2 Endplate potential analysis using p-conotoxin
Nerve-muscle preparations were bathed in p-conotoxin (2pM) to abolish muscle
action potentials, enabling an accurate analysis of EPPs at Wlds neuromuscular
junctions after axotomy. Although this concentration was sufficient to abolish muscle
action potentials in wild-type muscles for long periods of time, in axotomized Wlds
muscles the effect of p-conotoxin appeared to wear off relatively rapidly. The cause
of this effect is unknown, but may as a result of a change in sodium channel isoform
to a p-conotoxin-resistant form, perhaps induced by denervation changes in the
muscle fibre due to absence of evoked activity. This made it difficult to perform
electrophysiological techniques for the necessary period of time. Nonetheless,
sufficient data were gathered to make the following observations.
Intracellular recordings were performed on muscles 3 to 10 days post axotomy.
Muscle fibres that responded to nerve stimulation were further analysed. At 3 days
post axotomy repeated stimulation did not result in any cases of failures (100
repetitions or more). In every case an EPP was elicited upon nerve stimulation. From
4 days post axotomy onwards the number of muscle fibres that displayed no failures
declined until at 10 days post axotomy all muscle fibres sampled had some failures
(Figure 2.31). The number of muscle fibres that showed 1-99% failures, such that
repeated nerve stimulation only erratically induced EPPs, transiently increased from
3 to 5 days post axotomy declining thereafter. Concurrently, the number of fibres in
which no EPP was elicited after repetitive stimulation linearly increased from 3 days
to 10 days after nerve lesion, at which time 95% of all fibres failed to respond to
stimulation.
Recordings from contralateral controls indicated that the majority of muscle fibres
invariably responded to nerve stimulation (see graph 0% failures). In contralateral
muscles to 6 day axotomized preparations 12.5% of muscle fibres intermittently
failed to respond to nerve stimulation (see graph 1-99% failures). However, at no
time did nerve stimulation entirely fail to produce an EPP after 100 stimulations in
contralateral control preparations.
In sum, reliable (100% probability) synaptic transmission at Wlds nerve terminals
that are still able to induce EPPs deteriorates from 3 to 10 days post axotomy. After
10 days post axotomy neuromuscular transmission is almost entirely abolished at all
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endplates. Thus, decline in the transmission of nerve impulses at a neuromuscular
junction appears to take place gradually, rather than precipitously. These data
correlate strongly with observations of nerve terminal withdrawal and loss of
endplate occupancy, as visualised by FM1-43 (Figure 2.13B,C).
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FIGURE 2.31: QUANTAL ANALYSIS OF FAILURES AT AXOTOMIZED WLDS
ENDPLATES.
A. The number of failures to respond to nerve stimulation increased at Wlds axotomized
FDB endplates bathed in saline containing p-conotoxin. Data pooled from 280 muscle
fibres from 14 axotomized muscles, and 240 muscle fibres from 12 contralateral
muscles.
B. Correlation between loss of endplate occupancy as assessed by FM1-43 (0% occupancy)
and loss of neuromuscular transmission (100% failures; in p-conotoxin saline).
C. Correlation between onset of nerve terminal withdrawal as assessed by FM1-43 (<100%


















2.3.3.3 Intracellular recording from identified junctions
In order to correlate morphological observations to the electrophysiological findings,
a study was undertaken to directly determine the relationship between structure and
function at axotomized Wlds endplates. Electrophysiological recordings were made
on junctions that had been stained with the vital dye FM1-43 4 days post nerve
lesion. Independent experiments have established that the FM1-43 loading protocol
did not affect the recovery of EPP amplitude or quantal content (Betz, Ridge and
Bewick, 1993; E. Costanzo, personal communication), p-conotoxin was used to
suppress the muscle action potential, but, as noted above, the effectiveness of this
procedure was limited at axotomized Wlds junctions. This procedure was technically
challenging, and the majority of attempts at recording from identified junctions were
unsuccessful. This was reflected in the low sample number of this study.
Recordings were made from 8 muscle fibres in 4 muscles, and the data represented in
Figure 2.32. Overall, the number of failures increased as the nerve terminal withdrew
(expressed as a decline in the % occupancy). This change was not statistically
significant. Analysis of the quantal content of identified endplates indicated that
there was no change in the amount of transmitter released per pm2 from withdrawing
nerve terminals (see Figure 2.32).
Thus, from the current data, it appears that the number of failures may increase
during the period of withdrawal. This does not appear to be attributable to a
weakening of the transmitter release per unit area, but as a consequence of the
decline in the area of the nerve terminal occupying the endplate region.
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Figure 2.32: QUANTAL ANALYSIS OF FAILURES AT IDENTIFIED AXOTOMIZED
WLDS ENDPLATES.
Analysis of quantal efficacy at 4 day axotomized Wlds TA neuromuscular junctions. Data
from 8 muscle fibres from 4 muscles, 4 days after nerve lesion. Muscles were bathed in
saline containing p-conotoxin.
A. Graph to show that the number of failures increased at Wlds axotomized endplates as
nerve terminal processes retracted. This change was not significant (Spearman rank
correlation: r — -0.5728, two tailedp = 0.1511).
B. Graph to show the relationship between the quantal content per unit area and the %
occupancy. There is no significant change in quantal content per unit area as overall















The main findings presented in this chapter are as follows. At Wlds neuromuscular
junctions, the majority of nerve terminals remain morphologically and functionally
normal for at least 3 days after a nerve lesion. From 3 days onwards there is a
systematic decline in the number of intact nerve terminals, coinciding with a decline
in transmitter release at these junctions. Loss of the nerve terminal did not occur
abruptly over the entire neuromuscular junction, but was manifested by a gradual
piecemeal reduction of terminal boutons. Fine strands connecting the remaining
regions of nerve terminal with the parent axon were evident (Figures 2.14, 2.15).
Eventually, the loss of terminal ramifications was accompanied by the formation of a
perijunctional retraction bulb (Figure 2.18). Spatio-temporal examination of
retraction bulbs indicated that these structures withdrew from the neuromuscular
junction, eventually receding to the intramuscular nerve: at 4 to 6 days retraction
bulbs were located close to neuromuscular junctions, whilst at later stages the
majority of retraction bulbs were located in or near to the intramuscular nerve bundle
(Figure 2.19). At 10 days post axotomy no structural remains of nerve terminals
could be detected at the neuromuscular junction. By 12 days after nerve lesion
stimulation of the severed distal nerve segment did not in any case elicit any
transmitter release at axotomized motor endplates (Figure 2.27).
In comparison, wild-type terminals assessed by the same morphological criteria were
in some cases visibly degraded at 6 hours after axotomy, and nearly all terminals
were completely degenerated by 24 hours post axotomy (Figures 2.24, 2.25, and
2.26).
Wlds nerve terminals proceed from a morphologically intact and functionally replete
state to a situation where there is a decline in the coverage of the endplate by the
nerve terminal, coinciding with a decrease in transmitter release and transmission
probability. This study provides evidence to support the hypothesis that axotomy of
Wlds nerve terminals results in withdrawal of axonal processes from the
neuromuscular junction rather than degeneration in situ (see discussion below, and
Fig 2.33: schematic of withdrawing synapse). Withdrawal is by nature progressive,
initiated at the endplate and resulting in retraction from the neuromuscular junction.
The alterations to Wlds nerve terminals are progressive in two ways. First, some
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nerve terminals withdraw earlier than others. Thus, in any one particular area, a
structurally intact endplate may neighbour another endplate in which withdrawal is
complete. Second, withdrawal is progressive within each endplate. FM1-43 labelling
indicates that at 3 days post axotomy nearly all nerve terminals were comparable to
unoperated terminals (Figure 2.3). As time progressed an increasing number of
endplates showed partial loss of synaptic staining over the endplate, until at 10 days
post axotomy all nerve terminals had retracted from the neuromuscular junction
(Figure 2.5). Thus, nerve terminal withdrawal is asynchronous on two levels: inter-
and intra-terminal.
The size and shape of nerve terminals undergoing withdrawal was analysed to
determine whether these factors influenced the rate of nerve terminal retraction
(Figures 2.9, 2.10). Overall, synapse withdrawal at Wlds terminals was not
influenced by either the shape or the size of the junction. However, at 7 and 9 days
post axotomy smaller endplates were significantly more persistent than larger ones.
This may have a bearing on the nature of withdrawal at Wlds junctions, when
contemplating the motor unit as a whole. Consider one motor unit and its collaterals,
terminating at endplates of large and small sizes. Perhaps larger nerve terminals are
more likely to retract at earlier stages due to the constraints and demands of their size
on the parent axon. Parent axons may retract larger endplates sooner due to
metabolic demands and overstretching of resources, before beginning to withdraw
smaller endplates. Elaborating on this hypothesis, presumably endplates more distant
from the intramuscular nerve would also be more likely to withdraw sooner.
These speculations are further substantiated by the finding that at 8 and 9 days post
axotomy regularly shaped (circular) endplates were more likely to have persistent
nerve terminals than irregularly shaped ones. Presumably retraction of a nerve
terminal would begin at the periphery of the junction and proceed back towards a
central point before reabsorption into the parent axon collateral. Large and irregular
shaped endplates would more likely show signs of withdrawal, therefore, than small
circular shaped endplates.
Intracellular recordings from axotomized Wlds fibres indicated that the number of
functionally innervated endplates declined from 4 to 13 days post axotomy (Figure
2.27). At those endplates that remained functionally innervated during this period,
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quantal content was significantly lower than that of contralateral controls (Figure
2.29). Repeated stimulation of axotomized but still innervated junctions resulted in a
higher probability of failure as time post axotomy progressed (Figure 2.30). Fibres in
which no EPP/action potential could be elicited still had spontaneous MEPPs,
demonstrating that axotomized Wlds nerve terminals spontaneously release
transmitter even after loss of evoked activity. The overall MEPP frequency declined
with time (Figure 2.28), but occasionally fibres with 'bursting activity', comprising
high MEPP rates (>10/10 second), were observed. These data indicate that there is a
gradual decline in the functional innervation of an axotomized muscle. In parallel to
the morphological observations, this takes place asynchronously between muscle
fibres. In addition, nerve terminals proceed through a transitional weakened state of
low quantal release, and MEPP frequency decreases.
It seems likely that the decline in function at Wlds junctions can be attributed to the
decline in the occupancy of the endplate. This proposition is supported by the strong
correlation between the incidence of 0% occupancy and 100% failures, as shown in
Figure 2.3 IB and C. Intracellular recordings from identified junctions indicated that
the number of failures appeared to increase at Wlds axotomized endplates as nerve
terminal processes retracted, although this change was not significant (Figure 2.32A).
Thus, it is likely that endplates that are only partly occupied by the nerve terminal
have lowered quantal responses, as would be expected from the reduced number of
boutons overlying acetylcholine receptors. Reduction of nerve terminal area and
volume would probably result in a reduction in the number of active zones, and
therefore the number of synaptic vesicles available for docking. This would reduce
the safety factor of neuromuscular transmission, which would result in a higher
probability of failure of transmission, and a lower MEPP rate. Indeed, this is
observed in muscles in the latter stages of withdrawal. Furthermore, the spontaneous
bursting activity observed in some fibres may be an indicator of the crowding of
synaptic vesicles into a more confined space, as would presumably occur during
withdrawal. Overcrowding of synaptic vesicles may increase the number of synaptic
vesicles in the vicinity of an active zone, and thus increase the probability of
spontaneous quantal release, resulting in very high frequency MEPP rates. There
were morphological indicators for this hypothesis: occasionally, FM1-43 labelled
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nerve terminals had a punctate staining pattern in some areas, which implied
clustering of synaptic vesicles.
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FIGURE 2.33: WITHDRAWAL OF NERVE TERMINAL BOUTONS AT AXOTOMIZED
WLDS NEUROMUSCULAR JUNCTIONS.
A schematic to illustrate the putative phenomenon of nerve terminal withdrawal following
nerve damage in the C57BLAVlds mutant mouse.
A. Morphologically intact nerve terminals (green) closely juxtapositioned to acetylcholine
receptors (red) on the postsynaptic muscle fibre.
B. Retraction of nerve terminal boutons at axotomized Wlds neuromuscular junctions. The
onset of withdrawal varies between endplates.
C. Complete withdrawal of nerve terminal processes is accompanied by the formation of a
perisynaptic retraction bulb, and several more proximal swellings. Other nerve terminals
initiate withdrawal of nerve terminal boutons.
D. Withdrawal of axonal processes into the parent axon in the intramuscular nerve bundle.




2.4.1 Nerve terminal morphology following axotomy
Nerve terminal structure was visualised using FM1-43 and NF/SV2. These
techniques enabled the observation nerve terminal morphology following axotomy.
FM1-43 labels actively recycling vesicles at the neuromuscular junction. Therefore,
it is possible that the reduction in vesicular staining may not represent an alteration in
the overall structure of the nerve terminal. In order to determine this, FM1-43
staining was validated in several ways. First, FM1-43 is a lipophilic dye that labels
not only synaptic vesicles, but also passively labels the nerve terminal membrane and
preterminal axon (Figures 2.2 and 2.23). Alterations in the distribution and quantity
of vesicles would lead to a reduction in staining, but if the nerve terminal membrane
remained this would be detected as a passively stained object. This did not occur.
Second, NF/SV2 labelling of fixed preparations, which yielded similar results,
appeared identical to FM1-43 staining in every instance. Third, the patterning of
FM1-43 and NF/SV2 labelling appears identical to that of zinc iodide osmium
staining (Ribchester et al., 1995; personal observations) and silver cholinesterase
staining (Crawford et al., 1995). Therefore, loss of FM1-43 staining or NF/SV2
labelling is assumed to represent a reduction in the size of the nerve terminal
overlying the muscle endplate.
2.4.2 Synapse withdrawal vs. degeneration
Synapse withdrawal rather than Wallerian degeneration is indicated at axotomized
Wlds neuromuscular junctions in several ways.
First, changes in the structure of axotomized nerve terminals took place in a gradual
bouton-by-bouton manner, as indicated by serial staining of preparations using FM1-
43 and NF/SV2, and by repeated visualisation. This was unlike the staining pattern of
denervated wild-type nerve-muscle preparations. At wild-type neuromuscular
junctions, this study indicated that nerve terminals undergo an abrupt and global
fragmentation resulting in the disintegration of the terminal and its parent axon.
Degeneration at wild-type junctions took place in situ, without any withdrawal or
gradual loss of synaptic staining. These findings are in agreement with other
morphological and ultrastructural investigations. Experiments which employed silver
stain techniques to label denervated nerve terminals (Tello, 1907; Korneliussen and
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Jansen, 1976; Kawabuchi et al., 1991) indicated that terminal structure becomes
fragmented and vacuolated, and the preterminal axon disintegrates along its length.
Numerous ultrastructural studies demonstrate that nerve terminals disintegrate in
situ, characterised by loss of synaptic vesicles, formation of vesicular aggregates,
disruption of mitochondria and eventual fragmentation and degeneration of terminal
structure resulting ultimately in Schwann cell phagocytosis (Birks, Katz and Miledi,
1960; Miledi and Slater, 1970; Manolov, 1974; Winlow and Usherwood, 1975;
Riley, 1981). FM1-43/NF/SV2 staining of wild-type terminals display many parallels
of these findings: reduction of FM1-43 staining over the entire junction coincident
with regions of intense staining (indicating a reduction of synaptic vesicles and
formation of vesicular aggregates), diffuse staining of the terminal by NF/SV2
(indicating fragmentation and loss of nerve terminal proteins), and discontinuous loss
of preterminal axonal labelling (disintegration of the intramuscular axon). None of
these structural alterations were observed at axotomized Wlds terminals. A study of
the physiological properties of axotomized Wlds muscles indicated that nerve
terminals proceed through a transitional weakened state of low quantal release, and
MEPP frequency decreases. These data differ in several ways from other reports of
functional decline in denervated wild-type muscles. Miledi and Slater (1970)
demonstrated that the ability to produce an EPP following distal nerve stimulation
declined with time after denervation. However, although the time course of
degeneration varied from fibre to fibre, the loss of neuromuscular transmission at an
individual muscle fibre occurred abruptly, without passing through an intermediary
stage. Thus, an all or none response was obtained after nerve stimulation. This would
be expected, as morphological degeneration occurs over the entire junction almost
simultaneously. Furthermore, this study reported that failure of the ability to transmit
action potentials was accompanied by cessation of spontaneous MEPPs. In Wlds
mice, MEPPs persist beyond the loss of neuromuscular transmission, and
spontaneous bursting activity occurs in some fibres. Loss of functionality occurs
gradually, with a gradual decline in quantal release. These differences highlight the
fact that Wlds nerve terminals proceed through an intermediate stage before complete
loss of neuromuscular transmission. This is unlike the decline in function in
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denervated wild-type muscles. To conclude, Wlds motor nerve terminals appear not
to be removed via a delayed Wallerian degeneration mechanism.
Although it is evident that severed Wlds axons do eventually degenerate, various
studies have provided evidence that the changes that occur after axotomy in Wlds
mice are dissimilar to those that occur during Wallerian degeneration. Isolated wild
type axon segments placed into culture undergo Wallerian degeneration at the same
rate as in vivo. However, axotomized Wlds axons placed into culture medium appear
to degenerate faster than in vivo (Buckmaster et al., 1995, Parson et al., 1997). Also,
the rate of axotomy-induced changes increases in ageing Wlds mice (older than 3
months), whereas Wallerian degeneration is slower in older wild type mice. The
wave of mitotic division of Schwann cells, observed after nerve section in wild type
mice, occurs in Wlds mice but the total number of Schwann cells never reaches that
observed in wild type mice (Brown et al., 1991b). If Wallerian degeneration was
merely delayed in Wlds mice, then one would expect identical phenomena to take
place after nerve section, although imposed on a slower timecourse. Clearly,
Schwann cells not only have a delayed reaction, but also a reduced reaction to
axotomy in Wlds mice. The rate of degeneration in Wlds mice should increase with
age, similar to normal mice, but the opposite takes place. The reaction of axotomized
Wlds axons in culture systems should reflect that of normal axons, but with a delay:
in fact, Wlds degenerate more rapidly. These observations indicate that axotomized
Wlds axons may utilise a separate and distinct mechanism than classical Wallerian
degeneration. Thus, it is not known at present whether the actual process of axon
destruction observed in the distal stump of axotomized Wlds is mediated by
Wallerian degeneration (Brown, Lunn and Perry, 1992).
Thus, it seems reasonable to propose that the reduction in motor nerve terminal
staining at the neuromuscular junction and the presence of retraction bulbs,
combined with a concurrent decline in quantal release, are as a result of the
withdrawal of Wlds nerve terminals following nerve lesion.
At face value, this seems to be a strange proposition when one would expect
degeneration of nerve terminals and axons after nerve damage. However, the
mutation inherent to the C57BL/Wlds mouse may convey a complete abolishment of
classical Wallerian degeneration rather than merely a delay, as was previously
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assumed. In the absence of rapid degeneration, nerve terminals may default to a
different and underlying mechanism involving retraction and resorption.
Cajal (1928) described terminal retraction bulbs in regenerating peripheral nerves.
These terminal bulbs were 'sterile axon tips' belonging to axons that had failed to
establish peripheral contacts, perhaps going awry during their growth phase, and
were destined to be reabsorbed. Recent evidence suggests that such aberrant growth
cones may have retracted due to the influence of repulsive cues (Pini, 1993; Fan and
Raper, 1995; Messersmith et al., 1995; Piischel, Adams, and Betz, 1995). These
repulsive cues have two mechanisms of action. First, by contact inhibition whereby
axons that come into direct contact with substrate adherent molecules collapse and
retract. The second mechanism involves the diffusion of soluble factors that, upon
contact with receptors on the growth cone, induce retraction. These are termed
chemorepellants. Both these processes inhibit axonal growth in the 'wrong' direction
by collapsing growth cones entering inappropriate areas. This collapse does not
result in the death of the axon, but rather encourages axonal elongation in the correct
direction. Perhaps these mechanisms effect the retraction of axotomized nerve
terminals at the neuromuscular junction. The cue for retraction could arise from other
cell types at the neuromuscular junction, such as Schwann cells, or the muscle fibre.
The initiating factor may be that the nerve terminal is no longer wholly functional,
and thus receives a signal for retraction in the form of repelling molecules from other
cell types. This will be proposal will be explored further in the discussion to follow.
It is possible that withdrawal in Wlds nerve terminals represents a recapitulation of
other fundamental withdrawal mechanisms. For instance, withdrawal of synapses
takes place both in the developing CNS and PNS as part of the refinement of
connections that leads to the establishment of mature neuronal networks. Thus, in the
visual system, auditory system, cerebellum, autonomic ganglia and skeletal muscle
the number of axons that form synapses on individual postsynaptic cells decreases in
the perinatal period (Purves and Lichtman, 1980, 1985). In these cases, loss of some
synaptic inputs during development leads to the strengthening of the other inputs,
which ultimately results in the efficacious innervation of the target cells by relatively
few (sometimes only one) axons. What causes withdrawal in these paradigms is still
subject to speculation. However, one system that has been intensively studied in
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recent years is that of synapse elimination at the neuromuscular junction. The exact
role of synapse elimination during development is not definitively known. In broad
terms, the process can be defined as follows. In developing mammalian muscle,
many axons converge on an individual muscle fibre, which results in the multiple
innervation of that fibre (Cajal, 1909; Redfern, 1970; Bennett and Pettigrew, 1974).
This is termed polyneuronal innervation. However, these supernumerary connections
are reduced during the first two to three weeks after birth until each muscle fibre is
innervated by only one axon. This reduction is not caused by a decrease in the
number of motor neurons innervating each muscle, but instead results from a decline
in the number of muscle fibres each motor neuron innervates (Brown, Jansen and van
Essen, 1976; Balice-Gordon and Thompson, 1988). This process results in a one-to-
one relationship between muscle fibre and axon, which is thought to aid gradation of
tension of the muscle by sequential motor unit recruitment (Lichtman 1995). The loss
of surplus synapses takes place via the phenomenon known as synapse elimination.
During elimination, it is known that axons that are not ultimately destined to
innervate a fibre are removed through a gradual process of withdrawal (Korneliussen
and Jansen, 1976; Riley, 1977, 1981; Bixby, 1981; Gorio et al., 1983; Balice-Gordon
et al., 1993). Riley (1977) first coined the phrase 'retraction bulb', whilst describing
the loss of excess inputs during synapse elimination. Riley (1977, 1981) described
the withdrawal of terminal boutons from the endplate region, which resulted in the
formation of a vesicle-laden retraction bulb. This retraction bulb then receded from
the junction and was eventually reabsorbed into the parent axon. Such observations
were later reaffirmed using a technique that selectively labels convergent inputs with
lipophilic dye isoforms called Dil and DiA, which fluoresce red and green
respectively (Balice-Gordon et al., 1993). This study revealed that one input
selectively lost synaptic territory whilst the other input consolidated synaptic area.
This eventually resulted in the complete removal of all nerve terminal boutons from
one input and the formation of a retraction bulb. Interestingly, the silver stained
images of Riley's and the fluorescently labelled endplates of Balice-Gordon and
colleagues, illustrating retracting axons undergoing synapse elimination, are
extremely similar to the images of withdrawal of Wlds nerve terminals following
axotomy. These images are compared with the withdrawal and retraction of
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axotomized Wlds nerve terminals in Figure 2.34. Such similarities may reflect an
underlying homology between these phenomena.
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Figure 2.34: COMPARISON OF MOTOR AXON RETRACTION BULBS.
Retraction bulbs arise from the withdrawal of motor axon processes during synapse
elimination and after axotomy in Wlds TA muscles.
A. Silver impregnated axons 14 days after birth. Arrows point to retraction bulbs, that form
as a result of axon collateral retraction during synapse elimination. Image taken from Riley
(1977).
B. Dil (red) and DiA (green) labelled axon arbors at postnatal day 10. The image shows a
mouse neuromuscular junction that is innervated by one axon (labelled red), with a
perijunctional retraction bulb (green). The authors proposed that the retraction bulb arose as
a consequence of synapse elimination. Image taken from Balice-Gordon et al., 1993.
C. Perijunctional retraction bulb at a 4 day axotomized Wlds TA neuromuscular junction (see
Figure 2.18).




One obvious difference between the two processes is that synapse elimination
involves the retraction of a nerve terminal from a multiply innervated junction, whilst
the withdrawal of axotomized Wlds terminals entails the loss of only one input from
a singly innervated junction. Synapse elimination is thought to be driven by
competition between the multiple axons resulting in 'losers', which retract, and a
'winner', which becomes firmly established. This kind of competitive interaction
does not seem possible in Wlds muscles because only one input resides at the
neuromuscular junction. However, it is far from clear how multiply innervating
axons compete at developing neuromuscular junction. From a theoretical standpoint
competitive interaction could take place in one of two ways: direct competition and
indirect competition.
Direct competition would be manifested by the successful establishment of one input
via the demise of the other inputs. In this paradigm, a conflict between inputs ensues,
after which one nerve terminal directly weakens the other nerve terminals, resulting
in their removal. For instance, direct competition could be mediated by activity-
dependent release of a protease from the nerve terminal, which would detach the
competitors from the synapse. This hypothesis was supported by the findings of
Vrbova and co-workers, who demonstrated that stimulation of muscles in vitro
resulted in the release of proteolytic enzymes (O'Brien, Ostberg and Vrbova, 1978).
In addition, activity induced loss of nerve terminals was reduced by the application
of broad-spectrum protease inhibitors (O'Brien, Ostberg and Vrbova, 1984; Connold,
Evers and Vrbova, 1986; Vrbova and Fisher, 1989). Further experiments suggested
that calcium modulation within the nerve terminal may be the cue for release of
endogenous neutral protease release (Connold, Evers and Vrbova, 1986; Swanson
and Vrbova, 1987; Tyc and Vrbova, 1995), supporting the theory that surplus
synapses are directly removed by the nerve terminal that is destined to remain.
Indirect competition would involve the loss of one input through no direct fault of
the other inputs. Thus, the competitors do not directly affect each other, but may be
competing for a limited resource or affected in an independent way by a third factor.
In this case, the conflict is resolved via the actions of a third factor. One such
determinant of synapse elimination may be the muscle fibre. The muscle fibre may
'choose' one axon over another axon, and effect the withdrawal of the losing axons.
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It is possible that synapse elimination is resolved by a combination of both direct and
indirect competition. However, there is accumulating evidence to suggest that a more
passive mechanism for the removal of superfluous axons, such as that of indirect
competition, may operate during synapse elimination. Various reports have
suggested that the postsynaptic cell acts as the arbiter in deciding which inputs are
removed. Developmental studies of multiply innervated ganglion cells show that
these cells also undergo a reduction in the number of innervating axons (Lichtman,
1977; Lichtman and Purves, 1980). These studies demonstrated that there is a
remarkable correlation between the number of dendrites on the postsynaptic neuron
and the number of axons the neuron is ultimately innervated by (Hume and Purves,
1981; Purves and Lichtman, 1985). Furthermore, ganglion cells that eventually
become singly innervated often have no dendrites (Lichtman, 1977, 1980; Lichtman
and Purves, 1981). These reports raise the possibility that withdrawal of axonal
inputs may be determined by the postsynaptic cell. At the neuromuscular junction
there is some evidence to suggest that the muscle fibre plays a role in synapse
elimination. In situ studies of developing muscles demonstrated that there was a
removal of postsynaptic acetylcholine receptors before terminal retraction (Balice-
Gordon and Lichtman, 1993). This precocious loss of receptor staining implies that
the muscle fibre is in some way initiating the withdrawal of the nerve terminal.
Although this does not occur at axotomized Wlds junctions (there was no significant
difference between receptors underlying persistent and withdrawn nerve terminals)
perhaps another mechanism, also mediated by the muscle fibre, induces the
withdrawal of axotomized Wlds nerve terminals. For example, in a modification of
the protease hypothesis, Nelson and colleagues provided evidence that muscle fibres
release thrombin or thrombin-like proteases into the synaptic cleft (Nelson et al.,
1993; Liu et al., 1994a; Liu et al., 1994b). Both prothrombin, the precursor to
thrombin, and thrombin itself are present in muscle fibres during early postnatal life
(Zoubine et al., 1996), and thrombin induces neurite retraction via thrombin
receptors in vitro (Suidan et al., 1992). Recent experiments demonstrated that
prothrombin and the thrombin receptor are maximally expressed at birth, and
decrease 10-fold by postnatal day 20 (Kim, Buonanno and Nelson, 1999).
Indiscriminate release of proteases would presumably effect the withdrawal of all
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synapses simultaneously. However, it is thought that presynaptic activity protects the
more active input from elimination. Protease nexin 1 and hirudin are specific
thrombin inhibitors, and application of these substances delays synapse elimination
(Liu et al., 1994b). Protease nexin 1 is expressed by glia and muscle fibres, and is
localised to the neuromuscular junction (Gloor et al., 1986; Festoff, Rao and Hantai,
1991). In addition, protease nexin 1 is downregulated 4 to 5-fold at postnatal days 10
and 15, during the most intense period of synapse elimination (Kim, Buonanno and
Nelson, 1999). Therefore, release of thrombin from muscle fibres may result in the
elimination of synapses, whilst more active synapses are protected by the presence of
protease inhibitors. It is conceivable that withdrawal of axotomized Wlds nerve
terminals could be executed by such a mechanism. The release of a protease from the
muscle fibre could act as a repelling cue for the withdrawal of the nerve terminal in a
manner similar to that of a chemorepellant.
Another putative mechanism for indirect competition during synapse elimination
involves the release of a maintenance factor from the muscle fibre. In this paradigm,
the muscle fibre releases limiting amounts of a trophic factor which the more
competitive (active) nerve terminal is better able to utilise. This in turn strengthens
the more active nerve terminal whilst at the same time weakens the less active
terminals. Several factors produced by muscle fibres are capable of retarding synapse
elimination, although none as yet have entirely prevented elimination. The putative
trophic factors that delay elimination include androgenic steriods, brain-derived
neurotrophic factor (BDNF), ciliary neurotrophic factor (CNTF), fibroblast growth
factor 2 (FGF-2), glial derived neurotrophic factor (GDNF), insulin-like growth
factor 1 (IGF-1) and leukaemia inhibitory factor (LIF) (androgenic steriods: Jordan et
al., 1995; BDNF: Kwon and Gurney, 1996; CNTF: Jordan, 1996; CNTF, FGF-2:
English and Schwartz 1995; GDNF: Nguyen et al., 1998; IGF-1: Caroni and Becker,
1992; LIF: Kwon et al., 1995). However, the interpretation of many of these studies
is problematic. For instance, some of these factors induce axonal sprouting (CNTF,
FGF: Gurney, Yamamoto, and Gurney, 1992; CNTF: Kwon and Gurney, 1994), and
CNTF may cause a delay in synapse elimination by delaying muscle fibre maturation
(Martin et al., 1996). This issue is further complicated by the fact that trophic factors
often act in concert: there is usually inherent redundancy in trophic systems, whereby
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the removal of one factor is compensated by the increase in other factor(s).
Therefore, the experimental removal or addition of a single factor may not provide
startling results.
The withdrawal of trophic support could account for the retraction of nerve terminals
from Wlds neuromuscular junctions. Wlds nerve terminals undergo a decline in
quantal efficacy and spontaneous activity, which may give rise to a decline in the
release of a factor necessary for synaptic stability. Evidence from other systems
suggests that a decline in trophic factor support can induce axonal withdrawal.
Atrophy of axon arborisations has been induced by NGF withdrawal in sympathetic
neurons (Campenot, 1982a, b). Application of BDNF and neurotrophin-4 (NT-4)
prevent the formation of ocular dominance columns, suggesting that these factors
stabilise geniculate axon synapses that would otherwise be removed during the
segregation of axons into eye-specific regions (Cabelli, Hohn, and Schatz, 1995).
Increasing levels of activity, by adding of potassium chloride or lowering glutamate
concentration, dramatically increases BDNF synthesis by cortical neurons in vitro
(Ghosh, Carnahan, and Greenberg, 1994). In addition, the survival rate of retinal
ganglion cells is higher when cultured in the presence of neurotrophins and
potassium chloride, as opposed to neurotrophins alone (Meyer-Franke et al., 1995).
These reports suggest that neurotrophin release can be stimulated by activity, and
that the ability of axons to respond to trophic factors increases when they themselves
are active. At axotomized Wlds junctions, only spontaneous activity remains. Loss of
evoked activity may induce a reduction in the level of trophic support and thereby
induce nerve terminal withdrawal.
An alternate mechanism for synapse elimination involves the removal of a nerve
terminal without any competitive interactions. This theory, known as intrinsic
withdrawal, was first proposed in the light of an experiment by Brown and
colleagues (1976). In this study, neonatal rat soleus muscles were partially
denervated to the extent that the number of axons was drastically diminished to only
one or two. Therefore, some muscle fibres were only contacted by one axon
collateral. The authors predicted that synapse elimination would be prevented in the
absence of competitive interaction with other axons. However, this experiment
resulted in a surprising finding - the motor unit size, as estimated by tension
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measurements, still decreased. In a fully innervated muscle, the motor unit size (the
number of muscle fibres contacted by an individual neuron) declines during the
period of synapse elimination. This is as a consequence of the retraction and
reabsorption of some axon collaterals whilst the consolidation of other collaterals
ensues. As previously discussed, the retraction of axons from some endplates may be
due to competition with other axons at that neuromuscular junction. However, the
experiment of Brown and co-workers suggested that axons withdrew from some
junctions even though there were no other innervating nerve terminals present. There
are some technical criticisms of this study (see Lichtman, 1995), namely that tension
measurement can often be misleading because subthreshold responses are not
detected. More recently, Fladby and Jansen (1987) investigated this phenomenon in
the mouse soleus muscle using intracellular recording techniques in addition to
tension measurements to verify the innervation state (mono- or polyneuronally
innervated) of endplates after synapse elimination had ended, and reported a similar
result. Again, partial denervation of neonatal muscle, such that only one or two axons
remain, resulted in the reduction of average motor unit size. The remaining junctions
were tested using intracellular methods and all junctions were found to be mono-
neuronally innervated. Thus, some elimination of inputs must have occurred in the
absence of competitors. On the basis of these findings, axons are apparently able to
withdraw from neuromuscular junctions without any impetus from co-innervating
axons. The mechanism for this withdrawal remains subject to speculation. The nerve
terminal could self-activate a pre-programmed withdrawal mechanism after a critical
situation has been reached, resulting in the retraction of its terminal boutons from
that particular endplate. 'Inappropriate' innervation of muscle fibre may initiate this
withdrawal program. For instance, there is some evidence that adult innervation
patterns are derived via the pairing of appropriate motor units with a particular
muscle fibre type. Before synapse elimination, nerve terminals from a motor unit
often innervate both fast and slow muscle fibre types. However, the preferential
segregation of synaptic inputs through synapse elimination results in the
homogenous innervation of either fast or slow muscle fibres by a particular motor
unit (Thompson, Sutton and Riley, 1984; Fladby and Jansen, 1990; Gates and Ridge,
1992). This is known as mismatch withdrawal: fast fibres are paired with
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appropriately matched axons, and slow axons are similarly paired. Loss of
inappropriate inputs may occur via intrinsic withdrawal. Such a phenomenon may
apply to the withdrawal of axotomized Wlds axons. These axons are no longer
appropriately innervating the axotomized muscle fibres, and are therefore withdrawn.
Perhaps this is mediated via an alteration of the adhesive attachments at the junction,
resulting in stepwise retraction of terminal boutons.
Thus, there are many similarities between the naturally occurring developmental
phenomenon of synapse elimination and the withdrawal of axons from Wlds
neuromuscular junctions after nerve damage. There are numerous morphological
correlates between these process - both involve the retraction of terminal
ramifications from the endplate, eventually resulting in the formation of a retraction
bulb which withdraws from the endplate region. Both types of withdrawal appear to
proceed to completion once initiated within 1-2 days. There are also physiological
similarities between withdrawal of Wlds nerve terminals after axotomy and synapse
elimination. During synapse elimination, the quantal content and efficacy of the axon
destined to withdraw declines as time progresses (Dunia and Herrera, 1993;
Coleman, Nabekura, and Lichtman, 1997). Likewise, the quantal efficacy of
axotomized Wlds nerve terminals declined as the nerve terminal withdrew from the
endplate region. Both processes are gradual and progressive, in terms of loss of
function and loss of morphological territory, at inter- and intra-endplate levels. This
is evidenced by the asynchronous loss of nerve terminals between endplates and
within endplates.
After consideration of all these factors, synapse elimination and nerve terminal
withdrawal in the C57BL/Wlds mouse after axotomy may indeed be related
phenomena. If these processes are the same, then it should be possible to manipulate
the withdrawal of Wlds nerve terminals using experimental perturbations that affect
synapse elimination. For instance, it has previously been shown that synapse
elimination can be prevented by abolishing transmitter release at the neuromuscular
junction (see Thompson, 1985). If the same treatment were applied to Wlds nerve
terminals one would expect the same result. This hypothesis will be explored further
in the following chapter (Chapter 3).
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In sum, the findings of this chapter are that Wlds motor nerve terminals undergo




Effect of activity on nerve terminal withdrawal following
axotomy in C57BL/wlds mice.
Chapter 3
Chapter 3: The role of activity in nerve terminal withdrawal
following axotomy in C57BL/WLDs mice.
3,1 Introduction
The previous chapter demonstrated that Wlds nerve terminals appear to withdraw
from the neuromuscular junction rather than degenerate after nerve damage. The
nature of this withdrawal is not known, but the discussion accompanying Chapter 2
alluded to the similarities between the withdrawal of nerve terminals that occurs
during developmental synapse elimination and the withdrawal that takes place after
axotomy at Wlds neuromuscular junctions. Abolishing activity during synapse
elimination has the effect of preventing nerve terminal withdrawal (see below, 3.12).
This chapter comprises a study of the consequences of abolishing activity at
withdrawing Wlds motor nerve terminals. Axotomized Wlds nerve terminals do not
sustain evoked activity, in the form of action potentials conducted from the cell body
to the neuromuscular junction, because nerve conduction is interrupted by the
axotomy. However, Wlds nerve terminals disconnected from their cell bodies
maintain robust spontaneous activity, and remain able to release neurotransmitter
after stimulation of the severed distal nerve for considerable periods of time after
axotomy (see 2.3.3). Therefore, it is proposed that if synapse elimination and nerve
terminal withdrawal of severed Wlds motor axons share similar mechanisms, then
removal of activity will prevent or delay withdrawal.
3.1.1 Hypotheses
Hypothesis: Activity regulates motor nerve terminal withdrawal.
Three eventualities may occur as a of result abolishing transmitter release at
withdrawing Wlds junctions, and these can be summarised as follows:
1. Nerve terminal withdrawal is abolished.
2. Nerve terminal withdrawal is delayed, but not prevented.
3. Nerve terminal withdrawal is accelerated.
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If axotomy-induced withdrawal of Wlds nerve terminals is identical to the
withdrawal that takes place during synapse elimination, then abolishing activity
should have the effect of preventing nerve terminal withdrawal.
3.1.2 The role of activity in synapse elimination
Numerous studies have demonstrated that alterations in the level of activity can
profoundly influence synapse elimination. For instance, the removal of activity from
developing neuromuscular junctions prevents or delays synapse elimination.
Experimental inhibition of activity has been carried out in several ways. Muscle
tenotomy, deafferentation, and spinal cord section all delay synapse elimination at
the neuromuscular junction (Benoit and Changeux, 1975; Pestronk, Drachman and
Griffin, 1976; Caldwell and Ridge, 1983). Pharmacological manipulation of
neuromuscular activity has been carried out in three ways: via tetrodotoxin (TTX),
botulinum toxin, or bungarotoxin administration. Local TTX infusion of the entire
nerve supply, which prevents the conduction of nerve action potentials via sodium
channel blockade, effectively blocks synapse elimination (Thompson, Kuffler and
Jansen, 1979; Taxt, 1983), as does the inhibition of neurotransmitter release by
botulinum toxin (Brown, Hopkins and Keynes, 1982). Postsynaptic inhibition of
activity, using bungarotoxin to prevent the binding of acetylcholine to its receptors,
also blocks synapse elimination (Duxson, 1982; Callaway and Van Essen, 1989).
Thus, it appears that synapse elimination is inhibited or retarded at inactive nerve
terminals, and at paralysed neuromuscular junctions.
The conduction of an action potential into a nerve terminal results in the
simultaneous and uniform release of neurotransmitter from all the boutons of the
affected nerve terminal (Betz, Mao and Bewick, 1992; Ribchester, Mao and Betz,
1994). Thus, at the level of an individual neuromuscular junction, it is probable that
activity-dependent synapse elimination is regulated by the relative levels of activity
of each nerve terminal, rather than each bouton. Current paradigms favour the
proposal that the more active nerve terminal has a competitive advantage over less
active nerve terminals. This hypothesis is corroborated by in vitro experiments which
indicate that in dually innervated frog myotubes selective stimulation of one input
results in the rapid and long-lasting suppression of the less active co-innervating
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axon (Lo and Poo, 1991). Simultaneous stimulation of both axons in most cases
prevented alterations in the synaptic strengths of the axons (Dan and Poo, 1992),
consistent with the theory that competition is mediated by contrasting levels of
activity. Selective stimulation of motor units during synapse elimination appears to
convey a competitive advantage to the more active inputs: the stimulated motor units
remain expanded in comparison with unstimulated axons (Ridge and Betz, 1984).
Similarly, regenerating axons that are active reinnervate more muscle fibres than
axons in which evoked activity has been prevented, by infusion of TTX (Ribchester
and Taxt, 1983, 1984; Ribchester, 1988), although these experiments are subject to
interpretation (Callaway, Soha, and Van Essen, 1987, 1989). Furthermore, during
synapse elimination withdrawing axons, although still capable of transmitter release
after some terminal boutons have been retracted, appear to have lowered quantal
efficacy (Dunia and Herrera, 1993; Coleman et al., 1997).
Overall, it is apparent that disparate levels of activity of each innervating axon
influence synapse elimination. Thus, different levels of activity at multiply
innervated neuromuscular junctions appears to effect the retraction of terminal
boutons belonging to less active terminals. On the other hand inhibition of activity,
resulting in inactive nerve terminals results in the stable coexistence of multiple
nerve terminals, which do not undergo synapse withdrawal. Furthermore, mature
synapses in mammalian muscles are generally extremely efficaceous, with a high
safety factor of transmission and large quantal contents (Wood and Slater, 1997).
Thus, it appears that disparate levels of activity, and the relative strength of
transmission, are major determinants of synapse elimination.
However, conflicting results indicate that increasing neuromuscular activity, which
simultaneously raises the level of activity at all nerve terminals, accelerates synapse
elimination: chronic nerve stimulation precipitates synapse elimination (O'Brien,
Ostberg and Vrbova, 1978). This treatment is more effective at high frequency bursts
than with equal numbers of stimuli at 1 Hz (Thompson, 1983). There is some
difficulty in interpreting these experiments. Chronic stimulation of a neonatal nerve
may elicit different levels of activity at each neuromuscular junction, both due to the
loss of nerve conduction at weak branch points, and due to relatively lower
transmitter release at endplates occupied by smaller nerve terminals (in comparison
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to their neighbours), resulting in subthreshold responses. Further, the chronic
synchronous activity imposed on each junction by the experimental paradigm may
merely superimpose the endogenous asynchronous activity of each input.
These apparently conflicting results may reflect the subtlety of the process. In sum,
although inhibition of activity has a profound effect on axon withdrawal during
synapse elimination, the role of dissimilar levels of activity at polyneuronally
innervated neuromuscular junctions remains unclear.
3.1,3 Botulinum Toxin
Botulinum toxins are produced by the bacterium Clostridium botidinum. Their mode
of action is confined to the peripheral nervous system, where they block presynaptic
release of neurotransmitters into the synaptic cleft. They exist in several different
serotypes, which share structural homology: all botulinum toxins are composed of
two disulfide-linked polypeptide chains. The larger subunit is responsible for
neurospecific binding and cell penetration. Reduction releases the smaller chain into
the axonal cytoplasm, which cleaves specific protein components of the
neuroexocytosis apparatus via zinc-endopeptidase activity. Botulinum A and E
specifically cleave synaptosome-associated protein of 25kDa (SNAP-25) (Blasi et
al., 1993a; Schiavo et al., 1993a; Binz et al., 1994), whilst botulinum C cleaves
syntaxin (Blasi et al., 1993b; Schiavo et al., 1995). Both SNAP-25 and syntaxin are
proteins specific to the presynaptic plasma membrane. Botulinum toxins B, D, F and
G specifically recognise vesicle-associated membrane protein
(VAMP/synaptobrevin) (Schiavo et al., 1992, 1993c,d, 1994; Yamasaki et al.,
1994a,b). This is an integral protein of the synaptic vesicle membrane, and is cleaved
at single peptide bonds which differ for each serotype. SNAP-25 and syntaxin on the
presynaptic membrane, and VAMP/synaptobrevin on vesicles, interact by binding
identified amino acid domains (Hayashi et al., 1994; Chapman et al., 1995;
Pellegrini et al., 1995) and are thought to facilitate vesicle docking at active zones,
sites at which neurotransmitter is released from vesicles into the synaptic cleft
(Sollner et al., 1993; Pevsner et al., 1994). At a physiological level, Botulinum toxin
A prevents all evoked and spontaneous presynaptic release from motor nerve
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terminals, thereby preventing neuromuscular conduction of action potentials/EPPs
and MEPPs.
The administration of botulinum toxin to intact adult neuromuscular junctions results
in the formation of fine nerve processes known as sprouts, which elongate to form an
intricate network across the muscle (Duchen and Strich, 1968; for review see Brown,
Holland and Hopkins, 1981). In neonatal muscles botulinum toxin has been shown to
prevent nerve terminal withdrawal during developmental synapse elimination
(Brown, Hopkins and Keynes, 1982).
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3,2 Materials and Methods
Animal care and surgery were as detailed in chapter 2 (2.2.1, 2.2.2), except where
otherwise described here. One month old female C57BL/Wlds mice were used for
this study. The left transversus abdominus (TA) muscle was axotomized by unilateral
section of the left second to eighth intercostal nerves. At this time, botulinum toxin
was applied to the endplate region of the left TA muscle. A small section of the
superficial internal oblique muscle was carefully dissected away to expose the
endplate region of the underlying TA muscle. A Gilson micropipette was used to
administer 0.15ng of botulinum toxin serotype A in 5 pi of buffer (see solutions -
appendix). This buffer solution was used by Thompson and colleagues, in a study of
the effect of botulinum toxin on Schwann cell sprouting, and was shown to have
minimal effects on the muscle (Son and Thompson, 1995a). During this procedure
the muscle was not touched by the tip of the pipette, in order to minimise the risk of
muscular damage due to the operation. The muscle was then left for 5 minutes to
allow dispersion of the toxin over the muscle. The region was then liberally washed
with buffer solution (without botulinum toxin), and carefully resealed using 7/0
Mersilk suture. Although the dosage appeared to be correct in terms of
neuromuscular transmission blockade, a small number of animals became
systemically affected by the toxin, and did not survive the experiment. All animals
were carefully monitored, and affected animals were immediately sacrificed.
Negative controls for botulinum toxin administration were performed, using the same
procedure as above but omitting botulinum toxin from the buffer solution.
Alternatively, as another form of control, the left TA muscle was axotomized by
unilateral section of the second to eighth intercostal nerves, but without botulinum or
buffer administration directly to the TA muscle.
TA nerve-muscle preparations were dissected, attached to the base of a Slygard-lined
recording chamber using fine steel pins, and bathed with aerated normal
physiological saline. Neuromuscular transmission was tested in botulinum and
buffer-alone treated muscles. The axotomized intercostal nerves were carefully pared
away from the intercostal muscles to expose a 5 mm length of nerve. The muscle
nerve was then electrically stimulated using a suction electrode with pulses up to 100
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V in amplitude. TA muscle fibres were carefully examined for signs of contraction,
as evidence of neuromuscular transmission. This procedure was repeated on all
axotomized intercostal nerves, and for all (unoperated) contralateral control
intercostal nerves. Neuromuscular conduction was blocked in the vast majority of
preparations. Only one preparation displayed any signs of activity, and was
discarded.
Wholemount nerve-muscle preparations were fixed, the axon/nerve terminal labelled
with antibodies to NF and SV2, and acetylcholine receptors stained with TRITC-
conjugated a-Bungarotoxin as previously described (see 2.2.4). The slides were





A morphological study was carried out to determine the effect of presynaptic
inhibition of synaptic vesicle fusion on synapse withdrawal of Wlds nerve terminals
4, 6 and 10 days after nerve lesion. Nerve terminal and preterminal axonal
morphology was assessed in fixed preparations using immunocytochemical
techniques to stain NF and SV2 proteins. Postsynaptic acetylcholine receptors were
irreversibly labelled using TRITC-conjugated a-Bungarotoxin. Morphometric
assessment of endplate occupancy by the nerve terminal was identical to that of the
morphological studies detailed in Chapter 2: namely that the overlap between the
staining pattern of the nerve terminal boutons and the distribution of acetylcholine
receptors was quantitatively compared. Complete correspondence between the
staining patterns was denoted 100% occupancy. Terminals that were in various
stages of withdrawal were placed into 'bins' of 0%, 1-24%, 25-75%, and 76-99%
occupancy.
Unoperated motor nerve terminals appeared identical to those of wild-type terminals.
All unoperated terminals observed had complete overlap between the NF/SV2 and a-
Bungarotoxin staining patterns (100% occupancy).
Muscles that had been axotomized, but not subjected to botulinum toxin, had similar
withdrawal of endplates in comparison to FM1-43 terminal staining at the same
stages. Axotomized muscles treated with buffer alone displayed similar levels of
nerve terminal withdrawal to that of axotomized-alone preparations (Figure 3.1)
indicating that the buffer solution had no inherent effect on Wlds nerve terminal
withdrawal after axotomy.
Nerve-muscle preparations superfused with 0.15 ng botulinum toxin were clearly
labelled by antibodies to NF/SV2 proteins, and a-Bungarotoxin. Although there was
evidence of some intact nerve terminals, particularly at 4 and 6 days, nerve terminal
withdrawal was not prevented. Terminals in varying stages of withdrawal are
represented in Figures 3.2 and 3.3. Thus, Wlds nerve terminal withdrawal was not
entirely abolished with removal of activity. Nerve terminals withdrew from
axotomized neuromuscular junctions in the same way as axotomized-alone terminals,
with gradual retraction of nerve terminal processes and manifestation of a
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perijunctional retraction bulb. Changes in terminal morphology leading to the
formation of retraction bulbs appeared similar to that of axotomized-alone nerve
terminals (Figure 3.4). However, morphometric analysis of nerve terminal
occupancies revealed that nerve terminal withdrawal was delayed by the removal of
activity (Figure 3.5). In axotomized but untreated muscles, 22% of nerve terminals
had completely withdrawn (0% occupancy) by 4 days post axotomy, increasing to
55% at 6 days and 99% at 10 days post axotomy. In botulinum treated Wlds muscles,
there was a delay in the withdrawal of motor nerve terminals following axotomy: at 4
days only 6% had withdrawn, increasing to 18% at 6 days and 91% at 10 days. This
delay was most striking at 6 days post axotomy, where 36% more endplates
remained occupied by Wlds nerve terminals (significantly different; paired t-test, p =
0.0071). A low magnification comparison of these preparations is presented in Figure
3.3.
The rate of withdrawal was clearly affected by the addition of botulinum toxin to the
muscle. However, the difference between axotomized botulinum treated and
axotomized-alone muscles at 10 days post axotomy, although significant (paired t-
test, p = 0.0008), was small - only 7%. Thus, although the inhibition of activity
delayed withdrawal at 4 and 6 days, it appears that the rate of withdrawal closely
resembled that of untreated axotomized muscles by 10 days. This suggests that the
effect of botulinum toxin lessened during the latter stages of withdrawal in
axotomized Wlds muscles. However, whilst the majority of nerve terminals had
withdrawn at 10 days post axotomy in botulinum treated muscles, persistent nerve
terminals appeared to be localised to relatively specific regions of the muscle,
demonstrating that nerve terminals in some areas of the muscle were more resistant
to withdrawal than those in other areas (Figure 3.3). This did not appear to be the
case in axotomized -alone muscles.
Analysis of the linear regression using the Spearman rank correlation indicated that
the numbers of endplates that become completely vacated (0% occupancy) increases
linearly for both axotomized-alone and botulinum treated muscles (r = 0.9461 and
0.9066 respectively, two-tailed p value <0.0001 for both correlations; see graph X).
The rate of nerve withdrawal in botulinum treated muscles, estimated from the slope
of the linear regression, was 14.9% in comparison to 12.6% for axotomized alone
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muscles. This suggests that nerve terminal withdrawal proceeds faster in botulinum
treated muscles, once initiated. However, there appears to be a delay in the initiation
of nerve terminal withdrawal in muscles treated with botulinum toxin. Although the
linear regression lines converge, an estimate of the overall delay can be made by
taking the difference between the linear regressions, taken at the midpoint at 7 days
post axotomy, and calculating the delay over the entire period of the experiment
(Figure 3.6). Overall, nerve terminal withdrawal in botulinum treated muscles was
delayed by approximately 1.14 days following the inhibition of activity, caused by
the topical administration of botulinum.
In addition to the withdrawal of nerve terminals, muscles treated with botulinum
toxin also exhibited a small number of nerve terminal sprouts (Figure 3.7). These
sprouts were NF/SV2 stained fdamentous processes originating from axotomized
nerve terminals. They were of small diameter (no larger than 5 micrometer in
diameter) and sometimes spanned some distance from the neuromuscular junction.
Motor nerve terminal sprouts were not observed at any of the 812 axotomized-alone
endplates. This demonstrates that axotomized Wlds nerve terminals treated with
botulinum toxin have the ability to sprout even after isolation from their cell body.
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Figure 3.1: WITHDRAWAL OF NERVE TERMINAL PROCESSES FROM
AXOTOMIZED WLDS NEUROMUSCULAR JUNCTIONS FOLLOWING BOTULINUM
BUFFER ADMINISTRATION.
The superfusion of botulinum buffer solution does not affect the rate of withdrawal of Wlds
TA nerve terminal processes from the endplate following nerve lesion. The histogram shows
a comparison of occupancies at 6 days post axotomy with and without botulinum buffer
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FIGURE 3.2: WITHDRAWAL OF NERVE TERMINAL PROCESSES FROM
AXOTOMIZED WLDS NEUROMUSCULAR JUNCTIONS FOLLOWING BOTULINUM
ADMINISTRATION.
The superfusion of botulinum toxin does not prevent nerve terminal withdrawal. Wlds TA
nerve terminal processes remain able to retract from the endplate following nerve lesion.
A and B show acetylcholine receptors labelled with TRITC-conjugated a-Bungarotoxin
(red), and NF/SV2 staining (green) from the same neuromuscular junction. Nerve terminal
ramifications are in the process of withdrawing from the endplate region. Note the
preterminal varicosities in A, which presumably form prior to retraction, and intact and fully
occupied endplates neighbouring withdrawing nerve terminals in B.




Figure 3.3: COMPARISON OF BOTULINUM TREATED AXOTOMIZED AND
AXOTOMIZED-ALONE WLDS NEUROMUSCULAR JUNCTIONS.
Low power images of axotomized-alone and botulinum treated axotomized Wlds
neuromuscular junctions. Botulinum toxin delays Wlds nerve terminal withdrawal following
nerve lesion. All images illustrate an overview of NF/SV2 and a-Bungarotoxin labelled Wlds
TA muscles (xlO magnification).
A. 6 day axotomized axotomized-alone muscle. An overview of endplates shows many nerve
terminals in advanced stages of withdrawal.
B. Overview of a 6 day axotomized Wlds TA muscle to which botulinum toxin was added at
the time of axotomy. The majority of motor endplates are innervated by axons, and axons in
intramuscular nerve bundles are clearly visible. Most endplates show signs of withdrawal.
C. 10 day axotomized-alone muscle. No endplates are contacted by axon processes. The
remaining axons are diffusely labelled.
D. 10 day axotomized botulinum treated muscle. Although many endplates are vacant of
nerve terminal processes, some cndplates remain innervated Note that this image is not
representative of the majority of regions in these muscles, but is only used here to illustrate
the persistence of nerve terminals in some regions.




Figure 3.4: RETRACTION BULBS AT AXOTOMIZED WLDS NEUROMUSCULAR
JUNCTIONS TREATED WITH BOTULINUM TOXIN.
Retraction bulbs are present at various stages after nerve lesion at endplates paralysed by
botulinum toxin.
A to C depict progressive formation of retractions bulbs in botulinum treated Wlds TA
muscles 10 days after nerve lesion.
A. Centre left of picture: nerve terminal in advanced stages of withdrawal. The nerve
terminal ramifications have coalesced in three regions, presumably in preparation for
withdrawal from the endplate. A large swelling has formed preterminally. At the left of this
image, a retraction bulb appears to be receding from a vacant endplate.
B. Progressive withdrawal of retraction bulbs from the endplate area. Large varicosities with
secondary swellings are located next to vacant endplates.
C illustrates two retraction bulbs at different distances from vacant endplates. The retraction
bulb located at the top of this image appears to be withdrawing to the intramuscular nerve
bundle.




Figure 3.5: WITHDRAWAL OF AXOTOMIZED WLDS NERVE TERMINALS IN
BOTULINUM TREATED MUSCLES.
Inhibition of activity delays the withdrawal of Wlds nerve terminals following nerve lesion.
The graphs show axotomized Wlds TA muscles with and without botulinum toxin treatment.
Each bar represents data from one muscle. A total of 1672 endplates from 26 muscles were
analysed.
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Figure 3.6: RATE OF WITHDRAWAL FOLLOWING AXOTOMY OF WLDS NERVE
TERMINALS IN BOTULINUM TREATED MUSCLES.
The increase in the number of completely vacated endplates is delayed in botulinum treated
Wlds TA muscles. Data pooled from 841 endplates and 26 muscles. Each point represents
one muscle.
An estimation of the delay was made by taking the difference between the regressions at the
















Figure 3.7: NERVE TERMINAL SPROUTS AT AXOTOMIZED WLDS
NEUROMUSCULAR JUNCTIONS TREATED WITH BOTULINUM TOXIN.
Wlds TA nerve terminals extend NF/SV2 labelled processes following axotomy and
botulinum administration.
A. Nerve terminal 4 days after axotomy and botulinum treatment. Nerve terminal boutons
appear to be withdrawing from this endplate. However, a small process extends from the
junctional region, possibly elongating towards a vacant neighbouring endplate.
B. Nerve terminal sprouts extending from 6 day axotomized, botulinum treated
neuromuscular junction.





The principal aim of this chapter was to discover the effect of inhibiting activity on
the withdrawal of axotomized Wlds motor nerve terminals. Essentially, this is a study
of the prevention of spontaneous MEPP release at Wlds neuromuscular junctions,
and the consequences of this on the retraction of axotomized nerve terminals.
The results show that, in botulinum-treated animals, Wlds motor nerve terminals
withdraw from the neuromuscular junction after nerve lesion. However, there is a
significant but small delay in the retraction of nerve terminals following nerve lesion.
This overall delay was estimated from the linear regression calculations to be 1.14
days over the period investigated. If the delay was caused by a decline in the rate of
retraction of terminal boutons once withdrawal had been initiated, then the linear
regression lines depicted in Figure 3. 6 would diverge. In fact, the rate of withdrawal
after the initial trigger appeared to be slightly accelerated. The analysis indicates that
the decrease in the overall rate of nerve terminal retraction was therefore probably
attributable to a delay in the initiation of withdrawal rather than a delay in the
progression of the withdrawal process once started.
The delayed response to axotomy in botulinum treated muscles demonstrates that
activity influences the withdrawal of Wlds nerve terminals after nerve injury. This
intriguing result indicates that spontaneous activity may play a role in the retraction
of terminal boutons. The findings of the chapter 2 indicate that MEPPs persist
beyond the ability of the nerve terminal to elicit action potentials or EPPs, suggesting
a fairly robust mechanism for spontaneous release of neurotransmitter at axotomized
Wlds neuromuscular junctions (see 2.3.3). Furthermore, MEPP frequencies were
similar to those of unoperated controls 4, 5, 6, and 7 days post axotomy, indicating
that MEPP rate remained normal for up to 7 days post axotomy. However, MEPP
frequencies declined at 8 and 12 days post axotomy, until at 13 days no MEPPs were
recorded. Botulinum toxin appears to have a greater effect on the delay in the
initiation of nerve terminal withdrawal at 4 and 6 days post axotomy, times at which
the MEPP rate remains comparable to unoperated control muscles. The effect of
botulinum treatment is lessened at 10 days post axotomy, where the levels of
withdrawal were similar to axotomized-alone preparations, and incidentally around
the time when MEPPs fail altogether (see chapter 2, 2.4). Therefore, the effect of the
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prevention of synaptic vesicle fusion via botulinum toxin is most pronounced during
the time when the mechanism for the generation of spontaneous MEPPs remains
normal. Botulinum toxin had less effect on nerve terminals which probably did not
have normal rates of spontaneous transmitter release, at 10 days post axotomy. This
implies that spontaneous transmitter release influences nerve terminal withdrawal at
axotomized Wlds junctions.
The mechanism for this may at first seem obscure. However, consider a structurally
persistent nerve terminal that is spontaneously and asynchronously active. MEPPs
occur as a result of the spontaneous fusion of synaptic vesicles to the plasma
membrane, resulting in the release of transmitter into the synaptic cleft which
produces a postsynaptic potential. These spontaneous events take place at different
boutons, and therefore different locations of the junction. Spontaneous fusion of a
number of synaptic vesicles at one bouton could produce several MEPPs, and may
perhaps cause the 'bursting activity' observed at some endplates (see 2.3.3).
Furthermore, axotomized Wlds muscles exhibit a considerable amount of
spontaneous contractile activity that resembles fibrillation (see 2.3.3, Ribchester et
al., 1995). Intracellular recordings revealed spontaneous action potentials were the
cause of this contractile activity, and these were apparently triggered from the rising
phase of abnormally large MEPPs (Ribchester et al., 1995). It is not inconceivable
that the generation of a number of MEPPs, or a spontaneous action potential, from a
particular bouton could establish a form of competition between the synaptic boutons
similar to activity-dependent competition between nerve terminals during synapse
elimination. In this paradigm, more functionally robust boutons would be more
spontaneously active than their neighbours, thus competitively disadvantaging these
weaker boutons. These boutons would then retract. However, because overall the
axotomized Wlds synapse is functionally weak (due to the lack of persistent and
evoked action potentials) eventually all boutons undergo retraction. Whether synapse
withdrawal is a result of a disparity in the levels of activity or not, it is likely that it is
the relatively low level of acetylcholine release that predisposes axotomized Wlds
nerve terminals to withdrawal. Axotomized Wlds nerve terminals are functionally
weak in comparison to unoperated controls (see 2.3.3). Inefficaceous synaptic
transmission essentially means that the function of the neuromuscular junction, to
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induce muscle action potentials, is compromised. Therefore, this is probably the
initial signal that induces the retraction of Wlds nerve terminal processes from the
muscle endplate. It is possible that this is due to a decline in trophic support from the
muscle, or a decline in the ability to receive trophic support. Various studies have
shown that trophic factor release, and trophic factor uptake, are dependent on the
ability to release neurotransmitter (see 2.4). A decrease in trophic factor release from
muscle fibres due to weak activity, or perhaps a decline in trophic factor receptors on
the nerve terminal, could induce nerve terminal retraction. Alternatively, an increase
in the release of protease such as thrombin, and a concurrent decline in protease
inhibitor (such as protease nexin 1 - see 2.4), may initiate the withdrawal of
axotomized Wlds terminals. This would result in a decline in the adhesivity of the
nerve terminal structure to the neuromuscular junction, eventually resulting in
retraction of terminal ramifications.
Assuming that the decline in activity, or a disparity in the levels of intra-terminal
spontaneous activity, could mediate nerve terminal retraction, how then does
botulinum toxin delay synapse withdraw at Wlds junctions following nerve lesion?
Complete abolishment of all activity, which was performed in this experiment using
botulinum toxin, results in complete inactivity. This may effect a change in the
signalling events that take place at the neuromuscular junction, which removes
activity-dependent withdrawal signals, and instead promotes growth signals. This
would also explain the tentative formation of sprouts at botulinum treated endplates.
It is well established that botulinum toxin produces denervation-like changes in
muscle fibres (see Khan, 1995, for review). Note that denervation changes are
delayed in axotomized Wlds muscles (Brown et al., 1991). Denervation of wild type
muscle results in changes in the production of growth promoting factors. These
include an upregulation of BDNF and downreulation ofNT-4 in muscles (Funakoshi
et al., 1993), and an upregulation of GAP-43, the p75 NGF receptor, NGF, BDNF
and NT-4 and downregultion of CNTF in Schwann cells (Friedman et al., 1992;
Sendtner, Stockli and Thoenen, 1992; Funakoshi et al., 1993; Hassan et al., 1994).
Caroni and Schneider (1994) demonstrated that IGF1 and IGF2 increases in
denervated muscle, which in turn promotes the proliferation of perisynaptic
interstitial cells thought to facilitate growth of axons. The investigators also observed
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the same phenomena in botulinum-poisoned muscles (Caroni and Schneider, 1994).
Alterations in the expression of any of these molecules may signal a change in the
local environment of the endplate, from growth limiting to growth promoting. Thus,
complete blockade of neuromuscular activity may inadvertently provide stability for
persistent axotomized Wlds nerve terminals, and cause a delay in the withdrawal of
terminal boutons. In sum, protracted absence of muscle activity may initiate cellular
and molecular reactions aimed at restoring neuromuscular transmission and
preventing withdrawal. Weak and sporadic activity would promote signals that
remove the aberrant input from the neuromuscular junction.
However, this hypothesis cannot entirely account for the withdrawal of nerve
terminals at axotomized Wlds junctions, as the withdrawal process was delayed, but
not prevented. Therefore, an alternate mechanism must also affect terminal
withdrawal. Perhaps a component of the withdrawal of boutons from a
neuromuscular junction is activity-dependent, and another component is intrinsic to
the nerve terminal. Thus, although nerve terminal retraction is affected by the
abolishment of activity, some pre-programmed mechanism executes the final
withdrawal of the nerve terminal. This may be similar to a mechanism such as that
proposed for intrinsic withdrawal. Intrinsic withdrawal is thought take place during
the period of synapse elimination, and involves the withdrawal of an axon from a
previously innervated endplate (see 2.4). The mechanism for this phenomenon is
unknown. However, it is possible that a similar mechanism, intrinsic to axotomized
Wlds axons, effects the removal of nerve terminal boutons from the endplate.
Alternatively, perhaps activity-mediated mechanisms are entirely responsible for the
retraction of axotomized Wlds nerve terminals, but that the supervision of botulinum
toxin at the time of nerve section did not immediately prevent neurotransmitter
release. Thus, a period of several days may have ensued during which the underlying
activity-dependent nerve terminal withdrawal mechanisms were activated. The
subsequent blockade of neurotransmitter may therefore have been less effective than
an immediate block after axotomy. This could be tested by the application of
botulinum toxin a few days prior to nerve section.
Botulinum toxin mediates the inhibition of transmitter via the cleavage of a protein
necessary for the fusion of synaptic vesicles to the presynaptic membrane. Therefore,
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it is possible that the delay in terminal bouton retraction is caused by the prevention
of exocytosis per se. Thus, synaptic vesicles remain in the nerve terminal, and the
neurotransmitter packaged within them is retained. If the withdrawal process were
mediated intrinsically then it is possible that the retention of transmitter, together
with the prevention of vesicle membrane fusion with the presynaptic plasma
membrane, may have a protective effect on those terminals in some way.
Overall, it is apparent that the inhibition of vesicle-associated neurotransmitter
release results in the delay of the withdrawal of Wlds nerve terminals following nerve
damage. The mechanism for this withdrawal is not known. Three hypotheses
proposed at the start of this chapter, namely that botulinum toxin would either
prevent, delay, or accelerate nerve terminal withdrawal. Prevention of nerve terminal
withdrawal would provide evidence that withdrawal of axotomized Wlds nerve
terminals occurred via a similar mechanism to that of developmental synapse
elimination. That this was not the case suggests that these two processes may be
dissimilar. However, the initiation of the retraction of nerve terminal boutons was
delayed for approximately 1.14 days, implying that spontaneous activity influences
the triggering signals that result in nerve terminal retraction. Further manipulation of
activity at axotomized Wlds neuromuscular junctions may yield more clues as to the
nature of this process.
Other events occur during synapse elimination that may shed light on the withdrawal
of Wlds nerve terminals after axotomy. For instance, during synapse elimination
Schwann cell cytoplasm overlying withdrawing boutons is withdrawn prior to nerve
terminal retraction (Culican, Nelson and Lichtman, 1998). In addition, Schwann cell
migration away from the neuromuscular junction, induced by topical application of
neuregulin during early postnatal life, results in nerve terminal retraction from the
areas that were vacated by Schwann cell processes (Trachtenburg and Thompson,
1997). These findings suggest that Schwann cells are intricately associated with
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Chapter 4: Reactive terminal Schwann cells at axotomized
Wlds neuromuscular junctions.
4,1 Introduction
Schwann cells are the glial cells of the peripheral nervous system. During
development, a common Schwann cell precursor differentiates into two
morphological, and functionally distinct types of Schwann cells: myelinating and
non-myelinating (for review, see Jessen and Mirsky, 1998). Myelinating Schwann
cells, as the name suggests, form the myelin that ensheaths axons, whilst non-
myelinating Schwann cells loosely surround axons of a smaller diameter. In the
adult, nerve damage causes both types of Schwann cells to de-differentiate and
proliferate, and these cells are known as 'reactive' Schwann cells (Cajal 1928;
Abercrombie and Johnson, 1946; Pellegrino and Spencer, 1985; Pellegrino et al.,
1986; Clemence et al., 1989). These Schwann cells congregate to form the Bands of
Bungner (see Chapter 1), which is thought to facilitate the regeneration of axonal
processes by providing trophic support (Bunge, 1993; Ide 1996). Regeneration and
restoration of function results in the re-differentiation of Schwann cells to
myelinating or non-myelinating cells depending on the axons they contact.
Terminal Schwann cells are a type of non-myelinating Schwann cell that caps
neuromuscular junctions. However, unlike Schwann cells of the main nerve trunk,
which form a permissive route for regenerating axons, the role of terminal Schwann
cells in aiding axon re-growth after nerve damage was unclear. Following
denervation, it was previously assumed that terminal Schwann cells simply
phagocytose degenerating axon terminals, withdraw from the synaptic gutter (Miledi
and Slater, 1968, 1970; Manolov, 1974), release small amounts of neurotransmitter
(Miledi and Slater, 1968; Bevan et al., 1973; Dennis and Miledi, 1974) and otherwise
remain quiescent until the return of axons to the neuromuscular junction (Gorio et
al., 1983). However, the recent findings of Thompson and colleagues suggest that




It is well established that regenerating axons reinnervate previously vacated
endplates with remarkable specificity, even though the motor endplate represents less
than 0.1% of the total muscle fibre surface (discussed in Sanes, 1989). Reinnervating
axons usually grow down the old endoneurial Schwann cell tubes leading to each
endplate. However, axons can find endplates even when they grow outwith the
confines of the endoneurial tube, and the pattern of branching of axon collaterals
from the intramuscular nerve to the endplate, established during development,
changes after reinnervation (Covault, Cunningham, and Sanes, 1987; Rich and
Lichtman, 1989). Also, many axons continue to grow beyond their endplates,
forming the so-called 'escaped fibres' described by neuroanatomists earlier this
century (Tello, 1907; Ramon y Cajal, 1928; Gutmann and Young, 1944). These
axons contact other endplates, resulting in polyneuronal innervation. Therefore, the
mechanism for the guidance of axon processes once they had reached the muscle was
debatable.
In muscles, various molecules present in basal lamina may provide a suitable
substrate for axonal growth, including N-CAM, fibronectin, tenascin, laminin and
heparin sulfate proteoglycan (Covault and Sanes, 1986; Reiger et al., 1985; Sanes,
Schachner, and Covault, 1986; Bixby, Lillien, and Reichardt, 1987; Fadic, Brandan,
and Inestroa, 1990). Denervation induces selective proliferation of interstitial cells in
perisynaptic areas, which leads to localisation of adhesive molecules such as tenascin
C and fibronectin (Sanes et al, 1986; Connor and McMahan, 1987; Caroni and
Schneider, 1994). Guidance of axons to the endplate itself may result from the
release of diffusible factors, such as insulin-like growth factor from the endplate,
establishing a concentration gradient centred at the endplate which preferentially
attracts axonal growth cones (Henderson, Huchet, and Changeux 1983; Kuffler,
1989; Caroni and Grandes, 1990). However, in the light of recent findings, it seems
probable that terminal Schwann cell processes provide the major guiding substrate
for regenerating axon sprouts in muscles.
Reynolds and Woolf (1992), using immunocytochemical techniques to label
Schwann cell specific S-100 protein, demonstrated that terminal Schwann cells
respond to denervation by not only removing the remains of the degenerating nerve
terminal, but also by extending long processes across the surface of the muscle.
142
Chapter 4
These processes, known as terminal Schwann cell sprouts, often reach lengths of
several hundred micrometers, and withdraw after reinnervation of the muscle. The
initial cue for this sprouting is as yet unknown. However, terminal Schwann cells
appear to be extremely sensitive to neuromuscular activity: stimulation of the motor
nerve elevates internal Schwann cell calcium concentration (Jahromi, Robitaille and
Charlton, 1992; Reist and Smith, 1992), and blockade of synaptic transmission using
TTX or co-conotoxin induces a rapid upregulation of glial fibrillary acidic protein
(GFAP) in terminal Schwann cells (Georgiou et al., 1994). Recently, it has been
shown that acetylcholine secreted from nerve terminals decreases GFAP in terminal
Schwann cells via muscarinic acetylcholine receptors (Georgiou, Robitaille and
Charlton, 1999). Therefore, terminal Schwann cells clearly respond to alterations in
nerve terminal activity. However, it is not known whether terminal Schwann cell
sprouting is as a result of cutoff of transmitter-release or related substances from the
nerve terminal, from the degeneration of the nerve terminal itself, or from a signal
(or decline in a signal) from the inactive muscle fibre. Interestingly, calcitonin gene-
related peptide (CGRP), a molecule released from motor nerve terminals, prevents
denervation-induced axonal sprouting in muscle (Matteoli et al., 1988; Tsujimoto
and Kuno, 1988).
These reports indicate that terminal Schwann cells respond to nerve terminal
degeneration by sprouting. What is the functional significance of this sprouting?
Numerous studies have demonstrated that Schwann cells are excellent, even
preferred, substrates for axonal growth in vitro (Fallon, 1985; Bolin and Shooter,
1994). Son and Thompson (1995a,b) labelled reactive Schwann cells during the
course of denervation and reinnervation. They observed that terminal Schwann cells,
after nerve terminal degeneration had occurred, dedifferentiate and extend long
filamentous sprouts, confirming the original reports of Reynolds and Woolf (1992).
Many of these processes fasciculated with others growing from adjacent endplates,
thus forming a network of sprouts that interconnect the denervated endplates.
Regenerating axons grew back to the muscle and re-occupied endplate sites.
However, these axons continued to elongate even after they had contact an endplate,
following the previously laid down network of Schwann cell sprouts. This lead the
axon sprouts to other endplates, and eventually resulted in polyneuronal innervation
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of motor endplates. Similarly, in partially denervated muscles terminal Schwann
cells sprout not only from denervated endplates, but also innervated neuromuscular
junctions (Son and Thompson, 1995a). However, most Schwann cell sprouts
originated from denervated endplates. This led the investigators to propose that in a
partially denervated muscle, Schwann cells from unoccupied endplates sprouted to
innervated endplates, and led the axonal sprouts back to the denervated endplates. In
order to resolve this, a foreign nerve was transected, and placed onto the surface of
another muscle three days later (to ensure that no axons would remain in the foreign
nerve). Schwann cells from the implanted nerve grew processes towards the endplate
zone of the muscle. In some preparations, in which Schwann cell sprouts had not yet
contacted endplates, no axonal sprouting was observed. However, in preparations in
which Schwann cell processes had fully penetrated the endplate zone rampant axonal
sprouting was observed, which in nearly every case followed the exact pathway of
Schwann cell processes. Botulinum toxin induces extensive axonal sprouting, in
response to inactivity (Brown et al., 1981). Son and Thompson (1995b) reapplied
this experimental paradigm to the investigation of Schwann cell sprouting, and
observed that not only did Schwann cells extend numerous processes, but that nerve
sprouts followed, or were associated with, Schwann cell processes. In fact, in some
cases, Schwann cell sprouts were longer than the axonal sprouts associated with
them, implying that Schwann cells were directly guiding nerve terminal sprouts. A
recent experiment confirmed these findings using a vital dye, Calcein Blue am ester,
that labels living mouse terminal Schwann cells without apparently damaging them
(O'Malley, Waran, and Balice-Gordon, 1999). Terminal Schwann cells sprouted in
response to nerve crush, and revisualisation of the same processes after reinnervation
indicated that axon sprouts used existing Schwann cell processes and chains of cell
bodies as substrates for outgrowth. Taken together, these studies suggest that
terminal Schwann cells are not only permissive for axon growth but also instructive
in the guidance of nerve sprouts following denervation.
In addition to their role in the guidance of regenerating axons, terminal Schwann
cells are also implicated in the formation and maintenance of stable neuromuscular
synapses. Schwann cells express a number of signalling molecules and receptors
(Reynolds and Woolf, 1993; Scherer and Salzer, 1996), and respond to synaptic
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changes by altering expression levels of neurotrophins (Funakoshi et al., 1993) and
CNTF (Friedman et al., 1992; Sendtner et al., 1992). As previously mentioned,
terminal Schwann cells respond to alterations in transmitter release. Schwann cells at
the neuromuscular junction have been implicated in the regulation of nerve terminal
number during synapse elimination (Flirata et al., 1997; Culican, Nelson and
Lichtman, 1998). Schwann cells can modify the expression of acetylcholinesterase
and butyrylcholinesterase, induce the formation of junctional folds and aggregate
acetylcholine receptors at developing cultured rat neuromuscular junctions (Chapron
et al., 1997; Koenig, de La Porte, and Chapron, 1998). In addition, exogenous
application of neuregulins causes retraction of Schwann cells from the endplate area,
which in turn induces nerve terminal withdrawal (Trachtenburg and Thompson,
1997). In sum, terminal Schwann cells actively participate in the formation,
maintenance and remodelling of the neuromuscular junction.
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4.1.1 Aims and hypotheses
Hypothesis: terminal Schwann cell sprouting is initiated by the absence of motor
nerve terminal contact.
This chapter will investigate the response of terminal Schwann cells following
axotomy of Wlds nerves. Specifically, do terminal Schwann cells respond as
expected at Wlds neuromuscular junctions when nerve terminal structure and
function persists? To this end, three alternative outcomes are proposed:
1. Terminal Schwann cell sprouting is inhibited at axotomized Wlds endplates.
2. Terminal Schwann cell sprouting is delayed at axotomized Wlds endplates.
3. Terminal Schwann cell sprouting proceeds as normal at axotomized Wlds
endplates.
Inhibition of terminal Schwann cell sprouting would suggest that the prolonged
presence of intact nerve terminals is sufficient to prevent the initiation of process
elongation. A delay in the sprouting response of terminal Schwann cells would
suggest that the presence of morphologically and functionally persistent nerve
terminals prevents Schwann cell sprouting until that nerve terminal withdraws from
the endplate. Alternatively, the withdrawal process that occurs following Wlds nerve
section may not affect terminal Schwann cell sprouting in any way.
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4,2 Materials and Methods
Animals, surgery, and anaesthesia were carried out as previously described in
Chapter 2 (2.2.1, 2.2.2), except where otherwise stated. One month old female
C57BL/Wlds mice and female CBA or C57/6J mice of the same age were used. The
nerve supply to the transversus abdominus (TA) muscle was resected, and nerve-
muscle preparations were dissected 3, 6, 8, and 10 - 12 and 32 days later. The
preparations were fixed and stained using an antibody that recognises S-100, a
calcium-binding protein present in non-myelinating and terminal Schwann cells
(Cocchia and Michetti, 1981; Mata, Alessi, and Fink, 1990), and to a lesser extent in
myelinating Schwann cells (Mata, Alesi and Fink, 1990; Mirsky and lessen, 1996).
Immunocytochemistry
Wholemount preparations were stained as follows (all steps performed on rotating
platform, if possible):
1. Fix for 30 minutes in 4% paraformaldehyde in lx phosphate buffered saline
(PBS) solution.
2. Wash for 1 hour in PBS.
3. Incubate at 37 °C with lmg/ml Collagenase.
4. Wash with PBS x 3.
5. Remove connective tissue from surface of muscle.
6. Inactivate collagenase activity with 0.1% sodium borohydride for 10 minutes
(place on rotating platform).
7. Wash for 10 minutes in PBS.
8. Incubate with TRITC conjugated a-Bungarotoxin (5pg/ml) for 20 minutes,
followed by 20 minute PBS wash.
9. Incubate with 1% Triton-X for 10 minutes.
10. Preblock (5% Donkey serum in 1% Triton-X solution) for 2 hours, or overnight.
11. Incubate with primary antibody (1:500 rabbit S-100 in preblock solution) for 2
hours.
12. Wash 1 hour with preblock solution.
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13. Incubate >1 hour with secondary antibody (donkey anti-rabbit FITC 1:200 in
preblock solution). Cover preparation with tinfoil from this point onwards.
14. Wash 1 hour with 1% Triton-X.




Fixed nerve muscle preparations 3, 6, 8, and 10 to 12 days post axotomy were
labelled with antibodies to S-100 protein, a Schwann cell-specific marker (Reynolds
and Woolf, 1992; Astrow, Son, and Thompson 1994), and with TRITC conjugated
a-Bungarotoxin to visualise acetylcholine receptors. Neuromuscular junctions were
examined for evidence of Schwann cell alterations. A morphometric assay for
terminal Schwann cell sprouting was performed.
Terminal Schwann cells in unoperated control Wlds mice were closely
juxtapositioned to acetylcholine receptors. In fact, the distribution of terminal
Schwann cell staining corresponded directly to that of a-Bungarotoxin labelled
acetylcholine receptors (Figure 4.1). This was also the case at unoperated CBA
neuromuscular junctions.
Neuromuscular junctions were examined for evidence of terminal Schwann cell
sprouts. These were categorised as S-100 positive processes that extended beyond
the confines of the neuromuscular junction for distances greater than 20 micrometers.
Initial observations of axotomized Wlds junctions revealed that Schwann cell sprouts
were present. Terminal Schwann cell sprouts were very rarely detected at control,
unoperated Wlds junctions (<1%) or CBA/6J junctions (3.8%). Terminal Schwann
cell sprouts were observed at CBA and Wlds junctions as early as 3 days after nerve
section. In both wild type and Wlds muscles sprouts of over 200 micrometers were
observed. Thus, axotomy-induced Schwann cell sprouting was not inhibited at Wlds
junctions (Figure 4.2). However, there was a difference between the amount of S-100
sprouts at Wlds and wild type junctions at 3, 6 and 8 days post axotomy. Schwann
cell sprouting at axotomized Wlds endplates at these time points was significantly
lower than sprouting at wild type endplates. These findings are represented in Figure
4.3. This difference was most exaggerated at 6 days: 64% of CBA/6J endplates
exhibited terminal Schwann cell sprouts, whilst only 20% of axotomized Wlds
endplates showed signs of Schwann cell sprouting. By 10 to 12 days post axotomy,
there was no significant difference between the amount of sprouting in Wlds and
CBA/6J muscles. However, during the period of the experiment, Schwann cell
sprouting at Wlds endplates did not ever reach the maximal level of sprouting
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observed at denervated wild type endplates (64% at 6 days post axotomy). This
suggests that Schwann cell sprouting at axotomized Wlds endplates is not only
delayed, but also reduced.
Overall, Schwann cells exhibiting sprouts from wild type and Wlds junctions were
generally similar in their morphological characteristics. S-100 labelled Schwann cell
processes extended from a central 'body' which may have been one or more
Schwann cell nucleus. This body usually occupied less than 100% of the endplate
area (Figure 4.2A). However, there were some differences between the axotomy-
induced alterations in Schwann cells at wild type and Wlds endplates. At wild type
endplates, Schwann cell cytoplasm withdrew slightly from the boundary of the
endplate region. However, Schwann cells at some Wlds endplates withdrew
considerably from the boundary in a pattern reminiscent of axotomized Wlds nerve
terminal withdrawal (Figure 4.4). Unfortunately, triple labelling of nerve terminal
(NF/SV2), acetylcholine receptors (a-Bungarotoxin), and Schwann cell (S-100) was
unsuccessful.
In sum, the formation of terminal Schwann cell processes following nerve injury was
considerably and significantly delayed at Wlds neuromuscular junctions. The overall
quantity of Schwann cell sprouting was less than that observed in wild type muscle,
for the duration of the experiment. In addition, terminal Schwann cell withdrawal
appears to mirror that of nerve terminal withdrawal at axotomized Wlds endplates.
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Figure 4.1: S-100 STAINING AT WLDS NEUROMUSCULAR JUNCTIONS.
S-100 staining at unoperated control C57BL/6J (A) and Wlds (B) TA neuromuscular
junctions.
Images A and B show S-100 labelled Schwann cell processes (green) and TRITC-conjugated
a-Bungarotoxin labelled acetylcholine receptors (red) visualised with a triple band pass filter
block. A yellow colour appears where a-Bungarotoxin and S-100 staining coincide.
Note the precise overlap between the s-100 stained terminal Schwann cell processes and
postsynaptic acetylcholine receptors.




Figure 4.2: TERMINAL SCHWANN CELL SPROUTING AT AXOTOMIZED
NEUROMUSCULAR JUNCTIONS.
Terminal Schwann cells sprout at axotomized wild type and Wlds TA neuromuscular
junctions.
A. Images taken from 12 day axotomized CBA muscle. An S-100 positive sprout extends
from a neuromuscular junction. This sprout extends for a considerable distance from the
endplate. Note that terminal Schwann cell processes have withdrawn from the majority of
the endplate region.
B. Two sprouts extend from a 6 day denervated C57BL/6J endplate.
C. and D. Terminal Schwann cell sprouts at 8 day axotomized Wlds neuromuscular
junctions.






FIGURE 4.3: TERMINAL SCHWANN CELL SPROUTING IS DELAYED AT
AXOTOMIZED WLDS NEUROMUSCULAR JUNCTIONS.
Terminal Schwann cell sprouting is delayed at axotomized Wlds TA neuromuscular
junctions in comparison with wild type (C57BL/6J and CBA) TA junctions. Data pooled
from analysis of 1372 endplates from 16 Wlds muscles and 936 endplates from 14 wild type
muscles. Statistical analysis was performed using a paired t-test to test significances within
groups (i.e. between C57BLAVlds and CBA/6J).
* denotes p < 0.05
** denotes p <0.001
All other groups were not significantly different.
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FIGURE 4.4: TERMINAL SCHWANN CELLS PROGRESSIVELY RETRACT AT
AXOTOMIZED WLDS NEUROMUSCULAR JUNCTIONS.
Terminal Schwann cells at axotomized Wlcf TA neuromuscular junctions withdraw in a
manner similar to nerve terminal withdrawal.
Images A to D illustrate S-100 stained terminal Schwann cells withdrawing from the
perimeter of the endplate region in a piecemeal fashion. Note the large swellings shown in B.
C and D. which are reminiscent of axonal varicosities presented in Figures 2.18 and 2.19. Of
particular interest is the Schwann cell process depicted in D, which strongly resembles a
terminal retraction bulb.








The results show that terminal Schwann cells at Wlds endplates remain able to
respond to axotomy of distal nerves by extending sprouts from the endplate region.
However, the extent of sprouting is delayed, and appears to be reduced in
comparison with that observed at denervated wild type junctions.
In unoperated muscles, terminal Schwann cell cytoplasm is very closely aligned with
acetylcholine receptor areas (see Figure 4.1), and thus similar to the distribution of
motor nerve terminal ramifications (see chapter 2, 2.3; Reynolds and Woolf, 1992;
Son and Thompson, 1995a,b; O'Malley, Waran, and Balice-Gordon, 1999). In only a
very small number of endplates were Schwann cell processes extending beyond the
confines of the endplate area observed. These Schwann cell processes may form as
part of the natural and ongoing remodelling of adult neuromuscular junctions
(Lichtman, Magrassi and Purves, 1987; Wigston, 1990).
At wild type junctions, Schwann cell processes increased in number from 3 days to 6
days post denervation, thereafter declining (see Figure 4.3). This concurs with a
recent study of terminal Schwann cell sprouting following nerve damage by
O'Malley et al. (1999), which demonstrated that process length and number declined
from 10 days onwards. This suggests that the peak of Schwann cell sprouting lies
within the period of observation in this study.
At axotomized Wlds junctions, Schwann cell sprouting was less abundant and did not
reach the levels observed in denervated wild type muscles during the period of
observation. There are two possible explanations for the delay in terminal Schwann
cell sprouting following Wlds nerve lesion.
First, the presence of an intact nerve terminal may inhibit Schwann cell sprouting at
these junctions. Schwann cells are sensitive to variations in the level of activity, and
the persistence of spontaneous activity at axotomized Wlds endplates may be
sufficient to prevent sprout formation. Thus, nerve terminal withdrawal and loss of
spontaneous activity may dictate the rate of terminal Schwann cell sprouting.
Alternatively, perhaps intact but axotomized Wlds nerve terminals release CGRP,
which has been shown to inhibit axonal sprouting (cf. Matteoli et al., 1988;
Tsujimoto and Kuno, 1988).
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Second, it is possible that terminal Schwann cells may themselves regulate the
withdrawal of nerve terminal ramifications, and it is not until after nerve terminal
processes withdraw that Schwann cells sprout. Schwann cells have been implicated
in the regulation of nerve terminal withdrawal during synapse elimination (Hirata et
al., 1997; Culican, Nelson and Lichtman, 1998). Furthermore, the removal of
terminal Schwann cell cytoplasm from the endplate region, induced by topical
application of neuregulin, causes retraction of nerve terminal boutons underlying the
absent Schwann cell process (Trachtenburg and Thompson, 1997). Thus, the
withdrawal of Schwann cell cytoplasm observed at Wlds junctions may induce nerve
terminal withdrawal. Both these hypotheses are supported by the fact that withdrawal
of Schwann cell cytoplasm from the endplate regions strongly resembles the
withdrawal of nerve terminal boutons (see picture). However, it is not possible to
verify either of these propositions from this study alone.
The fact that the overall number of sprouts did not eventually compare to that
observed in wild type muscles suggests two possibilities. First, that Schwann cell
sprouting was not only delayed but also reduced in Wlds muscles, or second, that
Schwann cell sprouting was merely delayed, and if the period of the observation was
extended then sprouting would eventually reach that of normal denervated muscle. It
is likely that the former suggestion is correct: in a parallel study by Dr. J. Barry,
using mouse sternomastoid muscle, Schwann cell sprouting was examined up to 30
days post nerve crush in wild type and Wlds mice (Barry et al., 1997). In these
muscles, sprouting of terminal Schwann cells at axotomized Wlds endplates, even
after 30 days, did not reach the levels of sprouting observed in the wild type muscles.
Thus, it appears that not only is sprout formation delayed, but it is also reduced at
Wlds junctions. If this statement is correct, this is further evidence that the Schwann
cell reaction to axotomy of Wlds nerves is not merely delayed, but altered. In the
main nerve trunk the wave of mitotic division of Schwann cells, observed after nerve
section in wild type mice, occurs in Wlds mice but the total number of Schwann cells
never reaches that observed in wild type mice (Brown et al., 1991b). Thus, that the




These changes in the reaction of terminal Schwann cells to axotomy in Wlds mice
may be as a result of a change in the function of Schwann cells conferred by the Wld
mutation itself. Although the phenotype of terminal Schwann cells has not previously
been specifically investigated, Thomson and colleagues (1991) have investigated
alterations in the Schwann cells that inhabit the main nerve trunk following axotomy.
They observed that downregulation of the P0 gene, that normally occurs following
nerve damage, did not occur in lesion Wlds nerves. However, dissociated Wlds
Schwann cells cultured without axons reduced expression of the P0 protein in the
normal manner, indicating that in this respect at least Wlds Schwann cells appear to
function normally. Therefore, for this process dissociated Wlds Schwann cells behave
as expected, and given that other experiments have indicated that the Wlds mutation
is intrinsic to axons (see Chapter 1, 1.3.1), it seems unlikely that the Wlds mutation is
conferred specifically and directly to terminal Schwann cells.
The conclusions of this chapter are that Schwann cell withdrawal and process
formation induced by nerve damage is affected by the persistence of intact Wld"
motor nerve terminals. Axotomy of Wlds nerves results in a reduction and delay of
Schwann cell sprouting and abnormal retraction of Schwann cell cytoplasm
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Wallerian degeneration is a fundamental phenomenon involving the disintegration of
distal severed axons, and is succeeded by regenerative responses in the peripheral
nervous system. The C57BLAVlds mutant mouse is unique in that central and
peripheral nerve degeneration is slowed. That such a fundamental phenomenon,
common to both central and peripheral axons, is profoundly delayed in the
C57BL/Wlds mutant mouse is remarkable, and suggests that Wallerian degeneration
may be subject to genetic regulation. The studies of this mouse to date have focused
on aspects of the disintegration of axons in peripheral nerves. The main conclusion of
these studies is that loss of nerve conduction and disruption of axon structure induced
by nerve damage, which occurs relatively rapidly in mammals, is delayed in
C57BL/Wlds mice for considerable lengths of time.
One of the first events of Wallerian degeneration is the disintegration of motor nerve
terminals. This occurs rapidly, is complete in rodents after 2-3 days. Ribchester and
colleagues (1995) investigated this phenomenon in C57BL/Wlds mice, and reported
that nerve terminal loss was delayed by up to 2 weeks. The initial investigations of this
thesis were primarily to further examine the phenomenon of slow Wallerian
degeneration at Wlds neuromuscular junctions. However, the main findings of this
thesis demonstrate that, surprisingly, motor nerve terminals did not appear to
degenerate at all. Instead, nerve terminals retract progressively from the endplate, and
eventually axonal processes withdrew from the endplate region completely. This
intriguing observation was verified in several ways - by the use of vital dyes to
examine the loss of actively recycling vesicles, by labelling of neurofilament and SV2
proteins, by the periodic examination of living neuromuscular junctions, and finally by
the examination of the changes in the functional properties of the nerve terminal.
These experiments suggest that severed Wlds motor axons undergo a progressive
retraction of nerve terminal processes resulting in the formation of swollen retraction
bulbs, which were eventually destined for reabsorption into the parent axon in the
intramuscular nerve. During the withdrawal of nerve terminal boutons there was an
concurrent decline in neurotransmitter release. These observations raised the question
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that perhaps these changes were similar to those that took place at wild type
neuromuscular junctions, but that at wild type junctions this processes was greatly
accelerated. A catalogue of previous studies indicate that axotomy of wild type nerves
results in in situ degeneration of motor nerve terminals rather than progressive
withdrawal; there have been no reports of retraction bulbs, and rather than a gradual
decline in nerve terminal function, the ability to elicit action potentials/EPPs after
nerve stimulation is lost abruptly (Birks, Katz, and Miledi, 1960; Miledi and Slater,
1970; Manolov, 1974; Winlow and Usherwood, 1975; Korneliussen and Jansen,
1976; Riley, 1981; Kawabuchi et al, 1991). However, the techniques employed in
this thesis have not previously been used to investigate Wallerian degeneration of wild
type motor nerve terminals. It is possible that the use of these modern techniques
could reveal similar, but simply more rapid, changes at denervated wild type junctions
to those observed at axotomized Wlds junctions. Thus, degenerating wild type motor
nerve terminals were examined using vital staining and immunocytochemical
techniques. This study confirmed previous reports of Wallerian degeneration at
neuromuscular junctions, and indicated that wild type degeneration appeared to differ
in several ways from nerve terminal withdrawal at axotomized Wlds junctions.
Therefore, this thesis proposes that axotomy of Wlds nerve terminals results in
withdrawal of nerve terminal processes which is dissimilar to wild type degeneration.
Further experiments are required to conclusively affirm this hypothesis. An electron
microscopic study of the ultrastructural changes that occur following axotomy would
reveal the alterations in nerve terminal morphology that lead up to the retraction of
nerve terminal boutons and formation of retraction bulbs. Photoconversion of FM1-43
such as that employed by Betz and colleaugues (1996), to relocate FM1-43 label
ultrastructurally, would prove particularly useful. Further examination of the
physiology of nerve terminal withdrawal, and in particular at vitally stained junctions,
is needed to fully characterise the changes in synaptic efficacy that take place during
the reduction in endplate coverage by the nerve terminal. For instance, how is the
vesicle recycling mechanism affected during withdrawal of nerve terminal boutons?
This question could be addressed by examining the staining and destaining of synaptic
vesicles in axotomized Wlds nerve terminals with FM1-43.
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Assuming that axotomized Wlds withdraw rather than degenerate, how is nerve
terminal withdrawal in axons severed from their cell body regulated, and are there any
similarities between withdrawal of axotomized Wlds nerve terminals and other types
of motor axon withdrawal? The possibility that withdrawal of axotomized Wlds nerve
terminals is similar to the retraction of axon arbours from multiply innervated
junctions during the developmental phenomenon of synapse elimination is discussed in
detail in Chapter 2 (2.4). Motor axons withdraw nerve terminals during synapse
elimination, and morphological studies of this process show that, in a parallel to the
observations of Wlds nerve terminals, nerve terminal withdrawal is progressive and
piecemeal, and results in the formation of a retraction bulbs, which recedes from the
endplate zone (Riley, 1977, 1981; Bixby, 1981; Gorio et al., 1983; Balice-Gordon et
al., 1993). Given that morphologically these processes seem so similar, an experiment
was devised to test the relationship of synapse elimination to the withdrawal of
axotomized Wlds nerve terminals. During synapse elimination, abolishing activity has
the effect of preventing, or in some cases delaying, nerve terminal withdrawal (Benoit
and Changeux, 1975; Pestronk, Drachman and Griffin, 1976; Thompson, Kuffler and
Jansen, 1979; Brown, Hopkins and Keynes, 1982; Caldwell and Ridge, 1983; Taxt,
1983). Botulinum toxin was used to prevent vesicle-associated transmitter release at
Wlds neuromuscular junctions following nerve lesion. The results show that nerve
terminal withdrawal was delayed by 1.14 days, but not prevented. Thus, activity
influences the withdrawal of motor nerve terminal boutons in Wlds mice. These results
imply that there may be some underlying homology between activity-dependent
synapse elimination and nerve terminal withdrawal in Wlds mice. Further experiments
are required to validate this statement. Manipulation of other factors known to affect
nerve terminal withdrawal during synapse elimination should yield further insights into
the similarities between these phenomenon. For instance, addition or removal of
trophic factors such as GDNF (and others), or proteases such as thrombin and its
inhibitor protease nexin 1, at axotomized Wlds motor nerve terminals may reveal an
underlying and homologous fundamental mechanism in synapse withdrawal induced
by different conditions.
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Figure 5.1 outlines one way in which synapse growth, elimination, maintenance, and
withdrawal of axotomized Wlds nerve terminals could be regulated. This model is
based on the supposition that activity can regulate these components of synaptic
plasticity at the neuromuscular junction. It is known that muscle fibres that are not
innervated, or that are paralysed, can release growth promoting trophic factors such
as BDNF and IGF1 and 2 (Funakoshi et al., 1993; Caroni and Schneider, 1994). The
release of these factors may result a change of the local environment such that the
growth of motor axons, and Schwann cells, is promoted (Figure 5.1 A). Thus, absence
of neurotransmitter induced activity in muscle fibres may initiate a change in the local
environment that promotes restoration of function, preventing withdrawal. This is one
mechanism that can account for the delay of nerve terminal retraction in botulinum
poisoned Wlds muscles (see 3.4).
The level of activity strongly influences the process of synapse withdrawal during
synapse elimination (see 3.1.2, Figure 5. IB). A number of reports suggest that more
active nerve terminals at multiply innervated junctions displace less active inputs
(Ridge and Betz, 1984; Ribchester and Taxt, 1983, 1984; Ribchester, 1988; Lo and
Poo, 1991; Dan and Poo, 1992; Dunia and Herrera, 1993; Coleman et al., 1997). An
attractive explanation for this is that more active inputs successfully compete and are
rewarded for a trophic factor, whilst less active inputs receive less of this factor, and
withdraw (see Sanes and Lichtman, 1999). A simplistic interpretation of this theory is
to suppose that activity of a nerve terminal increases both the release of trophic factor
from the muscle fibre (or other cell type), whilst at the same time inducing the
upregulation of trophic factor receptor on its own surface membranes. Such a positive
feedback mechanism would strongly favour more active inputs, which would swiftly
outdistance less active nerve terminals in competitive terms. This mechanism has been
implicated in other neuronal systems (Ghosh et al., 1994; Cabelli et al., 1995; Meyer-
Franke et al., 1995). Alternatively, less active inputs may be 'punished' by a
retrograde factor released from the muscle, again resulting in withdrawal, whilst more
active inputs are protected. Candidate molecules for this mechanism include the
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protease thrombin, and its inhibitor protease nexin-1 (Nelson et al., 1993; Liu et al.,
1994a; Liu et al., 1994b). It is possible that the withdrawal of nerve terminal boutons
at axotomized Wlds neuromuscular junctions are regulated in much the same way
(Figure 5.1C). In this paradigm, the nerve terminal is only weakly active (spontaneous
activity). This induces a change in the local environment resulting in a decline in
trophic factor release, or a decline in the trophic factor receptor expression on the
surface of the axotomized nerve terminal. In addition, the nerve terminal is no longer
supported by protease inhibitors, and proteases released from the muscle cleave the
adhesive bonds that bind the nerve terminal to the neuromuscular junction, resulting in
withdrawal.
Finally, strong and synchronous activity at neuromuscular junctions may promote
synapse maintenance and stability (Figure 5. ID). The level of trophic factor release is
sufficient for the support of the nerve terminal, and the nerve terminal expresses
enough trophic factor receptors to receive this support. The action of proteases is
negligible as the active nerve terminal induces protease inhibitor release.
It is clear that further experiments are needed to elucidate the relationship between
synapse elimination and nerve terminal withdrawal in axotomized Wlds muscles.
Perhaps, although some of the triggers for the withdrawal of nerve terminals may be
different, these processes may share the same basic mechanism.
The role of terminal Schwann cell sprouting following nerve lesion was investigated in
Wlds mice. The fact that Wlds nerve terminals persist for several days following
axotomy provides an interesting paradigm for the study of terminal Schwann cell
reaction to axotomy. In wild type mice, terminal Schwann cells respond to nerve
lesion by extending long sprouts, which are thought to provide a growth substrate for
regenerating axons (Reynolds and Woolf, 1992; Son and Thompson, 1995a,b;
O'Malley, Waran, and Balice-Gordon, 1999). The trigger for terminal Schwann cell
sprouting is as yet unknown. Therefore, it would be interesting to discover how
terminal Schwann cells are influenced by the presence of an intact nerve terminal
following axotomy. The results indicate that terminal Schwann cell sprouting was
delayed in line with the persistence of intact nerve terminals. This implies that, in
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response to axotomy at least, terminal Schwann cell sprouting is prevented by intact
nerve terminals, and the withdrawal of those nerve terminals allows the subsequent
sprouting reaction. Several questions result from this study. For instance, is Schwann
cell sprouting prevented by physical contact, or a signal from intact nerve terminal?
Observations of terminal Schwann cells at axotomized Wlds neuromuscular junctions
indicate that Schwann cell processes, which usually correspond precisely to the shape
of the nerve terminal, retract in a manner identical to that of Wlds nerve terminals.
This suggests that there is a strong relationship between the distribution of Schwann
cell processes and retracting nerve terminal cytoplasm. Such a relationship exists
between withdrawing nerve terminals and Schwann cells during developmental
synapse elimination. Further investigation into the precise overlap between retracting
nerve terminals and Schwann cell processes is needed to verify this at axotomized
Wlds neuromuscular junctions. In particular, a multiply staining preparation, enabling
visualisation of acetylcholine receptors, nerve terminal, and terminal Schwann cell
simultaneously, would elucidate the interactions between these three cell types at the
neuromuscular junction. Unfortunately, although this was attempted, it is technically
challenging to prepare multiply stained neuromuscular junctions, and was beyond the
scope of this thesis. The effect of delaying nerve terminal withdrawal, such as by
botulinum toxin administration, would also further our current knowledge of the
relationship between withdrawing nerve terminals and Schwann cells.
Further investigation into the precise nature of the Wld mutation should prove
beneficial to many fields of study. It is important to understand the precise nature of
Wallerian degeneration, and this may become possible with the characterisation of the
Wld mutation. Such knowledge may aid in the therapeutic treatment of many neuronal
degenerative disease states. Interestingly, the withdrawal of Wlds nerve terminals
resembles that observed in a murine model of progressive motor neuron disease
(Haase et al., 1997). Finally, elucidation of the precise mechanism of motor nerve
terminal withdrawal in C57BLAVlds mice may yield insights into other withdrawal
phenomena that take place during synapse development, maintenance and repair.
In sum, this thesis demonstrates that there may be fundamental differences between
Wallerian degeneration of motor nerve terminals in wild type mice and axotomy-
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induced changes that take place in C57BLAVlds mice. Wlds motor nerve terminals
undergo progressive synapse disassembly and withdrawal, which is influenced by
neurotransmitter release. In addition, terminal Schwann cell sprouting is delayed.
The fact that this thesis may have raised more questions than it has answered reflects
the complexity of the issues surrounding motor nerve terminal withdrawal, and the
paucity of our current knowledge of axotomy-induced phenomena in C57BL/Wlds
mice. Many of the results obtained in this study were unexpected, and further
investigation of C57BL/Wlds mice may clarify our understanding of the mechanisms
involved in nerve terminal withdrawal.
To conclude, the findings of this thesis suggest a re-examination of the phenomenon
of slow Wallerian degeneration of severed distal axons in C57BL/Wlds mice.
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FIGURE 5.1: MECHANISMS OF SYNAPSE FORMATION, WITHDRAWAL AND
MAINTENANCE.
A schematic to illustrate mechanisms by which activity may influence the plasticity of
neuromuscular synapses.
A. Growth-promoting state. Absence of axon-derived activity over the neuromuscular junction
results in the upregulation and/or release of factors responsible for the promotion of functional
innervation. Such a state may exist during development, or regeneration following nerve
lesion, before axons form neuromuscular synapses. Alternatively, inactivity produced by
botulinum toxin application, or another type of activity blockade, may result in this state.
Competitive interactions leading to synapse withdrawal are suppressed.
B. Disparate activity state - synapse elimination. Multiply innervated junctions are
asynchronously active. More active axons successfully compete with less active nerve
terminals, resulting in the weakening and retraction of the less active input. Thus, activity
rewards the more active input, whilst the less active or efficacious input is removed.
C. Weak activity - synapse withdrawal. As with synapse elimination, inconsistent and weak
activity results in the withdrawal of axon arbours from the neuromuscular junction.
Inefficacious release of neurotransmitter disrupts the fine balance of factors responsible for
synapse maintenance, resulting in a local environment which no longer supports the presence
of the nerve terminal. This activates the molecular and cellular machinery responsible for
synapse withdrawal.
D. Efficacious activity - synapse maintenance. Synchronous and persistently efficacious
activity at the neuromuscular junction results in stable innervation, regulated by a fine
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